Toxicological effects of nanoparticle deposition in the liver by Modrzynska, Justyna
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 30, 2019
Toxicological effects of nanoparticle deposition in the liver
Modrzynska, Justyna
Publication date:
2018
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Modrzynska, J. (2018). Toxicological effects of nanoparticle deposition in the liver. Kgs. Lyngby, Denmark:
Technical University of Denmark.
  
 
 
 
 
Toxicological effects of nanoparticle deposition 
in the liver 
 
 
 
 
 
 
 
 
 
 
Justyna Modrzyńska                            
PhD Thesis                                      
October 2017 
PhD thesis by Justyna Modrzyńska 
October 2017 
 
 
 
 
 
Toxicological effects of nanoparticle deposition in the 
liver 
 
 
 
 
 
 
 
 
Research Group for Risk-Benefit, National Food Institute, Technical University of 
Denmark 
National Research Centre for the Working Environment, Denmark 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per aspera ad astra –  
                                                                                                                      Przez trudy do gwiazd 
  
SUPERVISORS  
 
Principal supervisor 
Senior Researcher Gitte Ravn-Haren 
National Food Institute, Technical University of Denmark 
Research Group for Risk-Benefit 
 
Co-supervisors: 
Professor Ulla Birgitte Vogel 
National Research Centre for the Working Environment, Denmark 
 
Senior Researcher Anne Thoustrup Saber 
National Research Centre for the Working Environment, Denmark 
 
Senior Researcher Katrin Löschner 
National Food Institute, Technical University of Denmark 
Research Group for Nano-Bio Science 
 
Former supervisors: 
Alicja Mortensen, PhD  
National Research Centre for the Working Environment, Denmark  
 
Erik Huusfeldt Larsen, PhD 
National Food Institute, Technical University of Denmark 
 
 
 
 
 
 
© Justyna Modrzyńska, 2017 
5 
 
PREFACE AND ACKNOWLEDGEMENTS  
It’s been a long and challenging journey and here, I would like to express my sincere gratitude to 
many people that have contributed to this PhD work – I would have never accomplished the aims 
if it wasn’t for you! 
Great thanks to my main supervisor - Gitte Ravn-Haren - who made the last few months of the 
PhD work much easier. Thank you for your invaluable support, friendship and, most importantly, 
for your incessant faith in my ability to finish this task. You were always there for me, even when 
I thought I didn’t need your assistance and I am not sure if I could ever pay you back! 
Ulla Vogel – thank you that you believed in me and gave me the opportunity to become a part of 
the scientific world. Things were not always as we wanted and expected, but you always had time 
and never-ending enthusiasm, and you left your door open for both the trivial and clever 
questions. You have challenged me and it resulted in the development of a new, matured 
scientist.  
Anne Thoustrup Saber – you were my anchor at NFA and my “role model” of a wise researcher 
and dedicated mother. Thank you for both professional and everyday-life advices, fruitful 
discussions and positive atmosphere coming along with a warm smile whenever I needed. 
Katrin Löschner – thank you for the trip to the world of tricky analytical chemistry analysis. For 
your countless great ideas of how to solve the next insolvable problem, sharing your knowledge 
and for your patience although it was not always so easy.  
I would like to express my special thanks to Erik Huusfeldt Larsen who was my co-supervisor 
and who is now enjoying non-academia life. You mesmerized me with the analytical chemistry 
and its power in the world of nano as well as provided me with the tools I needed to complete my 
PhD. It has been fantastic to be part of your research group and I really missed our collaboration.  
Alicja Mortensen – thank you for your valuable input and constructive comments that improved 
this thesis, all the efforts and good laughs that we had during the whole period.  
6 
 
This work would never be possible without the excellent laboratory and technical support. 
Therefore, I would like to thank Annette Landin, Sarah Grundt Simonsen, Anne-Marie Ørngreen, 
Maja Danielsen and other technicians from DTU for your priceless help in conducting animal 
experiments. Many thanks to Birgitte Koch Herbst, Marianne Hansen and Rie Romme Rasmussen, 
also from DTU, that have introduced the ICP-MS enigma to me. Last but not least, I would like to 
send warm acknowledgements to Anne-Karin Asp, Anne Abildtrup, Michael Guldbrandsen, 
Zdenka Orabi Kyjovska, Lourdes Pedersen and Elzbieta Christiansen from NFA for their 
assistance and help that have been worth a lot. I have learnt so much from you all and I will 
definitely use this knowledge in my future career.  
I would also wish to thank all my colleagues from both DTU and NFA, for the inspiring 
conversations and for the opportunity to share ups and downs of the young scientist life. 
Finally, I want to send my deep gratitude to my family. To my little daughter Hanna, for being my 
sunshine in the cloudy days and the best achievement in my life. You are an inexhaustible source 
of pure joy and happiness that makes my life better and complete. To my son Antoni, for being 
the biggest motivation to finalize this thesis. And, eventually, to my beloved husband Kuba, for 
being my best friend, always with me whenever I needed. You are constantly one step ahead, 
serving with help and support. Thank you for all you did and all you will do. 
The work presented in this thesis was conducted at the Technical University of Denmark, 
National Food Institute, in the Research Group for Risk-Benefit and in the Research Group for 
Nano-Bio Science and at the National Research Centre for the Working Environment. The project 
started on the 1st of September 2012, was prolonged by the sick and maternity leaves, and the 
final thesis was handed in October 2017. The work was financially supported by The Danish 
Centre for Nanosafety (grant no. 20110092173-3) from the Danish Working Environment 
Research Foundation. 
Justyna Modrzyńska 
October 2017 
7 
 
TABLE OF CONTENT 
 
PREFACE AND ACKNOWLEDGEMENTS ...................................................................................................................................... 5 
SUMMARY................................................................................................................................................................................................. 9 
DANSK RESUMÉ .................................................................................................................................................................................. 12 
LIST OF ABBREVIATIONS ............................................................................................................................................................... 15 
1. INTRODUCTION ............................................................................................................................................................................. 19 
1.1 Nanoparticles – two-faced materials ............................................................................................................................. 19 
1.2 Biodistribution of administered particles ................................................................................................................... 21 
1.2.1 Biodistribution of inhaled NPs ................................................................................................................................. 21 
1.2.2 Biodistribution of ingested NPs ............................................................................................................................... 23 
1.2.3 Biodistribution of injected NPs ................................................................................................................................ 23 
1.3 Adverse health effects upon exposure to NPs ............................................................................................................ 25 
1.3.1 Pulmonary inflammation ........................................................................................................................................... 25 
1.3.2 Acute phase response .................................................................................................................................................. 26 
1.3.3 Particle-induced genotoxicity ................................................................................................................................... 27 
1.3.4 Histopathological alterations of liver and lung tissues .................................................................................. 29 
1.4 Liver as an important endpoint in particle toxicity ................................................................................................. 30 
1.4.1 Liver structure and functions ................................................................................................................................... 30 
1.4.2 Kupffer cells – essential role in NP clearance .................................................................................................... 31 
1.4.3 NP-induced hepatotoxicity ........................................................................................................................................ 32 
2. HYPOTHESES AND AIMS ............................................................................................................................................................ 33 
3. MATERIALS AND METHODS ..................................................................................................................................................... 35 
3.1 Characterization of particles used in the present study ........................................................................................ 35 
3.1.1 Titanium dioxide (TiO2) .............................................................................................................................................. 35 
3.1.2 Cerium oxide (CeO2) ..................................................................................................................................................... 36 
3.1.3 Carbon black (CB) .......................................................................................................................................................... 36 
3.2 Animal model and exposure routes................................................................................................................................ 37 
3.2.1 C57BL/6 mice ................................................................................................................................................................. 37 
3.2.2 Exposure routes for NP administration ............................................................................................................... 37 
3.3 Methods and techniques used in the present study ................................................................................................ 38 
8 
 
3.3.1 Particle size determination by dynamic light scattering............................................................................... 39 
3.3.2 Determination of NP presence in biological tissues ........................................................................................ 40 
3.3.2.1 CytoViva® Enhanced Darkfield Hyperspectral Microscopy .................................................................................... 40 
3.3.2.2 Inductively coupled plasma mass spectrometry ........................................................................................................... 40 
3.3.2.3 Single particle inductively coupled plasma mass spectrometry ............................................................................ 41 
3.3.3 Assessment of particle-induced toxicity .............................................................................................................. 42 
3.3.3.1 BAL fluid cellular composition – assessment of pulmonary inflammation ....................................................... 42 
3.3.3.2 Comet assay – assessment of genotoxicity ....................................................................................................................... 42 
3.3.3.3 Real time RT-PCR – assessment of pulmonary and hepatic acute phase response induction .................. 43 
3.3.3.4 Brightfield microscopy – assessment of particle-induced histopathological changes ................................. 44 
3.3.3.5 DCFH-assay – assessment of ROS generation ability exhibited by NPs .............................................................. 45 
3.3.3.6 Haematology and biochemistry – assessment of general biomarkers for particle-induced toxicity ..... 45 
4. SUMMARY OF RESULTS .............................................................................................................................................................. 47 
4.1 Manuscript 1 ............................................................................................................................................................................ 47 
4.2 Manuscript 2 ............................................................................................................................................................................ 50 
4.3 Manuscript 3 ............................................................................................................................................................................ 52 
5. DISCUSSION ..................................................................................................................................................................................... 54 
5.1. Experimental set-up............................................................................................................................................................. 54 
5.2 Biological implications following exposure to NPs .................................................................................................. 58 
6. CONCLUSIONS AND PERSPECTIVES ..................................................................................................................................... 78 
REFERENCES ........................................................................................................................................................................................ 81 
MANUSCRIPT 1 ................................................................................................................................................................................. 105 
MANUSCRIPT 2 ................................................................................................................................................................................. 127 
MANUSCRIPT 3 ................................................................................................................................................................................. 145 
 
  
9 
 
SUMMARY 
A number of studies have demonstrated that pulmonary exposure to nanoparticles (NPs) by 
inhalation or intratracheal instillation leads to size-dependent accumulation of particles and 
causes adverse pulmonary effects including, among others, inflammation, induction of acute 
phase response and histopathological alterations of the lung tissue. Upon deposition in the 
respiratory tract particles appear to translocate readily across the alveolar epithelium, through 
interstitium and further into systemic circulation getting access to the extrapulmonary sites and 
reaching various distant organs. The degree of translocation strongly depends on particles size, 
chemical composition, solubility, shape, surface properties etc. A portion of lung-deposited 
particles could also be transported up into the pharynx by the mucociliary escalator and when 
swallowed, cause secondary exposure via gastrointestinal tract (GIT). Liver, among other 
secondary organs, seems to be the major tissue for sequestration of extrapulmonary-translocated 
NPs. When particles reach the liver, they accumulate in the Kupffer cells, residence liver 
macrophages, from where their clearance is protracted. It has been shown that particles were 
still present in the liver 6 months after exposure. Prolonged hepatic accumulation of NPs raises 
questions about the possible acute and long-term toxicological consequences.  
Deposition of NPs in the liver makes it very susceptible to many diseases and causes disturbances 
in its normal functioning. Our research group has previously demonstrated that inhalation and 
intratracheal instillation of CB Printex 90 and TiO2 NPs induced genotoxicity in terms of 
increased DNA strand break levels and increased levels of oxidative DNA damage in the liver 
tissue. Moreover, recent epidemiological studies indicated association between exposure to 
particulate air pollutions and development of liver cancer.  
This PhD aimed at investigating toxicological effects of NP accumulation in the liver. We have 
decided to focus primarily on NP-elicited genotoxicity, inflammation, acute phase response as 
well as evaluating several other systemic endpoints including histopathology of lung and liver 
tissue, general liver biochemistry and haematology. Extrapulmonary translocation and liver 
deposition were also assessed in the study. Close attention was given to the nature of NP-induced 
genotoxicity observed in the liver tissue – whether it is caused by the presence of translocated 
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particles or by indirect effects of inflammation and acute phase response in the lungs that could 
trigger production of secondary messengers and, in turn, induce secondary genotoxicity in the 
liver tissue. Moreover, potential contribution from the secondary oral exposure could also result 
in the observed genotoxic effect.  
To achieve the aims 324 young adult C57BL/6 female mice were exposed by single intratracheal 
instillation (IT), intravenous injection (IV) and oral gavage (PO) to 162 μg/mouse of titanium 
dioxide (TiO2), cerium oxide (CeO2) or carbon black (CB) NPs and terminated 1, 28 and 180 days 
post-exposure.  
In Manuscript 1 we investigated liver deposition of TiO2 and CeO2 NPs following IT, IV and PO 
exposure. Our results indicated similar extrapulmonary translocation of both particles to the 
liver following IT exposure. Despite different chemical composition, shape and potential 
differences in solubility that could affect hepatic accumulation calculated translocation rates for 
TiO2 and CeO2 NPs were comparable and stood at 1.24 ± 1.98 % and 2.87 ± 3.37 %, respectively 
of the initial pulmonary dose. No NPs were detected in the liver following oral gavage which 
indicates that the main translocation route for pulmonary-deposited NPs is the translocation via 
systemic circulation and that secondary oral exposure did not contribute to the observed liver 
deposition. Moreover, analysis of size distribution of CeO2 NPs revealed that they underwent in 
vivo-induced size transformation over time both in lung and liver tissue.  
In order to extend the knowledge in understanding the mechanism responsible for the hepatic 
genotoxicity (i.e. primary or secondary NP-driven genotoxicity) in Manuscript 2 we evaluated 
induction of pulmonary inflammation, pulmonary and hepatic acute phase response and 
genotoxicity following exposure to TiO2, CeO2 and CB NPs. Indications of presence of all three NPs 
in the liver following IT and IV exposure were found. We observed increased number of DNA 
strand breaks in the liver after IT and IV exposure to CB NPs but not after exposure to TiO2 or 
CeO2. Pulmonary inflammation was observed for all three NPs on day 1 and day 28 following IT 
exposure. Pulmonary acute phase response was also detected for all nanomaterials and lasted up 
to day 180. Induction of hepatic acute phase response was transient and measurable only on day 
1 in IT and IV exposed groups to TiO2 and CeO2 NPs. In contrast to TiO2 and CeO2 NPs, only CB 
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NPs generated reactive oxygen species (ROS) in an acellular assay. In a holistic view our data 
indicate that DNA damages in the liver tissue are likely caused by the direct effects of 
translocated CB NPs and further production of ROS rather than by systemic inflammation and 
acute phase response.  
In Manuscript 3 we assessed various blood markers, liver biochemical parameters, analyzed 
changes in body as well as in liver weight, and performed histopathological evaluation of liver 
and lung tissue in order to determine potential consequences of (prolonged) accumulation of NPs 
in the liver. We did not observe any significant alterations in mice body weights at any of the 
analyzed time points. Moreover, exposure to CeO2 and CB NPs did not induce changes in the liver 
weight. Oral exposure to TiO2 decreased absolute and relative liver weight but it was regarded as 
a chance finding. Haematological analysis of blood revealed occasional and negligible alterations 
of a few markers. No changes in the selected biochemical parameters were measured. 
Histopathological examination of the liver tissue revealed high inflammatory background in all 
vehicle and NP-exposed groups regardless the administration route and it was impossible to 
determine whether these changes were treatment-related. Similarly, necrotic changes could not 
be uniquely associated with the treatment. In general, we concluded that neither IT, IV nor PO 
exposure to TiO2, CeO2 or CB NPs induced any significant systemic or hepatotoxic effects.  
Overall, collected data suggest that liver is an important endpoint in the assessment of NP safety 
and more studies will enable broadening the knowledge and clarify whether NPs pose a liver-
threat. 
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DANSK RESUMÉ 
En række undersøgelser har vist, at eksponering af lunger for nanopartikler (NP’er) fører til 
størrelsesafhængig partikelakkumulering og forårsager skadelige effekter i lungerne, herunder 
inflammation, opregulering af akutfaseresponset og histopatologiske forandringer. Efter 
deponering i luftvejene translokerer NP’erne over i kredsløbet, hvorfra de kan nå andre organer. 
Graden af translokation afhænger af partikelstørrelse, kemisk sammensætning, opløselighed, 
form, overfladeegenskaber mv. Leveren synes at være det primære organ, hvor sekvestrering af 
translokerede NP'er finder sted. De akkumulerer i Kupffer-celler, leverens specialiserede 
makrofager, hvorfra deres clearance er langsommelig. Langvarig ophobning af NP'er i leveren 
rejser spørgsmål om mulige akutte og langsigtede toksikologiske effekter af NP’er. 
Formålet med denne ph.d. var at undersøge mulige toksikologiske effekter af NP'ers 
akkumulering i lever med primært fokus på genotoksicitet, inflammation, akutfaserespons, samt 
andre systemiske end-points, histopatologi af lunge- og levervæv, leverenzymaktiviteter og 
hæmatologi. Ekstrapulmonær translokation og leverdeponering blev ligeledes vurderet. Særlig 
opmærksomhed blev givet til typen af NP-induceret genotoksicitet observeret i leveren - om den 
skyldes tilstedeværelsen af translokerede partikler eller indirekte virkninger af inflammation og 
akutfasespons i lunger, der kunne udløse produktion af sekundære messengers og dermed 
fremkalde sekundær genotoksicitet i levervæv. 
Ialt 324 yngre voksne C57BL/6 hunmus blev eksponeret for en enkelt dosis vehikel eller 162 
μg/mus af titandioxid (TiO2), ceriumoxid (CeO2) eller carbon black (CB) NP'er ved enten 
intratracheal instillation (IT), intravenøs injektion (IV) eller oral gavage (PO). Aflivninger fandt 
sted 1, 28 eller 180 dage efter eksponering. 
I Manuskript 1 undersøgte vi leverdeponering af TiO2 og CeO2 NP'er efter IT og PO eksponering. 
Vores resultater indikerede sammenligneligt niveau of translokation af begge typer partikler til 
leveren efter IT-eksponering på trods af forskellig kemisk sammensætning, form og mulige 
forskelle i opløselighed. Beregnede lever mængder af NP’er var for TiO2 og CeO2 NP'er var 
henholdsvis 1.24 ± 1.98 % og 2.87 ± 3.37 %. Der blev ikke påvist nogen NP'er i leveren efter oral 
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dosering, hvilket indikerer, at NP’er deponeret i lunger primært translokerer via det systemiske 
kredsløb, og at sekundær oral eksponering ikke bidrager til den observerede leverdeponering. 
Desuden viste analysen af størrelsesfordeling af CeO2 NP'er, at de gennemgik in vivo-induceret 
størrelsestransformation og blev mindre over tid både i lunge- og levervæv. 
For at undersøge mekanismen bag levergenotoksiciteten (dvs. om der er tale om primær eller 
sekundær NP-drevet genotoksicitet) evaluerede vi i Manuskript 2 om eksponering for TiO2, 
CeO2 eller CB NP’er forårsagede pulmonær inflammation, inducerede akutfaserespons eller 
genotoksicitet i lunge og lever. Vi fandt indikationer på tilstedeværelse af alle tre NP'er i leveren 
efter IT- og IV-eksponering. Vi observerede øget antal DNA-strengsbrud i leveren efter IT- og IV-
eksponering for CB-NP'er, men ikke efter eksponering for TiO2 eller CeO2. Pulmonær 
inflammation blev observeret for alle tre NP'er på dag 1 og dag 28 efter IT-eksponering. 
Pulmonær akutfasespons blev også påvist for alle nanomaterialer og varede op til dag 180. TiO2 
og CeO2 NP’er inducerede et forbigående og målbart hepatisk akutfasespons på dag 1 i IT- og IV-
eksponerede grupper. Kun CB NP'er genererede reaktive oxygen forbindelser (ROS) i et 
acellulært assay. Dette indikerer, at DNA-skader i leveren sandsynligvis skyldes direkte 
påvirkninger af translokerede CB-NP'er og dannelsen af ROS, og ikke systemisk inflammation og 
akutfaserespons. 
I Manuskript 3 undersøgte vi forskellige blodmarkører og leverenzymaktiviteter, analyserede 
ændringer i krops- og levervægte og udførte histopatologisk evaluering af lever- og lungevæv for 
at bestemme mulige virkninger af (langvarig) ophobning af NP'er i leveren. Vi observerede ikke 
nogen signifikante ændringer i kropsvægt. Endvidere påvirkede eksponering for CeO2 og CB 
NP'er ikke levervægt. Oral indgift af TiO2 reducerede absolut og relativ levervægt, men dette fund 
betragtet som et chancefund. Hæmatologisk analyse af blod afslørede lejlighedsvise og 
ubetydelige ændringer af nogle få markører. Ingen ændringer i leverenzymaktiviteter blev målt. 
Histopatologisk undersøgelse af levervæv afslørede høj baggrundsinflammation hos alle vehikel- 
og NP-eksponerede grupper uanset administrationsvej, og derfor var det umuligt at afgøre, om 
observerede forandringer hos NP-doserede dyr kan relateres til behandlingen. På samme måde 
kunne nekrotiske forandringer ikke entydigt tilskrives behandlingen. Vi konkluderer, at hverken 
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IT, IV eller PO eksponering for TiO2, CeO2 eller CB NP'er inducerer signifikante systemiske eller 
hepatotoksiske effekter. 
Samlet set tyder de indsamlede data på, at leveren er et vigtigt målorgan i vurderingen af NP'er, 
og flere undersøgelser vil gøre det muligt at udvide kendskabet til NP'er og afklare, om de udgør 
en reel trussel mod leveren. 
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LIST OF ABBREVIATIONS 
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1. INTRODUCTION 
1.1 Nanoparticles – two-faced materials 
The sub micrometer scale, better known as a nanometer scale, offers new and unique properties 
to everyday consumer and industrial products. Manmade NPs are widely used in virtually every 
sector including manufacturing of sporting goods, tires, stain-resistant clothing, sunscreens, 
cosmetics, electronics and more and more often in the food sector (as food additives, dietary 
supplements or in food packaging) and in medicine (as drug-delivery agents or for diagnostic and 
imaging purposes) [1,2].  
The Royal Society of London defined the term ‘nanoscience’ as follow: 
“Nanoscience is the study of phenomena and manipulation of materials at atomic, molecular and 
macromolecular scales, where the properties differ significantly from those at larger scale” [3]. 
Indeed, unique properties exhibited by NPs are attributed to their small size and relatively large 
surface area. Other physicochemical features of NPs that allow seemingly infinite applications 
and that distinguish them from their bulk counterparts are unusual surface structure, solubility, 
shape, aggregation and chemical composition [1]. Although, mankind has been exposed to 
airborne nanosized particles for centuries due to volcanic activities, forest fires, fine sand, 
disintegration of meteorites entering the atmosphere or cosmic dust, recent development of 
nanotechnology has led to augmented human exposure [4].  
On the one hand, the exceptional properties possessed by engineered nanomaterials offer novel 
potential and beneficial applications unavailable up to now. On the other hand, widespread use in 
the consumer products and lack or limited knowledge of toxicological effects of nano-scale 
products continuously rising concern about general safety of nanomaterials and unpredictable 
health consequences.  
As a matter of fact, several studies demonstrated association between particle exposure and 
increased incidence of different adverse effects on biological systems at the organismal, cellular, 
subcellular and, eventually, genomic and protein level. Moreover, particle ability to readily 
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translocate from the site of exposure to various distant organs exacerbates potential deleterious 
effects [1].  
Numerous epidemiological investigations showed positive correlation between exposure to 
ambient particulate matter and increased morbidity and mortality attributed to cardiovascular 
diseases [5]. Furthermore, constant exposure to air pollution results in respiratory tract 
disorders such as asthma or lung cancer [6,7]. Recently, animal studies demonstrated that air 
pollutants are able to induce liver toxicity and cause liver inflammation and steatosis [8].  
In the present work, the main focus will be on particle biodistribution and subsequent biological 
effects induced by exposure and further deposition of NPs with a special consideration of the 
liver outcomes.  
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1.2 Biodistribution of administered particles 
Increased production of NP-containing products will inevitably result in augmented human 
exposure. Since NPs due to their unique properties are widely used in different fields many 
possible routes of accessing human body exist. NPs could either enter the body by inhalation 
(NPs present in the ambient air and/or in the workplace), ingestion (dietary supplements, food 
or water containing NPs) or injection (medical usage of nanomaterials for drug delivery or 
diagnostic). 
Dermal exposure is also one of the most frequent routes of NP administration, but since it was 
not included in this study, it will not be further discussed. 
1.2.1 Biodistribution of inhaled NPs 
2300 km of airways, 500 million alveoli and 75-140 m2 of surface area. These magnificent 
numbers characterize human lungs (as reviewed in: [9]). Lungs are in a continuous contact with 
the ambient environment and therefore pulmonary exposure is considered as the most relevant 
administration route for particles present both at the home address as well as in the occupational 
environment. Deposition pattern of inhaled particles strongly depends on particle size: large 
particles are mainly deposited in the upper airways (nasal, pharyngeal and laryngeal regions) 
while smaller particles penetrate deeper pulmonary regions with a subsequent deposition in 
tracheobronchial and alveolar regions [4,10]. In order to keep mucosal surface free of particles 
they are cleared from the respiratory tract via two clearance pathways: physical translocation 
and chemical clearance mechanisms. Chemical clearance refers only to biosoluble particles or 
soluble particle constituents whereas physical translocation involves several diverse processes 
that are particle-size-dependent and characteristic only for specific regions of the respiratory 
tract (Fig. 1). 
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Figure 1. Different clearance pathways of deposited particles from the respiratory tract. AM – alveolar 
macrophages, GIT – gastrointestinal tract (modified from [4]). 
Physical clearance mediated by alveolar macrophages is the most prominent way of removing 
particles deposited in the alveolar region. Chemotactically attracted macrophages phagocyte the 
foreign material and gradually move it towards the mucociliary escalator, prevalent clearance 
mechanism in the upper airways, that transports particles away from the lungs [4,9]. Mucus, with 
the internalized particles, is moved by the action of the ciliated cells to the pharynx and, if 
swallowed, could induce secondary exposure via GIT [2,9]. Particles could also be excreted 
through the mouth [11] and removed by coughing [12]. Several studies conducted over the last 
few decades [13–16] indicated that larger particles could be retrieved with the macrophages by 
the lavage procedure, while the vast majority of small particles (ultrafine particles, UFPs) 
retained in the lungs. This indicates that UFPs are able to translocate through the epithelial cell 
layer to the interstitium and further to the extrapulmonary sites by blood circulation [4]. Large 
surface area of the alveoli together with less than 400 nm distance between alveolar lumen and 
the blood capillaries establish favorable conditions for accessing systemic circulation [9]. Several 
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secondary tissues are the target sites of extrapulmonary translocated NPs, however, liver seems 
to be one of the major organs that sequestrates circulating particles [13,17–21]. Neuronal uptake 
of inhaled particles was also demonstrated [22,23].  
1.2.2 Biodistribution of ingested NPs 
Gastrointestinal tract (GIT), next to lung and skin, is an important portal of entry for particles 
present in water, food (as food additives), drugs or cosmetics (e.g. toothpaste). Moreover, inhaled 
particles cleared from the lungs by the action of ciliated cells could be swallowed and thereby 
induce GIT exposure. Most of the studies that investigated the uptake of particles demonstrated 
negligible or lack of absorption of the tested materials from the GIT [24–28]. In a quantitative 
biokinetic study of TiO2 after oral application most of the gavaged [48V]TiO2 NPs were excreted 
via feces while only a small fraction of the material (0.6 % after 1 h and about 0.05 % after 7 
days) bestrode intestinal barrier and was absorbed by the liver, lungs, kidney, brain, spleen, 
uterus and skeleton [29]. On the other hand, a significant increase in Ti concentration was 
reported in the liver and kidney of female CD-1 (ICR) mice exposed to 80 nm TiO2 NPs by single 
oral gavage and in kidney of mice exposed to 25 nm TiO2 NPs 14 days post exposure [25]. 
Conflicting results are very likely due to the differences in the used doses as well as type, size and 
phase of studied NPs. The mechanism of NP absorption from the GIT is poorly understood but the 
role of Peyer’s patches (PP, aggregations of intestinal lymphatic tissue) containing M-cells 
(specialized phagocytic enterocytes) as well as contribution of normal enterocytes in particle 
uptake was suggested [2,30–32].  
1.2.3 Biodistribution of injected NPs 
Nowadays, NPs are commonly used in so called ‘nanomedicine’ as contrast agents, carriers for 
drugs and gene delivery agents [33]. Many of these applications require direct administration of 
NPs into systemic circulation. Biodistribution of NPs following intravenous injection is influenced 
by myriad factors including size and shape of particles, surface properties or morphology of the 
blood vessel endothelium. Moreover, upon accessing the systemic circulation NPs are 
surrounded by different blood proteins (in a process called ‘opsonization’) that could determine 
cellular uptake of particles by specific types of cells only [34,35]. Selected opsonins (e.g. the 
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complement proteins, IgG and laminin) can be absorbed on the surface of NPs. This allows for 
quicker recognition of the foreign material by immune cells of the mononuclear phagocytic 
system, like macrophages, and results in faster phagocytosis of particles from the blood stream 
[34,36]. Liver, spleen, lymph nodes and bone marrow, collectively make up the 
reticuloendothelial system (RES, also known as the monocyte–macrophage cell system) thus 
particles recognized and removed by macrophages are primary deposited in the organs of RES 
[34]. Essential role of Kupffer cells, resident macrophages localized in the liver, in NP clearance 
was previously reported [37]. The width of splenic inter-endothelial cell slits that aims at filtering 
old or damaged red blood cells is approximately 200 nm therefore larger particles are most likely 
taken up by the spleen [34]. In addition to the hepatic and splenic clearance, NPs can be excreted 
in kidneys by glomerular filtration however, the specific size-dependent mechanism of renal 
clearance prevents urinary excretion of particles larger than 8 nm [38].  
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1.3 Adverse health effects upon exposure to NPs 
As shown in numerous studies, NPs can pass through various defence mechanisms of the human 
body and be distributed to the secondary organs, distant from the exposure site. However, many 
details concerning interactions between NPs and biological systems remain unknown. Presence 
of NPs in the body may cause adverse health effects such as inflammation, acute phase response, 
genotoxicity as well as severely alter physiological structure and function of the affected tissues.  
1.3.1 Pulmonary inflammation 
Lungs are constantly exposed to air that contains a wide range of pollutants including respirable 
particles and therefore, efficient mechanisms that protect the host from the invading foreign 
materials must exist. Epithelial cells and alveolar macrophages (AM) play a pivotal role in a 
surveillance of the respiratory tract. Epithelial cells are capable of synthesizing of various 
inflammatory mediators, e.g. interleukin-8 (IL-8), that chemotactically attract phagocytic cells to 
the site of particles invasion (hence suggesting an important role of epithelial cells in particle-
induced inflammation) [39]. AM are resident lung macrophages which major job is phagocytosis 
of opsonised and non-opsonised particles. Toll-like receptors (TLRs) on the surface of 
macrophages are responsible for the recognition of invading pathogens. Upon activation, AM play 
a crucial pro-inflammatory role by secreting different cytokines and other mediators that 
orchestrate a cascade of immune response [40]. Among all secreted cytokines that initiate the 
inflammatory process, tumor necrosis factor α (TNF-α) seems to be the most prominent agent. 
Bioactivity of TNF-α includes inducement of adhesion molecule expression, stimulation of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) production by leukocytes and, 
most importantly, stimulation of the production of other pro-inflammatory cytokines, i.e. 
interleukin-1 (IL-1), interleukin-6 (IL-6), platelet-derived growth factor (PDGF) and transforming 
growth factor α (TGF-α) that further propagate the immune response [41].  
Augmented release of cytotoxic mediators such as ROS and RNS by activated macrophages can 
lead to oxidative stress and result in oxidative DNA damage and subsequent genotoxicity [39,42]. 
Moreover, sustained inflammation is associated with the induction of fibrosis and carcinogenesis 
[39].  
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1.3.2 Acute phase response 
Many previous studies demonstrated that pulmonary inflammation caused by exposure to NPs is 
associated with the induction of acute phase response [43–46]. 
The acute phase response is an orchestrated, systemic response (part of the innate immune 
system) that is triggered by different stimuli: trauma, tissue injury, inflammation, infection, stress 
or neoplasia [47]. Several different proteins, collectively known as acute phase proteins, are 
secreted into plasma in order to restore the body homeostasis. We can distinguish both positive 
acute phase proteins whose concentrations increase (like serum amyloid A – SAA, c-reactive 
protein – CRP, haptoglobin, ceruloplasmin, fibrinogen, and constituents of the complement 
system), as well as negative acute phase proteins (albumin, transferrin, factor XII, insulin-like 
growth factor and others) whose concentrations decrease during the acute phase response [48]. 
Acute phase proteins are predominantly produced by the liver hepatocytes [47]. 
The acute phase response is individually moderated and different plasma concentrations of acute 
phase proteins in patients with similar disorders could exist. It is believed, that those disparities 
are caused by differences in the production of specific cytokines, intercellular signaling 
polypeptides, that govern the response [48]. Cytokines are important mediators produced by 
different types of activated cells (monocytes, macrophages, fibroblasts, endothelium, platelets, 
keratinocytes, T cells) and their major role is to modulate and regulate the immune response in 
order to restore and maintain internal stability by the recruitment of inflammatory cells from 
systemic circulation and by inducing production of other cytokines [47,49,50]. The key-cytokines, 
that play an essential role in the production of acute phase proteins are: interleukin-6 (IL-6), 
interleukin-1β (IL-1β), tumor necrosis factor α (TNF-α), interferon-γ (IFN-γ), transforming 
growth factor β (TGF-β) and interleukin-8 (IL-8). Stimulation of the production of acute phase 
proteins such as SAA, CRP, complement C3, haptoglobin (in rats) is induced by IL-1-like 
cytokines, which include IL-1α, IL-1β, TNF-α and TNF-β. Whereas fibrinogen, human haptoglobin, 
α1-antichymotrypsin, α1-antitrypsin, and α2- macroglobulin (rat) are induced by IL-6-like 
cytokines which comprise IL-6 and its family members [51]. In the production of acute phase 
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proteins cytokines could act in a cascade or in a network, stimulating (inhibiting or enhancing,) 
other cytokines to forward the biological message [48]. 
Serum amyloid A (SAA), a multifunctional apolipoprotein, is one of the major acute phase 
proteins. Plasma SAA concentration could be increased up to 1000-fold during the acute phase 
response. In humans, there are four isoforms of the SAA gene: SAA1 and SAA2 that are acute 
phase response-hyperinducible, SAA3 that is a pseudogene and SAA4 that is expressed 
constitutively [49]. In mice five members of the SAA family exist (Saa1, Saa2, Saa3, Saa4 now 
referred to as Saa-ps1 a pseudogene and Saa5 now referred to as Saa4). Genome mapping and 
transcriptional orientation indicate that human SAA1 and SAA2 and murine Saa1 and Saa2 are 
homologs. SAA genes are highly conserved, which indicates their important biological function in 
vertebrates [52]. Mouse Saa1 and Saa2 mRNA has a hepatic origin while Saa3 mRNA was found 
to be a product of macrophage secretion [52]. Previous studies confirmed that Saa3 was the most 
upregulated acute phase gene and/or the most differentially expressed gene. Therefore, it can 
serve as a biomarker to monitor the development of pulmonary acute phase response [45,46,53–
57]. Similarly, Saa1 was the most differentially expressed acute phase response gene in the liver 
(as demonstrated by [58]) and it can be used in the detection of hepatic acute phase response. 
During inflammation and acute phase response, SAA is replacing apolipoprotein A-1 (ApoA-1) in 
the third fraction of high-density lipoprotein (HDL3) causing partial depletion of ApoA-1 from 
HDL [52,59,60]. ApoA-1 is a cofactor of lecithin-cholesterol acyltransferase (LCAT), enzyme 
which major role is to esterify cholesterol allocated for extracellular transport. Moreover, it has 
been reported that SAA inhibits LCAT activity [61]. Taken together, these findings indicate that 
SAA, when incorporated into HDL, can impair cholesterol efflux [43]. 
1.3.3 Particle-induced genotoxicity 
There are a number of studies demonstrating that exposure to particles leads to irreversible 
alterations in the DNA structure and is associated with the increased risk of lung cancer 
development [62–66]. Particles themselves as well as systemic effects induced by NPs 
(inflammation, augmented cell proliferation and ROS generation) play a crucial role in triggering 
genotoxicity followed by mutagenesis and, eventually, onset of cancer [62].  
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Oxidative stress, known as an impairment in the production of ROS and the ability of the 
antioxidant system to scavenge the free radicals, is presently considered as a main mechanism 
underlying particle-induced genotoxicity. Particle characteristics like shape, size, solubility, 
surface activity, carrier function and surface chemistry can contribute to the acellular ability of 
particles to elicit genotoxic effects. In example, free radicals or oxidative groups as well as 
transition metals or organic compounds could be directly bounded to the surface of particles and 
therefore stimulate increased oxidant formation [62,67]. The cellular pathways involve particle-
induced production of ROS/RNS by target cells (vascular endothelial cells and lung epithelial 
cells) in absence of inflammation, or by activated phagocytic cells during inflammation [62].  
We can distinguish two separate mechanisms of NP-induced genotoxicity: primary and 
secondary genotoxicity. Primary genotoxicity refers to the genetic alterations evoked by NPs in 
the absence of inflammation. Particles can induce DNA lesions directly by a physical interaction 
with genetic material in the nucleus or essential components that ensure its integrity (e.g. mitotic 
spindle) or indirectly, by formation of ROS by NP-activated cells (i.e. arising from mitochondria-
produced ROS or by membrane bound NADPH oxidases) or by depletion of antioxidants [68,69]. 
Inhibition of DNA repair mechanism, demonstrated for many ions, could also be responsible for 
the primary indirect particles genotoxicity [68]. Secondary genotoxicity is characterized by the 
presence of inflammation driven by activated phagocytes: macrophages and polymorphonuclear 
neutrophilic leukocytes (PMNL), attracted to the site of particle deposition. ROS, RNS and 
possibly other mediators produced by activated cells strike on DNA and lead to genetic damages 
[68,69].  
Since only a sufficient dose of particles is able to induce lung inflammation there is a threshold in 
the occurrence of secondary genotoxicity [70]. ROS are capable of inducing oxidation of DNA 
bases, DNA strand breaks or formation of lipid peroxidation-mediated DNA adducts [70]. 
Sustained ROS production occurs in particle-induced inflammation. It is well documented that 
persistent inflammation [62,71] and increased ROS production by activated phagocytes [72,73] 
are associated with carcinogenesis.  
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1.3.4 Histopathological alterations of liver and lung tissues 
Once NPs are administered to the body their deposition in the tissue due to the slow clearance 
and low particle solubility could be prolonged. Constant presence of NPs could lead to grievous 
histopathological changes. Several studies have shown that regardless of the administration 
route, chemical composition and size of NPs a wide range of severe tissue alterations in liver and 
lungs occurred upon particle exposure. 
Repeated intraperitoneal injection of Ag NPs (2000 mg/kg bw, particle size <100 nm) caused 
swollen hepatic cells, narrowing of the sinusoidal lumen and appearance of hypertrophied 
Kupffer cells [74]. Liver histopathological evaluation following intragastric exposure to TiO2 NPs 
(10 mg/kg bw, particle size 5 nm) for 90 consecutive days demonstrated focal inflammatory cell 
infiltration, nucleus vacancy, vein congestion and edema in the liver tissue [75]. Intratracheal 
exposure to CeO2 NPs (1.0/3.5/7.0 mg/kg bw, particle size 10.14 ± 0.76 nm) exhibited evidence 
of liver pathology expressed as dose-dependent hydropic degeneration and enlargement of 
hepatocytes, binucleation of some hepatocytes, sinusoidal dilatation, occasionally focal 
inflammation and accumulation of granular material [76].  
A variety of changes in lung tissue including pulmonary fibrosis [77], multifocal microgranuloma 
[78], chronic alveolar inflammation including alveolaritis, granulomatous lesions, alveolar wall 
thickening and alveolar macrophage accumulation [79], pulmonary emphysema, macrophages 
accumulation, extensive disruption of alveolar septa, type II pneumocyte hyperplasia, and 
epithelial cell apoptosis [80] were reported following exposure to different NPs. 
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1.4 Liver as an important endpoint in particle toxicity 
Liver, followed by spleen, sequestrates a vast majority of the NPs that entered the human body. 
Deposited foreign material is retained in the liver and could elicit adverse, toxic effects. 
Therefore, assessment of liver toxicity is a crucial step in the evaluation of NP-induced noxious 
effects.  
1.4.1 Liver structure and functions 
Liver structure is organized around the main branches of the portal vein with polyhedron units 
called hepatic lobules merged together with a connective tissue. The classical liver lobule is made 
up of a central vein and areas of connective tissue, a portal area, that contains interlobular 
branches of a hepatic artery and a portal vein, biliary ductules, a lymphatic vessel and nerves 
(Fig. 2) [81]. 
 
Figure 2. Structure of mammalian liver tissue (modified from [82]).  
Both parenchymal cells (i.e. hepatocytes) and nonparenchymal cells (i.e. Kupffer cells, sinusoidal 
cells, stellate cells and intrahepatic lymphocytes) build up liver lobules. Hepatocytes make up ca. 
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80 % of the total liver volume and are responsible for performing the majority of the liver 
functions. Nonparenchymal cells, located in the sinusoidal compartment of the liver tissue, 
constitute 40 % of the total number of liver cells and are involved in filtration, secretion of 
cytokines, antigen presenting cell function (sinusoidal endothelial cells), phagocytosis, secretion 
of mediators of the inflammatory response (Kupffer cells) and vitamin A storage (stellate 
cells)[81].  
Generally speaking, liver is a metabolic center of the body that supplies the energy, regulates 
glucose level and, among others, synthesizes and degrades plasma proteins. Moreover, as a 
defence center is responsible for the metabolism of xenobiotics, scavenging ROS, phagocytosis, 
uptake and neutralization of bacteria, viruses and foreign materials (including particulate 
matter) and is involved in the induction of acute phase response. Liver serves as a blood 
reservoir, regulates blood pH as well as controls the hormonal system and acts as a 
immunoregulator [81].  
1.4.2 Kupffer cells – essential role in NP clearance  
Kupffer cells (KCs), resident liver macrophages, are essential components of the mononuclear 
phagocytic system and constitute up to 80-90 % of the total body macrophages [83]. Hepatic 
localization within the sinusoidal lumen leads to the constant exposition of KCs to gut-derived 
bacteria, bacterial endotoxins and microbial debris from the GIT and other intruders that reached 
the liver via the portal vein [83]. They are also highly specialized in the clearance of foreign 
materials including particles [84]. Upon activation, macrophages secrete a broad range of 
different mediators (i.e. ROS, eicosanoids, nitric oxide, carbon monoxide, TNF-α and other 
cytokines) and therefore, take part in the modulation of hepatic inflammatory response [81]. 
However, dysregulation of this process can lead to chronic inflammation and, eventually, to the 
liver injury [84].  
A study of the role of KCs following intravenous administration of Ag NPs demonstrated the 
crucial role of KCs in the hepatic anti-inflammatory response to Ag NPs [85]. Vascular infusion of 
CeO2 NPs resulted in the avid uptake of nanoceria by KCs as early as 1 h post-exposure [86]. KC-
mediated hepatic injury was also studied in vitro and in vivo with silica NPs. In vitro study using 
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Buffalo rat liver cells revealed that KCs upon stimulation by SiO2 NPs secreted large amounts of 
ROS, TNF-α and nitric oxide. In vivo exposure to SiO2 NPs caused KCs hyperplasia, hepatic 
inflammation and oxidative stress. Overall, these data suggest KC-mediated liver injury with the 
primary mechanism involving the production of reactive mediators by KCs [87].  
1.4.3 NP-induced hepatotoxicity 
NPs, regardless of the exposure route, when getting access to the systemic circulation are 
primarily taken up by the liver. Deposited particles can interfere with normal liver functions and 
cause liver toxicity followed by liver injury. 
Intratracheal instillation of rats with CeO2 NPs (7.0 mg/kg bw, particle size 10.14 ± 0.76 nm) 
resulted in increased liver ceria concentration followed by a significant reduction of the liver 
weight. NP exposure was also associated with elevated serum alanine transaminase (ALT) 
activity, reduced albumin (ALB) and decreased serum triglyceride (TG) levels which could be 
related to the histopathological alterations of the liver tissue. Gene expression analysis of serum 
proteins revealed statistically significant changes in the level of biomarkers correlating with the 
acute hepatic injury [76]. Several previous studies showed that exposure to TiO2 caused 
significant elevation of serum biochemical parameters (ALT, alkaline phosphatase – ALP, 
aspartate aminotransferase – AST, lactate dehydrogenase – LDH, plasma cholinesterase – PChE, 
and leucocyte alkaline phosphatase – LAP) [88], liver oxidative stress [89], imbalance in blood 
sugars and lipid metabolism [90], liver inflammation and significant alterations of several 
inflammatory cytokines [91]. Oral exposure to carbon black in lean Zucker rats was associated 
with oxidative stress and hepatocyte steatosis. This was in a good agreement with a concomitant 
in vitro study using cultured human hepatocyte (HepG2) cell line that showed increased 
intracellular lipid content after CB NPs treatment [92]. It was also demonstrated that inhalation 
[57] and intratracheal instillation [54] of CB NPs (particle size 14 nm) induced genotoxicity in the 
liver tissue. Furthermore, there is a growing concern that exposure to air pollutants, including CB 
NPs, could be associated with increased risk of hepatic cancer [93–96].  
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2. HYPOTHESES AND AIMS 
This PhD work was primarily focused on the assessment of toxicological effects caused by NPs 
accumulation in the liver.  
 
It is hypothesized that: 
 upon pulmonary exposure, deposited particles are cleared from the respiratory tract mainly 
by macrophage-mediated phagocytosis however, a small fraction of particles can get access to 
the systemic circulation and undergo extrapulmonary translocation to various secondary 
organs, including liver; 
 translocation rate depends on size, shape, surface properties and chemical composition of 
NPs; 
 a fraction of deposited particles that was transported up in the respiratory tract by the 
mucociliary escalator could be swallowed and therefore cause secondary exposure via GIT; 
 deposited particles cause inflammation, induction of acute phase response, genotoxicity and 
tissue lesions; 
 particle-mediated genotoxicity could be induced via two potential mechanisms: primary or 
secondary genotoxicity; primary genotoxicity refers to DNA damages caused by direct 
physical interaction between particles and genomic DNA or ROS formation by NP-activated 
cells in the absence of inflammation; secondary genotoxicity refers to DNA damages caused 
by ROS and other mediators released during particle-induced inflammation.  
 
The specific aims of this PhD work were: 
 to investigate possible toxicological effects of NP accumulation in the liver; 
 to investigate what is the direct cause of previously observed hepatic genotoxicity following 
intratracheal instillation: a physical presence of translocated particles or a systemic effect 
caused by inflammation and acute phase response that trigger the production of secondary 
messengers and, in turn, induce secondary genotoxicity in the liver tissue.  
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In order to achieve these aims a group of 324 mice were divided into 36 experimental groups and 
exposed by single intratracheal instillation (IT), intravenous injection (IV) and oral gavage (PO) 
to titanium dioxide (TiO2), cerium oxide (CeO2) and carbon black (CB) NPs. Animals were 
euthanized 1, 28 and 180 days following exposure and several endpoints were evaluated: 
detection of NPs in the liver and lung tissue by enhanced darkfield microscopy (EDFM), 
determination of Ti and Ce NP mass concentrations in the liver and lungs by inductively coupled 
plasma mass spectrometry (ICP-MS), determination of size distribution profile of CeO2 NPs in the 
liver by single-particle inductively coupled plasma mass spectrometry (spICP-MS), assessment of 
particle-induced acute phase response in the liver and lungs by real-time reverse transcription 
polymerase chain reaction (real-time RT-PCR), evaluation of particle-induced genotoxicity in the 
liver, lungs and bronchoalveolar lavage (BAL) cells by comet assay, assessment of pulmonary 
inflammation by analyzing cellular composition of BAL fluid (BALF), determination of ROS-
generating ability of NPs by 2’,7’–dichlorodihydrofluorescein (DCFH) assay, histopathological 
examination of particle-induced tissue lesions in the liver and lung tissue by light microscopy, 
evaluation of acute toxicity elicited by NPs exposure based on the assessment of general 
biochemical and haematological biomarkers. 
 
Results of the present study are reported in the following manuscripts: 
1. In vivo-induced size transformation of CeO2 NPs in both lung and liver does not affect long-
term accumulation of Ce in liver following pulmonary exposure 
2. Primary genotoxicity in the liver following pulmonary exposure to carbon black nanoparticles 
in mice 
3. Histopathological changes in the liver following pulmonary, oral and intravenous exposure to 
three different nanoparticles in mice 
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3. MATERIALS AND METHODS 
3.1 Characterization of particles used in the present study 
In the present study we investigated liver toxicity following intratracheal, intravenous and oral 
exposure to three NPs: titanium dioxide (TiO2), cerium oxide (CeO2) and carbon black (CB). The 
test materials used in this work were selected due to the similarity in the primary particle size 
(Table 1). Moreover, CB was included as a reference material that has been extensively studied in 
our laboratory and due to the elicited genotoxicity in the liver tissue previously observed after 
inhalation and intratracheal instillation. Similarly to CB NPs both TiO2 and CeO2 were also used in 
the previous studies conducted by our research group (NANOSUSTAIN and HINAMOX projects, 
respectively) but in contrast to CB NPs, TiO2 as well as CeO2 NPs are easily detectable by 
inductively coupled plasma mass spectrometry (ICP-MS), the major analytical technique used in 
this work to qualitatively determine deposition of particles in the selected tissues.  
Table 1. Key physicochemical parameters of the tested nanomaterials 
 TiO2 CeO2 CB 
Source NanoAmorb Degussa/Quimidrogaa Evonik-Degussa 
Product form Powder powder Powder 
Primary particle size 10.5 nmb 13.0 ± 12.1 nma 14 nmd 
Specific surface area 139.1 m2/g b 56.7 m2/ga 295 m2/ge 
Particle density 4,23 g/cm3 f 7.29 g/cm3 a 2.1 g/cm3 e 
a [97]; b [98]; c [99]; d [100]; e [101]; f [102] 
3.1.1 Titanium dioxide (TiO2) 
TiO2 is produced in large quantities and extensively used as a whitening agent due to its 
brightness and high refractive index [24]. It is an important component of paints, coatings, 
cosmetics (sunscreen, toothpaste) and pharmaceuticals [103]. Moreover, it has been approved as 
a food additive in Europe (also known as E171) used in candies and chewing gum [104] or as a 
pigment to whiten skim milk [103]. TiO2 NPs have been classified by The International Agency 
for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B) [105]. Several in 
vitro and in vivo studies reported TiO2 NP-induced genotoxicity [106–109] and oxidative stress 
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[110–113]. Exposure to TiO2 NPs was also linked to neutrophil infiltration [114,115] and 
pulmonary toxicity [80,114] as reviewed by Johnston [116]. 
3.1.2 Cerium oxide (CeO2) 
CeO2 NPs are extensively used in several consumer products as polishing agents for glass mirrors, 
television tubes and ophthalmic lenses [117], oxygen sensors [118], diesel fuel catalysts to 
improve combustion and reduce consumption of fuels [117] and in solid oxide fuel cells [119]. 
The Organization for Economic Co-operation and Development (OECD) has recently included 
CeO2 NPs among other particles as a high-priority nanomaterial that requires comprehensive 
toxicological evaluation [120]. It has been previously demonstrated that administration of CeO2 
particles caused inflammation [121–124], pulmonary damage and fibrosis [122,125], and in vivo 
and in vitro genotoxicity [126,127]. It was also reported by Nalabotu and co-workers [76] that 
intratracheal instillation of CeO2 NPs resulted in decreased liver weight, histopathological 
alterations of the liver tissue and elevated level of ALT. Contradictory information has been 
published regarding anti-/pro-inflammatory properties exhibited by CeO2 NPs. On the one hand 
several researchers reported CeO2 NP-induced oxidative stress [124,128] however, other studies 
claimed therapeutic properties – cardioprotective, neuroprotective and retinoprotective – 
exhibited by CeO2 NPs [129–131]. 
3.1.3 Carbon black (CB)  
Carbon black NPs (CB NPs, including Printex 90 used in the present work) are carbonaceous 
core-particles that are formed by the controlled combustion. CB NPs are used principally as 
reinforcing agents in tires and other rubber goods. They are also often used as a black pigment in 
printing inks, paints, and plastics [132]. IARC recently classified CB NPs as potentially 
carcinogenic to humans [133]. It can serve as a benchmark material in the study of ultrafine air 
pollution [134] since the toxicity of CB NPs has been well described and evaluated by several in 
vivo and in vitro studies. It has also been documented that intratracheal instillation and 
inhalation of CB NPs was associated with increased recruitment of neutrophils to the site of 
exposure [46,135,136], genotoxicity [56,57,99] and induction of acute phase response [54]. 
Recent studies have shown that exposure to CB NPs caused substantial alterations in global 
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expression of pulmonary and hepatic genes such as changes in genes responsible for lipid 
homeostasis in lung and liver tissue or changes in expression of genes involved in the 
inflammatory processes [44,137]. 
3.2 Animal model and exposure routes 
3.2.1 C57BL/6 mice 
C57BL/6 (B6JBOM-F) female mice were used as an animal model since this strain is commonly 
used in our laboratory and therefore, it is easy to handle and maintain by our animal technicians. 
Moreover, direct comparison of the data obtained in this study with the previous findings was 
possible.  
3.2.2 Exposure routes for NP administration 
NP suspensions were administered via three different routes of exposure: intratracheal 
instillation, intravenous injection and oral gavage. Regardless the administration route all mice 
from the treated groups received a single dose of 162 µg of TiO2, CeO2, or CB NP suspension in a 
volume of 50 µl. Control groups received 50 µl of 2 % serum that was used as a vehicle for the 
preparation of NP suspensions. The dose used in the experiment is equal to the pulmonary 
deposition after nine 8-h working days at the Danish occupational exposure limit of 3.5 mg/m3 
for CB or after thirteen 8-h working days at the Danish occupational exposure limit of 10 mg/m3 
for TiO2. Animals were euthanized after 1, 28 or 180 days following the exposure. A graphical 
presentation of the experimental set-up is shown in Fig. 3. 
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Figure 3. Overview of the experimental set-up used in the study.  
 
3.3 Methods and techniques used in the present study 
Table 2 presents an overview of the different methods used to determine the effects of NP 
administration in the liver and lung tissue as well as in blood and plasma collected from the 
exposed mice. 
39 
 
Table 2. Overview of the techniques and tissues used in the study 
                 Tissue 
Method 
Liver Lung Blood Plasma 
ICP-MS X X   
spICP-MS X X   
EDFM X X   
Comet assay X X   
RT-PCR X X   
BFM X X   
Haematology   X  
Biochemistry    X 
ICP-MS – inductively coupled plasma mass spectrometry, spICP-MS – single particle inductively coupled plasma mass 
spectrometry, EDFM – enhanced darkfield microscopy, RT-PCR – reverse transcriptase polymerase chain reaction, 
BFM – brightfield microscopy 
3.3.1 Particle size determination by dynamic light scattering  
Dynamic light scattering (DLS) was used to determine the hydrodynamic diameter 
(hydrodynamic since it refers to the movements of particles within a fluid) of NPs in the dosed 
suspensions. DLS relates the speed of particle diffusion due to the Brownian motions – random 
movements of particles due to the collision with surrounding solvent molecules, to the size of 
particles. Big particles are characterized by slow Brownian motions while small particles move 
much further and more rapidly. When the laser beam hits the particle the intensity of the 
scattered light fluctuations is measured followed by the determination of the geometrical 
structure and particle state of motion. In order to measure the hydrodynamic diameter the 
Stokes-Einstein equation is applied. The obtained hydrodynamic diameter is in fact a diameter of 
a sphere that has the exact same diffusion coefficient (velocity of the Brownian motions) as the 
measured particle [138,139].  
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3.3.2 Determination of NP presence in biological tissues 
3.3.2.1 CytoViva® Enhanced Darkfield Hyperspectral Microscopy 
Enhanced darkfield microscopy (EDFM) is a relatively new technique that enables optical 
detection of nanoparticles in biological tissues. EDFM compared to electron microscopy (EM) 
offers more rapid and less costly possibility to visualize and identify nanomaterials in different 
tissues. Even though EM could operate at higher magnification and resolution than EDFM, the 
cost of ownership and time needed for the training are in favor of EDFM [140]. Moreover, no 
additional sample preparation (e.g. labelling) is required since sample preparation for EDFM is 
the same as for the regular light microscopy. It also gives an opportunity to visualize particles 
that are difficult to detect by other methods (e.g. ICP-MS) such as CB NPs. In the present study we 
used a relatively new tool called CytoViva® Hyperspectral Microscopy (Auburn, Alabama, USA) 
that combined hyperspectral imaging technology with patented enhanced darkfield microscopy 
that in contrast to the conventional darkfield instruments provides images with better contrast 
and higher signal-to-noise ratio [141,142]. 
3.3.2.2 Inductively coupled plasma mass spectrometry 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is a powerful analytical technique that 
allows accurate quantitative and semi-quantitative determination of presence and content of 
most elements from the periodic table in virtually any material. The greatest advantages of this 
technique are: a very low detection limit (down to part per trillion = 1 ng/L), simultaneous 
measurement of different isotopes of the same element and high productivity. Liquid sample is 
introduced with a peristaltic pump and breaks into fine droplets by a nebulizer before entering 
the argon plasma. Plasma, that operates at 6000 °C, dries the sample, dissociates the molecules, 
removes an electron from the components and forms singly charged ions. Once ions are 
produced in plasma they are directed to the mass spectrometer via the interference region that 
ensures efficient transport of ions. Before entering the final chamber where the mass 
spectrometer and detector are placed, an ion deflection device separates ions from neutrals and 
photons to achieve the highest performance of the instrument and to decrease the background 
noise.  The mass spectrometer is a filtering device that allows only analyte ions of a specific mass-
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to-charge ratio (m/z) to reach the detector separating all the non-analyte, interfering and matrix 
ions away. Emerging from the mass spectrometer ions strike the active surface of the detector 
and electronic signal is generated. Thereafter, data handling software translates the electronic 
signal into the analyte concentration using ICP-MS calibration standards with the known 
contents of the analyte [143–145].  
3.3.2.3 Single particle inductively coupled plasma mass spectrometry 
ICP-MS can also operate at, so called, single particle mode (spICP-MS, single particle inductively 
coupled plasma mass spectrometry) that allows not only detection and quantification of NPs but 
also their physicochemical characterization [146]. It measures the size of NPs (if shape is known 
or assumed), assesses agglomeration and/or size distribution and allows differentiation between 
signal generated by soluble ions (background) and single particle [147]. In the conventional  
ICP-MS multiple intensity readings are integrated over long time intervals (i.e. dwell time of 0.3 – 
1 s) and an averaged continuous signal is generated for the analyte (Fig. 4a). In contrast, when 
operating at the single particle mode each intensity reading is integrated over short dwell times 
(i.e. 10 ms or less) resulting in a separate peak for each detected particle (Fig. 4b) [148,149]. 
 
Figure 4. ICP-MS signal from measuring a dissolved analyte (a), a signal from measuring 60 nm Ag NPs 
(b) (reproduced from: [149]). 
The fundamental assumption behind spICP-MS analysis tells that if the dwell time is short 
enough, constant flow rate is assured and particle suspension is sufficiently diluted each pulse 
represents a single particle event. If the assumption is correct then pulse frequency can be 
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directly translated into particle/aggregate number concentration and height (i.e. intensity) of 
each pulse can be directly referred to particle size (mass) [148]. 
3.3.3 Assessment of particle-induced toxicity 
Several toxic endpoints (i.e. inflammation, acute phase response, genotoxicity, alterations of 
blood parameters, changes in liver biochemistry and histopathological evaluation of exposed 
tissue) were determined in order to evaluate systemic deleterious effects elicited by exposure to 
NPs.  
3.3.3.1 BAL fluid cellular composition – assessment of pulmonary inflammation 
Lung inflammation is characterized by the recruitment of inflammatory cells, primarily 
polymorphonuclear neutrophils and alveolar macrophages, and is a common response to 
pulmonary exposure to NPs [53,100,150]. 
Assessment of pulmonary inflammation was accomplished by the determination of 
bronchoalveolar lavage (BAL) fluid cellular composition. Lungs from control and NP exposed 
mice were flushed twice with sterile saline (0.8 ml of 0.9 % of NaCl) and BAL cells were separated 
on microscope slides by centrifugation, fixed in ethanol and stained with May-Grünwald-Giemsa 
dye. Cellular composition (i.e. number of macrophages, neutrophils, lymphocytes and 
eosinophils) was determined on 100 cells under light microscope using the differential counting 
method.  
3.3.3.2 Comet assay – assessment of genotoxicity 
Comet assay (also known as a single cell gel electrophoresis) was used to analyze DNA strand 
breaks (DNA SB) and alkali-labile sites in the liver, lungs and BAL cells collected from mice 
exposed to NPs. It has been demonstrated that exposure to NPs is associated with the induction 
of genotoxic effects [54,57,62,151] and presence of DNA lesions is a crucial step in cancer 
development [152,153].  
In a standard comet assay procedure selected tissue is homogenized to yield single cells that are 
subsequently encapsulated in a low-melting point (LMP) agarose and embedded on a microscope 
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slide. When the agarose is solidified, the slide is submerged in a lysis solution that contains a high 
salt and detergent concentrations in order to lyse cell membranes. Prior to electrophoresis, the 
slide is incubated in an alkaline solution (pH > 13) to unwind the DNA. Alkaline environment is 
also maintained during electrophoresis where negatively charged DNA migrates towards the 
positively charged anode. Following electrophoresis, the slide is neutralized, fixed and stained 
with a fluorescent dye to allow visualization and scoring by a fluorescent microscopy. The 
obtained image resembles a “comet” where the “head” represents intact DNA and the “tail” 
represents DNA SB. The amount of DNA liberated from the nuclei during electrophoresis is 
proportional to the amount of damaged DNA [154–156]. 
3.3.3.3 Real time RT-PCR – assessment of pulmonary and hepatic acute phase response 
induction 
Particle-induced pulmonary acute phase response is a common organismal response to the lung-
administered NPs [46]. It has also been hypothesized that lung inflammation followed by 
induction of pulmonary acute phase response arising after exposure to NPs could evoke 
production of cytokines, that in turn, induce acute phase response in the liver [4,157].  
Serum amyloid A (SAA) is one of the major acute phase response proteins [48] and therefore, in 
the present study, we investigated alterations of pulmonary Saa3 and hepatic Saa1 mRNA 
expression levels by the real time reverse transcription polymerase chain reaction (real time RT-
PCR).  
RT-PCR is a standard method used for detection and quantification of target mRNA in order to 
determine gene expression level. The biggest advantages of this technique are: high sensitivity, 
accurate quantification and possibility to scale-up the analysis (high-throughput method). In 
principle, the major aim of the analysis is to follow formation of PCR-products that are amplified 
in each PCR cycle. It is a two-steps method. First step is a reverse transcription of isolated mRNA 
into complementary DNA (cDNA). Thereafter, cDNA is used as a template in a PCR reaction. In the 
present study, 18S rRNA was used as a reference gene to normalize the quantity of the template 
loaded to each reaction and to reduce variation of reverse transcription efficiency. 18S rRNA, 
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together with β-actin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine-
guanine phosphoribosyl transferase (HPRT), belongs to, so called, housekeeping genes group, 
that is characterized by a constitutive expression level unaffected by the treatment. In order to 
monitor progress of PCR reaction and to be able to quantify the expression level of reference 
(18S rRNA) and target (Saa) genes specific TaqMan® probes (Applied Biosystem) were used. 
Each probe consists of a fluorescent reporter dye attached to the 5’ end and a quencher dye 
attached to the 3’ end. As long as the reporter dye and quencher stay in a close proximity, 
fluorescent signal is repressed. However, during the PCR cycle complementary to the cDNA 
strand is amplified by a Taq DNA polymerase with endonuclease activity that cleaves the 
reported dye away from the quencher and thereby fluorescence can be emitted. Two major 
parameters characterize RT-PCR reaction: baseline and threshold cycle (Ct). Baseline refers to the 
number of cycles where the fluorescence is not detectable (is below detection limit of the 
instrument). Ct refers to the number of cycles where the fluorescent signal is above background 
fluorescence and is detected for the first time (threshold level of detection) [158–161]. In order 
to evaluate results of the PCR analysis, the target gene was first normalized to the 18S rRNA 
using the following equation: ∆Ct = Ct target – Ct reference. Thereafter, relative gene expression was 
determined using the comparative Ct method (2-∆Ct) [162].  
3.3.3.4 Brightfield microscopy – assessment of particle-induced histopathological changes  
Several previous studies demonstrated NP-induced histopathological changes in the liver and 
lung tissue that occurred upon exposure [76,88,163]. In order to evaluate particle-related 
changes in the liver and lung tissue, microscopic evaluation using brightfield microscopy was 
performed. 
Briefly, on the termination day small chunks of the liver tissue were sampled and fixed by 
submerging in 4 % neutral formalin buffer for 24h. Thereafter, samples were dehydrated and 
embedded in paraffin blocks. Lungs were removed intact, filled with formalin and submerged in  
4 % neutral buffered formalin. Liver and lung tissue sections of 4–6 µm thickness were cut and 
stained with hematoxylin and eosin. 
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3.3.3.5 DCFH-assay – assessment of ROS generation ability exhibited by NPs 
NP-induced oxidative stress (imbalance between generation of ROS induced by NPs and ability of 
biological systems to detoxify the reactive mediators) is presently considered as a main 
mechanism of genotoxicity caused by exposure to NPs [164]. Therefore, we measured the ability 
of NPs to generate ROS in a cell-free environment by the 2’,7’-dichlorofluorescein (DCFH) assay.  
2’,7’-dichlorofluorescein diacetate (DCFH-DA) is a non-polar, non-fluorescent compound that 
easily crosses cell membranes and is chemically hydrolysed (by NaOH) to polar, non-fluorescent 
2′,7′-dichlorodihydrofluorescein (DCFH2) that is trapped within the cells. In the presence of 
particle-generated ROS, DCFH2 is rapidly oxidized to highly fluorescent 2’,7’-dichlorofluorescein 
(DCF). The emitted fluorescence is spectrofluorimetrically measured. Excitation and emission 
wavelengths are λex = 490 nm and λem = 520 nm, respectively [165].  
3.3.3.6 Haematology and biochemistry – assessment of general biomarkers for particle-
induced toxicity 
Previous studies reported minute alterations of general blood parameters following exposure to 
NPs [74,166–169]. In the present study levels of basic haematological parameters including 
white blood cells (WBC), red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT), mean 
corpuscular volume (MCV), mean cell hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC) and platelets (PLT) were determined in order to evaluate welfare of 
animals exposed to NPs.  
In order to measure the core blood parameters, blood from the facial vein (~ 100 µl) was 
sampled and collected in EDTA tubes to prevent clot formation. Prior to the analysis blood was 
rotated for 20 min to equally distribute the EDTA powder. Subsequently, the abcTM Animal Blood 
Counter instrument (Horiba Abx, Scil Abc Vet Animal Blood Counter) was used to measure the 
selected blood biomarkers.  
Changes in the basic clinical biochemistry parameters after exposure to NPs were formerly 
described [76,170]. Levels of the three major liver enzymes, i.e. alanine aminotransferase (ALT), 
alkaline phosphatase (ALP) and aspartate aminotransferase (AST), were determined in the 
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present study. Liver enzyme activities were measured in plasma from mice exposed by 
intratracheal instillation, intravenous injection and oral gavage, and terminated 28 days after 
exposure using Pentra 400 (Horiba ABX, Montpellier, France) with commercially available kits 
(Horiba ABX Medical, Montpellier, France; catalogue no. A11A01627, A11A01626 and 
A11A01629, respectively). Samples from each exposure group were run in the same batch in 
random order to decrease variation and a control sample was included for every 15th sample. 
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4. SUMMARY OF RESULTS 
The main findings accomplished in this PhD project are listed below. More detailed description of 
the performed experiments and collected results can be found in the attached manuscripts. 
4.1 Manuscript 1 
In vivo-induced size transformation of CeO2 NPs in both lung and liver does not affect long-
term accumulation of Ce in liver following pulmonary exposure 
The main purpose of this study was to investigate liver deposition of cerium oxide (CeO2) and 
titanium dioxide (TiO2) NPs following intratracheal instillation. CeO2 and TiO2 NPs exhibit similar 
primary particle size (13 and 10.5 nm, respectively) but different chemical composition, shape 
and potential differences in their solubility might affect hepatic accumulation. In addition, we 
wanted to assess possible changes in size distribution of liver- and lung-deposited CeO2 NPs.  
Orally exposed groups were included in the study to evaluate if the presence of particles in the 
liver could be explained by the swallowing of a portion of lung-deposited particles as a result of 
mucociliary escalator-mediated clearance that would lead to the secondary exposure via GIT. 
Intravenously administered groups were included as reference groups to assess the amount of 
particles that reach the liver bypassing the extrapulmonary translocation.  
Presence of particles translocated from lung to the liver was confirmed by enhanced darkfield 
microscopy (EDFM) whereas inductively coupled plasma mass spectrometry (ICP-MS) 
determined mass concentration of Ce and Ti sequestrated in the liver tissue. EDFM analysis 
revealed that the foreign material was predominantly found in the liver sinusoids and often in 
close proximity to small nuclei, probably phagocytized by Kupffer cells (Fig. 5). ICP-MS analysis 
showed elevated concentration of Ce detected in the liver tissue 28 and 180 days post-exposure 
and elevated concentration of Ti detected in the liver tissue 180 days post-exposure (Fig. 6A and 
B). Calculated translocation rates were comparable and stood at 2.87 ± 3.37 % and 1.24 ± 1.98 % 
of the initial pulmonary dose for CeO2 and TiO2 NPs, respectively. No NPs were detected in the 
liver following oral gavage. Analysis of CeO2 NP size distribution revealed that the size of 
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particles had decreased over time in both liver and lung tissue resulting in the onset of smaller 
particles (Fig. 7A and B). 
 
Figure 5. Brightfield (1) and enhanced darkfield (2) microscopy images of H&E stained liver tissue from 
intratracheally instilled mice that received a control vehicle (A) or 162 µg/animal of CeO2 (B) or TiO2 (C) 
NPs at 180 days post-exposure. In the liver sections from mice exposed to CeO2 and TiO2 foreign material 
aggregates were observed using enhanced darkfield microscopy, mainly in sinusoids and often close to 
small nuclei (B and C, respectively, 2, 4 and 6, white arrowheads). The aggregates were not detectable in 
brightfield at 40x magnification (B1, C1) but exhibited a brownish appearance at 100x magnification (B 
and C, 3 and 5, black arrowheads). Appearance of a typical artefact is shown (A, 3-4, arrowheads). Panels 
3-6 correspond to the rectangular zones in panel 1-2 captured at higher magnification. 
49 
 
A 
 
Figure 6. Mass concentration of Ce (A) and Ti (B) in the liver tissue measured by ICP-MS following 
intratracheal instillation and oral gavage of CeO2 and TiO2 NPs, respectively. Data are presented as mean 
+ SD. An asterisk (*) denotes P ≤ 0.05, (***) P ≤ 0.001, (****) P < 0.0001 of Ce or Ti mass concentration in 
exposed groups compared to vehicle controls. Hashtags (###) denote P < 0.001 and (####) P < 0.0001 of 
Ce mass concentration in intratracheally exposed group (IT) compared to orally exposed groups (PO). 
LOD – Limit of detection. 
 
 
  
 
 
 
 
Figure 7. Particle size distribution of CeO2 NPs in lung tissue (A) 1 day (N=6) and 180 days (N=4) after 
intratracheal instillation and in liver tissue (B) 1 day (N=3), 28 days (N=2), 180 days (n=3) after 
intravenous injection and 180 days (N=5) after intratracheal instillation measured by spICP-MS and 
normalized to the maximum of the distribution. The particle size distribution of CeO2 NPs in the dosed 
suspension with and without enzymatic treatment is shown for comparative reasons. 
  
A 
B 
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4.2 Manuscript 2 
Primary genotoxicity in the liver following pulmonary exposure to carbon black 
nanoparticles in mice 
The major objective of this study was to determine the exact mechanism responsible for the 
genotoxic effect previously observed in the liver following pulmonary exposure to NPs. Two 
distinct mechanisms have been proposed: 
 primary genotoxicity mechanism due to physical interaction between particles and 
genomic DNA and by ROS-mediated DNA damage in the absence of inflammation; 
 secondary genotoxicity mechanism due to particle-induced systemic inflammation and 
acute phase response with subsequent release of various secondary mediators (ROS/RNS, 
cytokines, chemokines) that are capable of inducing downstream toxic effects resulting in 
DNA damages in the liver. 
 
Therefore, we investigated induction of pulmonary inflammation, pulmonary and hepatic acute 
phase response and genotoxicity following intratracheal (IT), intravenous (IV) and oral (PO) 
exposure to TiO2, CeO2 and CB NPs. 
All three NPs elicited similar level of pulmonary inflammation in terms of increased neutrophil 
influx that lasted up to day 28 and had decreased in a time-dependent manner. Sustained 
pulmonary acute phase response was measured for all NPs and was observed up to day 180 (Fig. 
8A). An interim induction of hepatic acute phase response was measured on day 1 in IT and IV 
exposed groups to TiO2 and CeO2 NPs (Fig. 8B). Furthermore, an increased number of DNA strand 
breaks was found only in the CB groups exposed by IV and IT (Fig. 9A and B). Unlike the TiO2 and 
CeO2 NPs, only CB NPs were capable to induce production of ROS in the cell-free assay.  
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Figure 8A. Pulmonary Saa3 mRNA expression levels in mice following IT administration of 162 µg of TiO2, 
CeO2 or CB NPs 1, 28 and 180 days after the exposure and B Hepatic Saa1 mRNA expression levels in mice 
following IT, IV and PO of 162 µg of TiO2, CeO2 or CB 1 day after exposure. All values are presented as 
mean + SD. Asterisks (**) denote P ≤ 0.01 and (***) P ≤ 0.001 of Saa1/Saa3 mRNA level in exposed groups 
versus vehicle control. Hashtag (#) denotes P ≤ 0.05 of Saa1 mRNA level in TiO2 vs CB groups. Crosses 
(†††) denote P ≤ 0.001 of Saa1 mRNA level in CeO2 vs CB groups. Double cross (‡) denotes P ≤ 0.05 and 
(‡‡‡) denote P ≤ 0.001 of Saa1 mRNA level in TiO2 vs CeO2 groups. 
 
 
Figure 9. DNA strand break levels (% tail DNA) in the liver tissue detected by comet assay following A 
intravenous injection and B intratracheal instillation of 162 µg of TiO2, CeO2 or CB NPs measured 1, 28 and 
180 days after exposure. Particle exposed groups n=9, vehicle control n=9. All values are presented as 
mean + SD. Asterisks (**) denote P ≤ 0.01, (***) denote P ≤ 0.001 of DNA SB level in exposed groups versus 
vehicle control. Hashtags (##) denote P ≤ 0.01, (###) denote P ≤ 0.001 of DNA SB level in TiO2 vs CB 
groups. Cross (†) denotes P ≤ 0.05, (†††) denote P ≤ 0.001 of DNA SB level in CeO2 vs CB groups.  
A B 
A B 
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4.3 Manuscript 3 
Histopathological changes in the liver following pulmonary, oral and intravenous 
exposure to three different nanoparticles in mice 
In this study we investigated potential toxicological consequences of short- and long-term 
deposition of NPs in the liver. Therefore, several systemic and liver-related endpoints were 
evaluated including: assessment of body and liver weight (absolute and relative liver weight), 
analysis of selected haematological and biochemical parameters and histopathological 
examination of lung and liver tissue.  
We found no significant changes in body weight of mice exposed by IT, IV and PO at any of the 
analyzed time points. Only oral administration of TiO2 NPs decreased absolute and relative liver 
weight, 28 and 180 days post-exposure, respectively, whereas exposure to CeO2 and CB NPs had 
no significant effects on the organ mass. Occasional and minor alterations in a few blood markers 
were measured. In addition, there were no significant changes in any of the analyzed biochemical 
parameters measured 28 days post-exposure.  
Histopathological examination of the lung tissue revealed presence of inflammatory changes. 
Liver tissue examination (Fig. 10) showed high incidence of inflammation in both control and 
NPs exposed groups regardless of the exposure route and the origin of inflammation remained 
unclear. Similarly, necrotic changes could not be unambiguously related with the treatment since 
increased numbers of necrotic changes were also noted in the control groups. An increased 
number of binucleate hepatocytes, a common finding in aging mice, was seen on day 1 and it 
might indicate hepatocytic regeneration typically seen after a toxic insult. Hypertrophy of Kupffer 
cells observed 1 day following IV exposure to TiO2 and CB NPs could be related to the 
phagocytosis of NPs.  
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Figure 10. Microscopic changes in the liver of mice 28 or 180 days after single intratracheal instillation 
(IT) of a vehicle (A-B), TiO2 (C-D), CeO2 (E-F) or CB (G-H) NPs. A-B: microfoci of necrosis (circles), 
hypertrophy of Kupffer cells (tiny arrows), binucleate hepatocytes (BH). C-D: PNCF (double arrows), 
eosinophilic necrosis (arrowheads), microfoci of necrosis (circles), pyknosis of nuclei (P), hyperplasia of 
Kupffer cells (thick arrow), binucleate hepatocytes (BH), vacuolar degeneration (white spaces in 
hepatocytes). E-F: PNCF (double arrows), eosinophilic necrosis (arrowheads), microfoci of necrosis 
(circles), area of necrosis (asterisk), binucleate hepatocytes (BH), apoptotic body (AB). G-H: PNCF (double 
arrow), eosinophilic necrosis (arrowheads), microfoci of necrosis (circles), hypertrophy of Kupffer cells 
(tiny arrows), hyperplasia of Kupffer cells (thick arrows), pyknosis of nuclei (P), vacuolar degeneration 
(white spaces in hepatocytes). HE staining, scale bar in A applies to all images. 
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5. DISCUSSION  
The main objectives of my PhD study were to evaluate potential toxicological effects of NP 
deposition in the liver following pulmonary exposure as well as to determine the specific 
mechanism for particle-induced genotoxicity in the liver that has been previously observed 
following pulmonary exposure to TiO2 and CB NPs [54,57,150].  
5.1. Experimental set-up 
Inhalation is a physiological route of exposure to NPs present in the ambient air. Therefore, most 
studies on pulmonary exposure to different NPs frequently use inhalation as a major 
administration route. The biggest advantage of the inhalation is the fact that it provides a natural 
way for the delivery of foreign materials thus deposition, distribution and clearance pattern 
resemble real-life scenario. However, this exposure method is often more time consuming, 
considered to be more expensive since larger quantities of the test materials are required and it 
also carries risk of unintended exposure for workers. The major limitation of the inhalation 
technique is the difficulty to precisely determine the deposited dose. Possibly dermal and/or fur 
contamination may occur during the procedure which could increase the delivery dose and 
subsequent fur grooming could lead to the GIT exposure [171]. 
Intratracheal instillation, in contrast to inhalation, allows precise control of the delivery dose. 
Because in our study we exposed mice via three different routes it was of utmost importance to 
accurately determine the administered dose in order to directly compare results from different 
exposure groups. In addition, intratracheal instillation allows administration of different 
materials within a short window-time, requires small quantities of test substance and is safe for 
staff performing the procedure [171]. It has also been demonstrated that intratracheal 
instillation resulted in even distribution in all lung lobes [172,173]. The obvious disadvantage of 
intratracheal instillation is the unnatural distribution of instilled material compared to the 
inhalation exposure – all particle, regardless size, are deposited deeper in the lungs. It bypasses 
upper respiratory tract regions: nasal and pharynx, that are naturally exposed to particles upon 
inhalation [171]. 
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Despite existing differences in pulmonary exposure by inhalation and intratracheal instillation 
[174] the latter is an accepted and commonly used method for pulmonary exposure to toxicants, 
including NPs.  
Oral administration was included to evaluate the role of secondary oral exposure since it has 
been hypothesized that upon pulmonary administration a fraction of the deposited particles 
could be transported up from the respiratory tract via mucociliary escalator and, when 
swallowed, induce GIT exposure and lead to NP sequestration in the liver [4]. Moreover, the oral 
route is relevant for NPs contained in food and water [175,176] or used as a drug component 
[177]. 
Exposure via intravenous injection was included in the present study to evaluate toxicological 
effects and to determine clearance rate of particles accumulated in the liver. Several studies 
documented that NPs could reach the blood circulation after pulmonary exposure [13,178]. 
Intratracheal instillation of 30 nm gold particles in rats resulted in the presence of a vast amount 
of administered NPs in the platelets of pulmonary capillaries [179]. When NPs reach the systemic 
circulation they are distributed throughout the body with liver followed by spleen being the 
major organs for particle deposition [4]. Intravenous injection is also the quickest method to 
deliver chemicals and is relevant for diagnostic and biomedical applications of NPs [4,180,181].  
Three types of NPs, i.e. titanium dioxide (TiO2), cerium oxide (CeO2) and carbon black (CB), were 
used in the study. The chosen particles exhibit similar primary size (10.5 - 14 nm), are produced 
in large quantities and widely used in versatile industrial and consumer products. Moreover, our 
research group used TiO2 and CeO2 in the previous studies (NANOSUSTAIN and HINAMOX 
projects, respectively), where a detailed physicochemical characterization was performed.  CB is 
a benchmark nanomaterial extensively used by our group in many toxicological evaluations 
[100,134]. Therefore, historical data to compare results from this study exist. Moreover, CB NPs 
were chosen because they consistently induced DNA SB in the liver [54,57,136]. TiO2 and CeO2 
are easily detected by the applied analytical technique - ICP-MS - that allows accurate 
quantitative analysis of particles in biological tissues. Detection of CB NPs by ICP-MS due to the 
high abundance of carbon in the ambient air was not possible. We did not decide to label CB NPs 
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due to the risk of leakage or dissociation of the label from NPs that might skew the data 
interpretation [182,183]. Instead, we included CytoViva Enhanced Hyperspectral Microscopy to 
confirm the presence of all three NPs in the selected tissues.  
C57BL/6 (B6JBOM-F) female mice were chosen as an animal model for the present study since 
this strain is commonly used in our laboratory. Therefore, direct comparison with the previous 
findings was possible. Mice share many common genetic as well as physiologic, anatomic and 
metabolic features with the humankind that make the extrapolation of the results from animal to 
human studies easier than from e.g. in vitro studies. Moreover, rats have a tendency for particles 
overload thus mice are a more suitable model to study effects of particle exposure [184]. 324 
mice were used in the study and one could think of the future reduction of number of mice used 
in the experimental work by using methods that enable obtainment of comparable levels of 
knowledge from fewer animals and replacement by using well established cell lines or computer 
models that allow prediction of toxic effects of chemicals (The 3R method). 
Regardless the exposure route all mice received a single dose of 162 µg of TiO2, CeO2 or CB NP 
suspension in a volume of 50 µl. Control mice received 50 µl of 2 % serum that served as a vehicle 
for the preparation of the NP suspensions. The chosen dose used in this work is equal to the 
pulmonary deposition during thirteen 8-h working days at the Danish occupational exposure 
limit of 10 mg/m3 for TiO2 or during nine 8-h working days at the Danish occupational exposure 
limit of 3.5 mg/m3 for CB. These dose calculations assume that 33.8 % of the inhaled particulate 
matter is deposited in the pulmonary region [151], that the inhalation of particulate air during  
8-h work shift is 1.8 L/h [185] and that comparable deposition patterns exist in man and mouse. 
The dose is realistic for the occupational exposure and does not elicit acute toxic effects as we 
demonstrated in our study by the lack of adverse effects on basic haematological and biochemical 
parameters. The exposure concentration was carefully selected based on the previous studies 
from our research group that aimed in detection of inflammatory response, acute phase response 
and genotoxicity following exposure to NPs without evoking acute toxicity.  
Previous studies [54,57,150] have shown that pulmonary exposure to CB and TiO2 NPs caused 
oxidative stress and hepatic genotoxicity. However, they did not present any evidences for the 
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physical presence of translocated particles in the tissue where the toxic effects were observed. 
Therefore, it remained unclear whether the genotoxicity and observed toxic systemic effects 
were due to the direct interaction between particles and the distant tissue or rather by 
infiltration of circulating inflammatory cells and activation of signaling cascade as a result of 
pulmonary inflammation followed by acute phase response in the lungs. Hence, in the present 
study, we confirmed the presence of extrapulmonary translocated NPs in the liver after 
intratracheal instillation by ICP-MS and EDFM techniques.  
Analytical methods play a pivotal role in filling gaps in toxicological knowledge regarding safety 
usage of nanomaterials before they are incorporated into consumer products. They are widely 
used to determine tissue concentration and composition of NPs (ex. ICP-MS, Electron-Dispersive 
X-ray Spectroscopy EDS), allow their visualization and localization within cells and tissues as 
well as provide crucial information about NP uptake (ex. Transmission Electron Microscopy TEM, 
EDFM) and last but not least, enable physicochemical characterization of nanomaterials (ex. 
spICP-MS, DLS, High Resolution Transmission Electron Microscopy HRTEM). Moreover, a 
combination of different techniques opens the door to the cognition of a “nanoworld” even 
widely [186]. Constant development of analytical methodology provide nanotoxicologists with 
new tools that enable deeper insight into the dynamic interface between particles and biological 
systems [187].  
The robustness of the ICP-MS method in determination of particles concentration and chemical 
composition has been demonstrated by numerous research groups [188,189]. Therefore, in the 
present work we decided to use the ICP-MS technique to detect and to quantify concentrations of 
CeO2 and TiO2 NPs in the liver tissue. 
Husain and co-workers [19] suggested that previously observed lack of evidence for the 
translocation of nano-TiO2 to the liver [190] might be due to the high limit of detection caused by 
polyatomic interferences from other molecules of similar molecular weight. In my work Ce 
concentrations were measured by the regular ICP-MS instrument whereas Triple Quadrupole 
ICP-MS instrument was used to determine concentration of Ti in the liver and lung tissue. The 
selected tool is able to overcome polyatomic interferences that imperil accurate determination of 
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trace elements, as Ti. The use of ammonia as a reactive gas, removes the polyatomic interferences 
by the formation of Ti-ammonia clusters with higher, but unique, mass-to-charge ratio.  
Darkfield microscopy combined with hyperspectral imaging (as applied in the CytoViva 
Enhanced Darkfield Hyperspectral Microscopy system, EDFM) is a novel yet powerful tool 
suitable for visualization and characterization of different nanomaterials in various complex 
matrices. Usefulness of the CytoViva method in the detection and characterization of Ti, Ce and 
Ag NPs has been previously demonstrated [191]. By using EDFM we proved that we are able to 
confirm the presence of all 3 NPs in the liver tissue after intratracheal instillation. This denotes 
the translocation of instilled particles from lungs to the liver. It was possible to track down 
particles even when presented in a low quantity due to the minor degree of translocation and 
therefore limited liver burden. We decided to use EDFM not electron microscopy (EM) because it 
offers more rapid and less costly possibility to visualize and identify nanomaterials in the tissue. 
Even though EM could operate at higher magnification and resolution than EDFM, the cost of 
ownership and time needed for the training are in favor of EDFM [140]. Moreover, no additional 
sample preparation is required since sample preparation for EDFM is the same as for the regular 
light microscopy. Light microscopy would not be suitable to accomplish the aim since it is 
inapplicable in characterization of nanomaterial dispersion due to its much lower spatial 
resolution [187]. So far, we were unable to create a reference spectral library, that consists of 
unique spectral signatures for each sample element and would allow us to precisely map all the 
foreign material in the analyzed tissues. Additional work is required to build the library in order 
to identify and localize NPs of the same chemical composition.  
5.2 Biological implications following exposure to NPs 
Pulmonary exposure to NPs is associated with the production of pro-inflammatory cytokines (i.e. 
tumor necrosis factor α - TNF-α, interleukin 1 β - IL-1β and interleukin 6 - IL-6) most likely by 
alveolar macrophages (AM) that engulfed inhaled or instilled particles [192]. However, a recently 
conducted study revealed that AM were not involved in the induction of the inflammatory 
response in lungs after intratracheal exposure to carbon NPs. Instead, type II (ATII) alveolar 
epithelial cells, that exhibited the highest induction of pro-inflammatory gene expression, could 
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be the initiators of acute neutrophilic pulmonary inflammation [193]. Upon secretion of pro-
inflammatory mediators, the inflammatory reaction is further propagated by migration and 
egression of inflammatory cells (i.e. neutrophils and eosinophils) into alveolar space, to the sites 
of inflammation [194,195]. Ongoing lung inflammation leads to induction of pulmonary acute 
phase response [136]. It is characterized by the increased release of several cytokines and other 
mediators, collectively known as acute phase proteins, from the inflamed areas [48]. Many 
scientists suggested that pulmonary inflammation followed by systemic exposure to circulating 
cytokines induces, in turn, acute phase response in the liver [4,43,157]. However, several studies 
conducted in our research group have determined that pulmonary exposure to NPs is indeed 
associated with a strong and sustained acute phase response in lungs whereas no or negligible 
induction of hepatic acute phase response was observed [43]. On the contrary, strong induction 
of hepatic acute phase response was observed after exposure to multi-walled carbon nanotubes 
[58,196]. The possible reason for the divergent response between liver and lung tissue could be 
due to the different impact of particles on residing macrophages. Particles in the lungs are 
retrieved by the AM that in turn, impairs their phagocytic function [197,198], whereas phagocytic 
activity of Kupffer cells, resident liver macrophages, was not affected by the ultrafine CB NP 
accumulation [199].  
Serum Amyloid A, SAA (murine Saa), is one of the major acute phase proteins. Saa is considered a 
murine homologue of C-reactive protein (CRP), the major marker used to assess acute phase 
response in human [200], that is only moderately affected by the various inflammatory factors in 
mice [43,201]. Previous research [43,45,46,56,202] demonstrated that Saa3 mRNA was the most 
upregulated acute phase gene during pulmonary acute phase response and, frequently, the most 
differentially expressed gene. Saa1 was the most differentially expressed acute phase response 
gene in the liver [58]. Therefore, we decided to use the expression level of Saa3 mRNA as a 
biomarker to monitor development of pulmonary acute phase response and Saa1 mRNA as a 
biomarker to monitor development of hepatic acute phase response [135,163].  
Chronic particle-elicited inflammation in lungs leads to augmented systemic release of reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) (and possibly other mediators) from 
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activated phagocytes (macrophages and/or neutrophils) and results in oxidative attack on 
genetic material evoking DNA damage (according to the mechanism of secondary genotoxicity). 
Nonetheless, in the absence of inflammation, genetic damage induced by NPs is also possible 
(according to the mechanism of primary genotoxicity). This may occur via direct pathways (i.e. 
physical interaction between particles and genomic DNA) or via indirect pathways (i.e. ROS 
production by metals or organic constituents) [203].  
Pulmonary exposure is the most relevant route of exposure for particles present in the ambient 
air. This applies for both occupational exposure in the workplace and incidental exposure at the 
home address. Inhaled particles deposit in the pulmonary region and the deposition pattern 
strongly depends on particle size. Upon deposition particles are cleared from the respiratory 
tract by several defense mechanisms in order to keep the mucosal surfaces free from the foreign 
material. A fraction of lung-deposited particles is removed from the upper airways as a result of 
mucociliary escalator-mediated clearance. When the fraction is swallowed it results in secondary 
exposure through the GIT. Additionally, particles deposited in the alveolar region can cross the 
air-blood barrier and by getting access to the systemic circulation and to the regional lymph 
nodes are translocated to various secondary organs of the body. Most of the previous studies 
reported low rate of translocation of pulmonary-deposited particles. Particle translocation to the 
distant tissues strongly depends on size, shape, solubility and surface properties of administered 
nanomaterials.  
It has been previously demonstrated by several scientists that liver is one of the major organs for 
sequestration of NPs translocated from lungs after pulmonary exposure as well as for NPs that 
reached the liver after intended administration (e.g. as a contrast or drug delivery agent). Several 
epidemiological studies showed that pulmonary exposure to NPs is strongly associated with the 
increased risk of respiratory and cardiovascular disorders [63,204] but there are many gaps in 
the knowledge regarding possible consequences of (long-term) hepatic accumulation of NPs and 
the exact molecular mechanism responsible for particle-induced liver toxicity has to be 
elucidated. Therefore, in the present study, we decided to focus our attention on the assessment 
of crucial endpoints related to the liver structure and function. Selected liver and systemic 
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endpoints, i.e. inflammation, acute phase response, genotoxicity, alteration of blood parameters, 
changes in liver biochemistry and histopathological evaluation of the exposed tissues, are 
common toxic effects elicited by NPs and numerous previous studies have shown their usefulness 
in the assessment of health risk posed by NP administration [46,54,76,100,205,206].  
Liver, as a prominent metabolic center of the body, is involved in several crucial metabolic 
processes that maintain body well-being. Moreover, as a defense center is aligned in 
detoxification of xenobiotic and other foreign materials like NPs. Hepatic sequestration of a vast 
amount of NPs that entered the body makes the liver very prone to many diseases and cause 
disturbances in its normal functioning. A detailed mechanism by which NPs evoke liver diseases 
remains unclear due to the significant diversity of NPs and NP components.  
Adverse hepatotoxic effects of ambient particulate matter (PM) air pollutants, including CB, have 
been demonstrated. Several studies using animal models showed that exposure to PM or CB is 
associated with the increased generation of ROS, oxidative DNA damage, production of pro-
inflammatory cytokines, lipid peroxidation and alterations in lipid homeostasis, perturbations in 
glucose metabolism as well as with mutagenic and carcinogenic activity (as reviewed in [8]). 
Moreover, it has been demonstrated that ultrafine CB NPs exert prothrombotic changes on the 
endothelial surface of hepatic microvessels by inducing platelet accumulation in the hepatic 
microcirculation in mice in the absence of inflammatory response in the liver [199].  Such 
noxious effects of NPs could lead to the progression of manifold, both acute and chronic, liver 
diseases like hepatotoxicity, non-alcoholic fatty liver disease (NAFLD), type II diabetes, liver 
fibrosis and, eventually, liver cancer [8].  
Air pollution, a complex mixture of thousands of chemical compounds including particles, has 
been classified by the International Agency for Research on Cancer (IARC) as a potent carcinogen 
[207]. While it is well documented that exposure to particulate matter air pollution is associated 
with lung cancer [63] occurrence of other cancers, like liver cancer, in relation to air pollution 
have been poorly studied. Even though the burden of translocated particles in the liver is several 
orders of magnitude lower than in the lungs, it might be sufficient to induce development of liver 
cancer. Previous epidemiological studies investigated the association between urban air 
62 
 
pollution and the onset of liver cancer [93–96,208]. Most of the studies concluded that the 
ambient air pollution was associated with a higher risk of liver cancer development. Moreover, 
meta-analysis of epidemiological studies with cigarette smokers showed that tobacco smoking is 
also associated with the increased risk of this cancer [209]. The possible explanation of how 
pulmonary exposure to NPs is associated with the carcinogenic process in the liver is 
extrapulmonary translocation of inhaled particles via systemic circulation and protracted 
elimination of NPs once deposited in the liver followed by induction of oxidative stress [210]. 
The three following tables (i.e. Table 3, Table 4, Table 5) summarize results from the relevant 
previous studies where NP-induced hepatotoxicity and other systemic toxic endpoints after 
exposure to TiO2, CeO2 and CB NPs were assessed. In general, all three NPs were able to induce a 
wide range of deleterious effects: inflammation, oxidative stress, genotoxicity, acute phase 
response, alterations of the liver tissue structure and changes in expression of various genes or 
biochemical parameters in the liver tissue. In the present study, we found that all three NPs 
elicited similar pulmonary inflammation that lasted up to day 28 after intratracheal exposure. 
Pulmonary acute phase response was observed also for the three NPs at all assessed time points. 
Negligible and transient induction of hepatic acute phase response was seen only on day 1 
following intratracheal instillation and intravenous injection of TiO2 and CeO2 NPs. An increased 
number of DNA SB in the liver tissue was observed exclusively in CB exposed groups 28 and 180 
days following intratracheal exposure and 1, 28 and 180 days following intravenous injection. 
Increased production of ROS was observed only for CB NPs. There were no alterations in any of 
the selected liver enzymes. Occasional and minor alterations in a few blood markers were 
measured. Histopathological changes in the liver tissue could not be explicitly related to NP 
exposure due to the high background of pathological changes in the control groups. Indications of 
NP presence in the liver tissue were found for all materials. Based on our results we concluded 
that pulmonary response (inflammation and acute phase response) was similar for all tested NPs 
whereas only CB NPs induced genotoxicity in the liver and increased the production of ROS. 
Apart from that, no overt liver or systemic toxicity was observed after exposure to TiO2, CeO2 or 
CB NPs.  
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Nemmar and Nalabotu [76,211] demonstrated that intratracheal instillation of CeO2 NPs was 
associated with oxidative stress, inflammation, histopathological changes and genotoxicity in the 
liver tissue. However, in my study exposure to CeO2 caused induction of pulmonary inflammation 
and acute phase response but negligible induction of hepatic acute phase response. No other 
hepatotoxic effects of CeO2 administration were seen. The discrepancy between my study and 
their study could be due to the different physicochemical characteristics of CeO2 NPs (e.g. surface 
area or shape) or animal model used in the mentioned studies (BALB/C mice and Sprague 
Dawley rats, respectively). Moreover, many researchers [212,213] have demonstrated 
antioxidant activity exhibited by CeO2 NPs in scavenging of both ROS and RNS that could explain 
the lack of CeO2 NP-induced ROS production observed in my study. Kumari, in the two selected 
experiments [126,214], found severe hepatotoxic effects after oral exposure of CeO2 NPs. In 
contrast, in my study there were no noxious effects of CeO2 NPs administration after oral 
exposure. However, the dose used in the Kumari study was extremely high, i.e. up to 2000 or 600 
mg/kg bw, respectively, compared to 9 mg/kg bw administered in my study which could explain 
the observed differences. In the selected studies presented in Table 3 intravenous injection of 
CeO2 NPs was associated with hepatic injury, oxidative stress and pathological lesions in the liver 
(granuloma formation, apoptosis) but as for the oral route, a relatively high dose of cerium, i.e. 85 
or 100 mg/kg bw was used [128,215]. In the study performed by Hirst and colleagues [216] no 
overt toxicity was observed after intravenous or intraperitoneal administration of 0.5 mg/kg bw 
of CeO2 NPs, a dose that is much more similar to the dose used in my study.  
In the selected experiments presented in Table 4 pulmonary exposure to TiO2 NPs resulted in 
oxidative stress and inflammatory response in the liver, changes in expression of genes involved 
in hepatic acute phase response and hepatic genotoxicity [19,150,217]. In contrast, Liang [218] 
and Yin [219] have shown that exposure to TiO2 NPs had only little influence on the liver 
function. This is in a good agreement with my study where pulmonary administration of TiO2 NPs 
was only related to the transient induction of hepatic acute phase response observed in the liver 
after day 1 but not after day 28 or day 180. Despite very low bioavailability reported for TiO2 NPs 
after oral exposure [220], Cui [75,221], Wang [24,25], Sycheva [109] and Shrivastava [222] found 
several hepatotoxic effects of TiO2 NPs following oral administration: liver inflammation, tissue 
64 
 
damage, oxidative stress, disturbances in the normal liver function and genotoxicity. In my study 
oral exposure to TiO2 NPs resulted in decreased absolute and relative liver weight 28 days post-
exposure. However, both Wang and Sycheva used a relatively high dose of TiO2, i.e. 200 and 1000 
mg/kg bw, respectively, that could elucidate the discrepancy. It is well known that size and 
surface area are closely related to the extent of toxic effects induced by NPs - the smaller the 
size/the larger the surface area is the greater toxicity could be evoked [25,223]. In the study 
conducted by Cui [75] the size of TiO2 NPs was 5 nm and the surface area was 174.8 m2/g 
(compared to 10.5 nm and 139.1 m2/g  for TiO2 NPs used in my study) and exposure to these NPs 
resulted in severe damage of mice liver tissue. Moreover, the 10 mg/kg bw dose was 
administered intragastrically for 90 consecutive days thus the total exposure dose was much 
higher than I used. Discrepant results were also reported for the intravenously administered TiO2 
NPs. In the study conducted by Suzuki [224], Umbreit [225] and Elgrabli [226] no hepatotoxic 
effects of TiO2 NPs were observed despite the fact that presence of Ti particles in the liver tissue 
was confirmed. On the other hand, both Xu [227] and Ma [88] reported acute liver toxicity 
followed by histopathological changes in the liver tissue, inflammatory response and alterations 
in basic haematological and biochemical parameters. However, also in this case, a high dose of 
TiO2 was used, i.e. 1387 or 150 mg/kg bw, respectively. Umbreit and colleagues also injected high 
amount of TiO2 NPs, i.e. 560 mg/kg bw, but apart from monitoring changes in body weight gain 
and histological evaluation of the liver tissue, they did not look for any other hepatic or systemic 
toxic endpoints. Liu and colleagues in the two selected studies [89,90] concluded that injection of 
TiO2 NPs caused severe damage to the liver demonstrated by increased liver weight, changes in 
several biochemical parameters and induction of oxidative stress. These alterations were 
however observed in the high exposure groups (i.e 50, 100 and 150 mg/kg bw) and, in addition 5 
nm NPs were used which could be a reason for the more pronounced toxicity. 
Even though neither TiO2 nor CeO2 NPs induced genotoxicity in the liver tissue and no other 
severe signs of hepatotoxicity assessed in the present study were observed we cannot 
unambiguously classify them as safe. Numerous studies demonstrated gross toxicity of TiO2 and 
CeO2 NPs towards liver and other organs and contradictions in the obtained results could be due 
to the physical and chemical features that result in different biological responses even when 
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administered NPs are of the same chemical composition. Immensity of the physicochemical 
properties exhibited by NPs such as size, surface area, shape, structure and elemental 
composition makes the investigation and prediction of their noxious effects very complex and 
challenging.  
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Table 3. Summary of studies assessing CeO2 NPs-induced toxicity 
Ref. Animal 
model 
Route of 
exposure 
Dose Exposure 
time 
NPs size 
(nm) 
Assessed liver and other relevant systemic end-points 
       [211] Balb/c 
mice 
IT 0.5 mg/kg 24 h 20 * significant reduction of antioxidant SOD activity  
    * significant increase of TNF-α and IL-6 levels 
     * significant increase of DNA SB level in the liver tissue measured by comet-assay 
      Conclusion: intratracheal exposure to CeO2 NPs induced oxidative stress, inflammation and 
genotoxicity in the liver tissue 
       [76] SD rats IT 1.0/3.5/7.0 
mg/kg 
28 d 10 ± 1 * the highest dose significantly reduced liver weight 
    * significant increase of liver ceria levels in the highest exposure group 
      * significant elevation of serum ALT level, reduced ALB level, reduced TG level in the group 
exposed to 7.0 mg/kg CeO2 and diminished Na:K ratio in all exposed groups 
      * evidence of (dose-dependent) liver pathology: hydropic degeneration of hepatocytes around the 
central vein region with sparing of the immediate periportal region, enlargement of hepatocytes, 
enlargement of the nucleus in the hepatocytes, binucleation of some hepatocytes, dilatation of the 
sinusoids, occasional focal inflammation areas in a few of the exposed rats 
      Conclusion: intratracheal exposure to CeO2 NPs may be associated with (dose-dependent) 
hepatotoxicity 
       [126] Wistar 
rats 
PO 5 - 2000 
mg/kg 
14 d 23 ± 2 * rats exposed to the highest dose showed dullness, irritation, moribund symptoms and 
insignificant reductions in feed intake, bw gain and relative organ weight 
   * tissue damage and focal areas of necrosis in the liver of rats exposed to the highest dose 
      * significant increase of DNA damage at the dose of 1000 mg/kg in the liver cells and peripheral 
blood leukocytes (measured by comet assay), micronucleus formation in bone marrow and blood 
cells and total cytogenic changes in bone marrow 
      * significant alterations of ALP and LDH activity in serum and GSH content in the liver at the 
highest dose 
      * elevated CeO2 concentration in the liver 
   
 
  Conclusion: oral exposure to CeO2 NPs elicited genotoxicity, biochemical alterations and 
hepatic damage at the high dose level 
      [214] Wistar 
rats 
PO 30/300/ 
600 mg/kg 
28 d 24 ± 2 * rats exposed to high doses of CeO2 NPs exhibited dullness, irritation, moribund symptoms and 
insignificant loss in feed intake, bw gain and relative organ weight 
   * significant increase of % tail DNA in the liver and peripheral blood leukocytes of rats exposed to 
300 and 600 mg/kg bw/day (as assessed by comet assay) 
      * significant increase of ALP and LDH activity in animals exposed to 300 and 600 mg/kg bw/day 
      * significant reduction of GSH content in the liver, kidneys and brain of animals exposed to 300 
and 600 mg/kg bw/day 
      * histopathological alterations in the liver, spleen and brain tissue 
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      Conclusion: prolonged oral exposure to CeO2 NPs caused genetic damage, biochemical 
alterations and histological changes after retention in vital organs of rats at high 
concentrations 
       [128] SD rats IV 85 mg/kg 1h/ 20h 
/30 d 
5 * sequestration of CeO2 NPs by Kupffer cells with subsequent bioretention in parenchymal cells, in 
hepatocytes; the agglomerated nanoceria were localized to the plasma membrane facing bile 
canaliculi; hepatic stellate also sequestrated nanoceria 
    * within the sinusoids deposited nanoceria was associated with granuloma formation comprised 
of Kupffer cells and intermingling CD3+T cells 
      * significant elevation of serum AST level at 1 and 20 h, but subsided by the day 30 after exposure 
      * nanoceria infusion affected hepatocellular programmed cell death in the liver as revealed by 
TUNEL assay; significant elevation of apoptotic cell counts 
      * increased hepatic protein carbonyl level, significant decrease in the liver CAT and GPx activity 
seen 30 days following ceria infusion 
      Conclusion: CeO2 NPs induced hepatic injury and oxidative stress 
       [215] SD rats IV ~100 
mg/kg 
1/7/30/90 
d 
30 * retention of CeO2 NPs by organs of the mononuclear phagocyte system (spleen, liver, bone 
marrow) and associated with adverse changes 
   * no appreciable clearance of CeO2 NPs over the 90 days post-exposure period 
      * short-term reduction in body weight 
      * granulomas in the liver 
      * splenomegaly 
      * time-dependent oxidative stress observed in the liver and spleen 
      Conclusion: despite abnormal changes detected in the liver and spleen IV exposure to CeO2 
NPs did not elicit profound toxicity 
       [216] CD-1 
mice 
PO/IV/IP 0.5 mg/kg weekly 
exposure 
for 2 or 5 w 
3 - 5 * following IV and IP administration the greatest deposition of CeO2 NPs was observed in the 
spleen followed by the liver, lungs, and kidneys; PO administration showed that mice excreted 
greater than 95% of CeO2 NPs via feces within 24 h after exposure 
   * increased WBC counts in IV and IP exposed groups 
     * potential of CeO2 NPs to reduce oxidative stress in vivo 
      Conclusion: lack of overt toxicity induced by CeO2 NPs; the obtained results suggested that 
CeO2 NPs may be a useful antioxidant to diminish oxidative stress 
       [86] SD rats VI 85 mg/kg 30 or 90 d 30 * reduced body weight gain during the first week after administration of CeO2 NPs 
      * histopathological changes observed in the liver tissue (granuloma formation, hepatic apoptosis) 
      * mild (not statistically significant) increase of ALT level  
      Conclusion: retention of CeO2 NPs in the liver over 90 days post-exposure period increased 
hepatic apoptosis and led to granuloma formation  
ALB – albumin, ALT – alanine transaminase, AST – aspartate transaminase, bw – body weight, CAT – catalase, DNA SB – DNA strand breaks, GPx – glutathione peroxidase, 
GSH – glutathione, IL-6 – interleukin 6, IP – intraperitoneal injection, IV – intravenous injection, IT – intratracheal instillation, LDH – lactate dehydrogenase, PO – oral 
exposure, SOD – superoxide dismutase, TG – triglycerides, TNF-α – tumor necrosis factor α, VI – vascular infusion, WBC – white blood cells; 
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Table 4. Summary of studies assessing TiO2 NPs-induced toxicity 
Ref. Animal 
model 
Route of 
exposure 
Dose Exposure 
time 
NPs size 
(nm) 
Assessed liver and other relevant systemic end-points 
       [217] Wistar 
rats 
IT 3.5 or 17.5 
mg/kg 
5 w 23 ± 5 * significant increase of MDA and NO level for both doses and significant decrease of GSH level for 
both doses measured in peripheral blood 
   * significant increase of MDA level and significant decrease of SOD and GSH level for both doses 
measured in the liver homogenate 
     * significant increase of IL-1 and significant decrease of IFN-γ and TNF-α in the high dose group 
     * significant increase of WBC level for both doses 
      * histopathological changes in the liver tissue (persistent and progressive liver inflammatory 
response) 
      Conclusion: intratracheal instillation of TiO2 induced oxidative stress, inflammatory 
response and led to pathological alterations of the liver tissue 
       [218] SD rats IT 0.5/5/50 
mg/kg 
7 d 5 /21 * significant decrease of SOD activity in plasma and liver tissue in a group exposed to 0.5 mg/kg of 
TiO2-S210 
* significant increase of MDA level in the liver tissue in 5 mg/kg and 50 mg/kg exposed groups 
* no significant histopathologic changes observed in the liver tissue 
Conclusions: intratracheal exposure to TiO2 did not significantly altered function of the 
liver tissue 
       [19] C57BL/6 
mice 
IT 18 or 162 
μg/mouse 
24h or 28d 21 * hyperspectral imaging of the liver tissue confirmed presence of TiO2 NPs in the liver of mice 
exposed to both doses at both post-exposure time points 
* 63 genes in the liver (involved in the acute phase response - 49 genes at 24 h and 14 genes at 
28 d) were differentially expressed 
      Conclusion: extrapulmonary translocated TiO2 NPs induced significant changes in 
expression of genes involved in hepatic acute phase response 
       [150] C57BL/6 
mice 
IT 18/54/162 
µg/mouse 
1/3/28 d 10 * significant increase of DNA SB level in the liver tissue for both TiO2 NPs 
* significant increase in Saa1 mRNA levels in the highest dose for both TiO2 NPs 
      Conclusion: intratracheal exposure of unmodified and positively charged TiO2 NPs induced 
genotoxicity and acute phase response in the liver tissue 
       [219] Kunming 
mice 
IH 6.34 ± 0.22 
mg/m3 
8 h/d, for 3 
w 
20 * significant increase of Ti content in the liver tissue 
* significant decrease of WBC and LYMPH level and significant increase of RETIC, NEUT and PLT 
level 
      * significant increase of ALT and AST level 
      * no obvious pathological changes in the liver 
      Conclusion: function of the liver tissue was slightly influenced by the administration of 
TiO2 NPs 
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[75] ICR mice PO 10 mg/kg 90 d 5 * increased Ti content in the liver 
* histopathological alterations of the liver tissue (indications of inflammation and hepatocyte 
damage) 
      * significant reduction of WBC, LYMPH, NEUT 
      * increased level of ALT, AST, ALP, and of LDH, Tchol and TG 
      * significant changes in gene expression profile (up- or down-regulation of genes involved in 
immune/inflammatory response, apoptosis, oxidative stress, metabolic process, response to 
stress, cell cycle, ion transport, signal transduction, cell proliferation, cytoskeleton, and cell 
differentiation) 
      Conclusion: oral exposure to TiO2 induced inflammatory response, liver tissue damage and 
hepatic dysfunction 
       [24] SD rats PO 10/50/200 
mg/kg 
30 d 75 ± 15 * histopathological changes in the liver tissue of young rats observed for the two highest doses 
(liver edema, hydropic degeneration, perilobular cell swelling); infiltration of inflammatory cells 
observed in the liver of adult rats in the 10 and 50 mg/kg TiO2 NPs-treated groups 
* changes in several biochemical parameters measured in young rats serum for the two highest 
doses (GLU, LDL-C, AST, ALT/AST, TBIL, HBDH, CK); changes in TBIL and BUN measured in the 
serum of adult rats 
      * increased plasma GSH/GSSG ratio in both young and adult rats 
      Conclusion: hepatotoxic effects induced by exposure to TiO2 NPs were more sever in young 
than in adult SD rats 
       [109] CBAB6F1 
mice 
PO 40/200/ 
1000 
mg/kg 
7 d 33 * increased number of DNA SB in the liver tissue 
Conclusion: orally administered TiO2 NPs induced genotoxicity in the liver tissue 
       [221] ICR mice PO 5/10/50 
mg/kg 
60 d 7 * changes in normal hepatocytes ultrastructure: mitochondria swelling (5 mg/kg), apoptotic cells 
(10 mg/kg), apoptotic cells and apoptotic body (50 mg/kg) 
* ROS accumulation and lipid peroxidation in 10 and 50 mg/kg exposed groups 
      * significant changes in expression of selected genes (decrease of the stress-related gene 
expression levels of SOD, CAT, GPx, MT, HSP 70, GSTs, P53, and transferrin); significant 
enhancement of cytochrome p4501A expression level in 10 and 50 mg/kg exposed groups 
      Conclusion: intragastric administration of 10 and 50 mg/kg TiO2 NPs caused oxidative 
stress and resulted in alterations of normal hepatocytes structure 
       [222] Swiss 
albino 
rats 
PO 500 mg/kg 21 d 50-75 * indications of oxidative stress in erythrocytes: lipid peroxidation, increased free radical 
generation, alterations in GSH, GPx and GST activities, reduction in SOD and CAT activities 
* significant increase of ROS production in the liver, significant elevation in TBARS level, 
significant reduction in SOD and CAT activities in the liver 
      Conclusion: oxidative stress in erythrocytes and liver tissue occurred after oral 
administration of TiO2 NPs 
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Table 4. – continued 
Ref. Animal 
model 
Route of 
exposure 
Dose Exposure 
time 
NPs size 
(nm) 
Assessed liver and other relevant systemic end-points 
 [25] ICR mice PO 5 g/kg 14 d 28 /80 * changes of serum biochemical parameters (ALT/AST, LDH) 
* indications of hepatic injury (hydropic degeneration around the central vein and spotty necrosis 
of hepatocytes) 
      * significantly elevated hepatic Ti content in mice exposed to 80 nm TiO2 NPs 
      Conclusion: orally administered TiO2 NPs translocated to the liver and caused hepatic 
injury and changes of biochemical parameters 
       [88] ICR mice IV 5/10/50/ 
100/150 
mg/kg 
14 d 5 * increased relative liver weight of animals treated with 50, 100, 150 mg/kg of TiO2 NPs 
* significantly elevated content of TiO2 NPs in the liver of all exposed animals 
     * alterations in gene expression of several inflammatory cytokines: NF-κB, MMIF, TNF-α, IL-6, IL-
1β, cross-reaction protein, IL-4, and IL-10 in all exposed groups 
     * alterations of several biochemical parameters: ALT, AST, ALP, LDH, PChE, LAP, ALB, GLB in the 
high exposure groups 
      * histopathological changes of the liver tissue in 100 and 150 mg/kg exposed groups 
      Conclusion: intravenous administration of TiO2 NPs induced inflammatory response and 
injury of the liver tissue 
       [226] SD rats IV 1.7 mg/rat 10 min, 1h, 
1/7/ 
28/56d 
< 25 * increased Ti content in the liver for all assessed time points 
* no significant histopathological alterations of the liver tissue 
     * no significant changes in any of the assessed liver biochemical and blood parameters 
     Conclusion: lack of toxic effects of intravenously administered TiO2 NPs 
       [224] C57BL/6J 
mice 
IV 2/10/50 
mg/kg 
4 w ~146 
(DLS) 
* majority of the injected TiO2 NPs in the liver were found in the sinuses and inside Kupffer cells 
whereas some were occasionally observed in the liver parenchymal cells 
* level of DNA damage (assessed by comet assay) as well as frequency of gpt and spi- mutations in 
the liver tissue were not affected by the TiO2 administration 
      Conclusion: exposure to TiO2 did not induce genotoxic effects in the mouse liver 
       [227] ICR mice IV 140/300/ 
645/1387 
mg/kg 
14 d 40 ± 5 * decreased food and water intake and decreased physical activity in the 1387 mg/kg dose group 
observed 7 days after treatment 
* significant decrease in relative liver weight in the 300 and 645 mg/kg dose groups 
     * significant decrease of direct bilirubin and indirect bilirubin in the 300 and 645 mg/kg dose 
groups 
     * significant increase of WBC counts in the 645 mg/kg dose group 
      * histopathological lesions (inflammatory cells infiltration, granulomas lesions, necrosis of 
hepatocytes, multifocal lesions) were observed in the liver 
      Conclusion: intravenous injection of different doses of TiO2 NPs could lead to acute liver 
toxicity 
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       [225] Balb/c 
mice 
IV/SI IV: 56 or 
560 
mg/kg;  
SI: 560 or 
5600 
mg/kg 
1/2 d 
2/4/12/ 
26 w 
12 - 30 * mice in the high s.i. dose group exhibited greater body weight gain at weeks 2 and 4 
* presence of TiO2 agglomerates in the liver tissue confirmed by light microscopy 
    * no liver tissue damaged was observed at any assessed time point 
     Conclusion: despite the presence of administered TiO2 NPs in the liver tissue no overt 
histopathological changes were observed 
       [113] B6C3F1 
mice 
IP 50 mg/kg 3 d 10 * increased Ti content in the liver 
* DNA damage in the liver tissue (as assessed by Comet assay) and increased oxidative DNA 
damage in the liver tissue (as assessed by enzyme-modified Comet assay) 
      * significant changes in gene expression profile (up- or down-regulation of genes involved in 
metabolic processes) 
      Conclusion: intraperitoneal exposure to TiO2 induced genotoxicity and interrupted 
metabolic homeostasis in the liver 
       [228] Wistar 
rats 
IP 63/126/ 
252 mg/rat 
24 or 48 h 50 ± 6 * significant increase of serum GOT and ALP activity 
* histopathological changes of hepatocytes (hydropic degeneration, cloudy swelling, fatty 
degeneration, portal and lobular infiltration by chronic inflammatory cells) 
      Conclusion: TiO2 NPs induced histologic changes in hepatocytes and compromised normal 
liver function 
       [229] ICR mice IP/IH 138 mg/kg 
of IP + 1mg 
of TiO2 
NPs via 
nasal 
exposure 
for the next 
7 days 
7 d < 25 * 15 out of 1400 selected proteins exhibited greater than 2-fold expressional changes in response 
to TiO2 administration (the proteins were involved in inflammation, apoptosis and antioxidative 
response) 
* significant increase of ALT, AST and ALP level in serum 
     *  decrease of CAT and SOD activity (assessed by the measurement of band intensity on the 
activity staining gel) 
     Conclusion: differentially expressed proteins may be involved in TiO2 NPs-induced 
hepatotoxicity 
       [230] Swiss 
mice 
IP 50/250/ 
500 mg/kg 
7/14/45 d 21 * significant decrease in hepatic total protein, glutathione and total antioxidant capacity; 
significant increase in AST, ALT, CAT, NO and MDA levels measured for all doses and time points 
* increased number of aberrant cells in the mice bone marrow 45 days post-injection of 500 mg of 
TiO2 NPs/kg body weight 
      * histopathological changes of the liver tissue 
      Conclusion: function of liver enzymes, markers of oxidative stress and liver histological 
structure were greatly influenced in a dose and time-dependent manner by IP injection of 
TiO2 NPs resulting in profound hepatotoxicity 
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Table 4. – continued 
Ref. Animal 
model 
Route of 
exposure 
Dose Exposure 
time 
NPs size 
(nm) 
Assessed liver and other relevant systemic end-points 
[231] Wistar 
rats 
IP 1.6 g/100 g 3 or 12 
months 
5/10/ 
150 
* histological evaluation confirmed presence of TiO2 NPs in the liver parenchyma, either outside 
the cells or phagocytosed by Kupffer cells at both time points 
* histopathological changes in the liver tissue (foci of necrosis, inflammatory cells infiltration) at 3 
and 12 months post-exposure 
      * significant time-dependent decrease in TiO2 NPs (10nm) concentration was observed in liver 
      * significant increase of CAT (all treatment groups) and TRAP (5 nm exposed group) activity in the 
liver tissue 
      Conclusion: exposure to different size TiO2 was associated with pathological lesions and 
oxidative stress in the liver tissue 
       [89] ICR mice ACI 5/10/50/ 
100/150 
mg/kg 
14 d 5 * increased relative liver weight of mice exposed to 50, 100 and 150 mg/kg bw of TiO2 NPs 
* significant increase of hepatic Ti level in all experimental groups 
     * significant increase of production of superoxide radical anion, H2O2 and MDA levels in the liver 
of mice exposed to 50, 100, and 150 mg/kg bw of TiO2 NPs 
      * significant reduction in activities of hepatic antioxidative enzymes i.e. SOD, CAT, GPx and APx in 
the liver of mice exposed to 50, 100 and 150 mg/kg bw of TiO2 NPs 
      Conclusion: antioxidative responses of liver were reduced in mice treated with TiO2 NPs 
       [90] ICR mice ACI 5/10/50/ 
100/150 
mg/kg 
14 d 5 * significant accumulation of Ti in the liver of mice from all experimental groups 
* increased relative liver weight of mice exposed to 50, 100 and 150 mg/kg bw of TiO2 NPs 
     * significant changes in biochemical liver parameters (i.e. elevation of ALT, ALP, LAP, ChE, TP, ALB 
and reduction of TBIL level) of mice exposed to 50, 100 and 150 mg/kg bw of TiO2 NPs 
      * significantly elevated contents of TG, GLU and HDL cholesterol 
      Conclusion: high doses of TiO2 NPs caused severe damage to the liver 
ACI – abdominal cavity injection, ALB – albumin, ALP – alkaline phosphatase, ALT – alanine transaminase, APx – ascorbate peroxidase, AST – aspartate transaminase, 
BUN – blood urea nitrogen, CAT – catalase, ChE – cholinesterase, CK – creatine kinase, DNA SB – DNA strand breaks, GLB – globulin, GLU – glucose, GOT – glutamate 
oxaloacetate transaminase, GPx – glutathione peroxidase, GSH – glutathione, GSSG – glutathione disulfide, GSTs – glutathione S transferase, HBDH – hydroxybutyrate 
dehydrogenase, HDL – high-density lipoprotein, HSP70 – heat shock protein 70, IFN-γ – interferon γ, IH – inhalation, IL-1 – interleukin 1, IL-4 – interleukin 4, IL-6 – 
interleukin 6, IL-10 – interleukin 10, IP – intraperitoneal injection, IT – intratracheal administration, IV – intravenous injection, LAP – leukocyte alkaline phosphatase, 
LDH – lactate dehydrogenase, LDL-c – low-density lipoprotein c, LYMPH – lymphocytes, MDA – malondialdehyde, MMIF – macrophage migration inhibitory factor, MT – 
metallothionein, NEUT – neutrophils, NF-κB – nucleic factor-kappa B, NO – nitrogen oxide, PChE – cholinesterase, PLT – platelets, PO – oral gavage, RETIC – reticulocytes, 
ROS – reactive oxygen species, SAA1 – serum amyloid A (1st isoform), SI – subcutaneous injection, SOD – superoxide dismutase, TBARS – thiobarbituric acid reactive 
substances, TBIL – total bilirubin, Tchol – total cholesterol, TG – triglycerides, TNF-α – tumor necrosis factor α, TRAP – total reactive antioxidant potential, WBC – white 
blood cells;  
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Table 5. Summary of studies assessing CB NPs-induced toxicity 
Ref. Animal 
model 
Route of 
exposure 
Dose Exposure 
time 
NPs size 
(nm) 
Assessed liver and other relevant systemic end-points 
       [54] C57BL/6 
mice 
IT 18/54/162 
µg/mouse 
1/3/28 d 14 * lack of hepatic acute phase response (based on Saa3 mRNA expression level) 
* significantly increased number of DNA SB in the liver tissue on day 1 and 28 for all doses 
      Conclusion: pulmonary deposition of CB NPs induced genotoxicity in the liver, the 
secondary tissue 
       [44] C57BL/6 
mice 
IT 18/54/162 
µg/mouse 
1/3/28 d 14 * changes in global hepatic gene expression (significant upregulation of HMG-CoA reductase 
pathway) 
* significant upregulation of Saa3 gene in the liver tissue on day 1 following the exposure  
      * elevated SAA protein level in plasma of mice exposed to 162 µg of CB NPs 
      * alterations in cholesterol homeostasis (decreased HDL and increased LDL level) 
      Conclusion: pulmonary exposure to CB NPs triggered molecular signaling cascades and 
affected liver metabolism 
       [57] C57BL/6 
mice 
IH/IT 42 mg/m3 
11/54/ 
268 
µg/mouse 
Dams were 
monitored 
until 
weaning and 
some 
offspring 
until 
adolescence 
14 * significantly increased number of DNA SB in the liver of time-mated mice and their offspring 
after inhalation exposure 
* no changes in the number of DNA SB in the liver following intratracheal instillation  
Conclusion: maternal exposure to CB NPs by inhalation induced DNA liver damage in 
mothers and in in utero exposed offspring 
       [232] C57BL/6 
mice 
IT 11/54/268 
µg/mouse 
Newborns 
were 
monitored 
until 
postnatal 
day 2 (4 d 
after the last 
maternal 
exposure) 
and dams 
were 
monitored 
until 26 to 
27 d post-
exposure 
14 * altered expression of genes associated with oxidative stress in dams (inflammatory chemokines, 
cytokine receptors, glycoproteins) 
* significant changes in hepatic gene expression in both male and female newborn offspring  
Conclusion: significant hepatic response observed in male and female offspring exposed in 
utero to the highest dose of CB NPs   
 
 
 
 
 
 
 
 
DNA SB – DNA strand breaks, HDL – high density lipoprotein, HMG-CoA reductase – 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, IH – inhalation, IT – 
intratracheal instillation, LDL – low-density lipoprotein, Saa3 – serum amyloid A (3rd isoform); 
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The main objective of my PhD study was to elucidate what mechanism underlays the genotoxicity 
that has been previously found in the liver tissue after pulmonary exposure to TiO2 and CB NPs 
[54,57,150]. Two separate mechanisms contributing to the observed genotoxicity have been 
proposed: primary genotoxicity that refers to the occurrence of DNA damages as a result of direct 
effects of (translocated) particles and their ability to induce increased production of ROS or 
secondary genotoxicity that refers to the DNA lesions that are formed as a result of lung-
mediated inflammation and acute phase response followed by infiltration and circulation of 
various secondary molecular mediators (cytokines, chemokines, ROS, RNS) that could initiate 
downstream toxic effects in secondary organs.  
It was previously speculated [54] that CB NPs as an active generators of ROS (in both cellular 
[233] and acellular systems [99]) and inflammatory response in lungs after pulmonary exposure 
would mediate secondary genotoxicity by means of inflammation and oxidative stress. However, 
none of the mentioned studies where the genotoxic effect of CB NPs (or of TiO2 NPs) was 
observed confirmed the physical presence of particles in the liver tissue. In this study, we 
corroborated extrapulmonary translocation of TiO2 and CeO2 NPs to the liver tissue by means of 
ICP-MS and demonstrated presence of CB NPs in the liver after intratracheal instillation by using 
enhanced darkfield and standard brightfield microscopy. Moreover, we have shown that hepatic 
genotoxicity induced by CB NPs occurred at the later time points (e.g. 28 and 180 days) after 
intratracheal exposure. This is in a good agreement with belated detection of TiO2 and CeO2 NPs 
that were detected in the liver tissue 180 days (in case of TiO2 NPs) or 28 and 180 days (in case of 
CeO2 NPs) post-exposure. This delay in the detection could reflect the time that is needed for the 
extrapulmonary translocation of NPs.  
Among the studied particles only CB NPs induced increased formation of ROS as we determined 
in the cell-free assay. Increased generation of ROS and consequent oxidative stress are one of the 
most frequently reported effects associated with NP exposure [234]. The exact cellular 
mechanism for particle-induced ROS production remains unclear and more studies are needed to 
better understand this phenomenon. However, this mechanism seems to be different for different 
NPs. That could be due to the fact that many acellular properties such as particle surface area, 
size, chemical composition, and presence of metals or other foreign components could modify the 
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toxicity of NPs. Therefore, thorough physicochemical characterization of NPs is required since 
some of the intrinsic properties exhibited by NPs, even by particles of the same chemical 
composition, could lead to increased or decreased catalysation of ROS [234]. In my study, low 
level of endotoxin detected on the surface of CB NPs (0.142 EU/mg CB NPs) [54] excluded the 
hypothesis that organic impurities (e.g. polycyclic aromatic hydrocarbons) contributed to the 
observed genotoxic effect.  
Intratracheal instillation of TiO2, CeO2 and CB NPs resulted in similar lung inflammation and long-
lasting pulmonary acute phase response. We found no significant differences between particles in 
terms of generated response in the lung tissue. Moreover, in the present study hepatic acute 
phase response was observed only on day 1 following intratracheal instillation and intravenous 
injection of TiO2 and CeO2 NPs but not after exposure to CB NPs. Potential explanations that could 
elucidate transient and negligible hepatic acute phase response are: 1) dosing-related stress is 
responsible for the temporary induction of systemic acute phase response, 2) very short duration 
of hepatic acute phase response makes the detection hindered, 3) liver as the major organ 
responsible for detoxification of foreign materials has defense mechanisms against translocated 
particles (as suggested by [19]), 4) particles used in the present study involve other molecular 
pathways and induce different, than Saa, acute phase proteins (as suggested by [135]). In 
addition, lack or negligible induction of inflammatory and acute phase response in the liver was 
previously reported by our research group after exposure to CB (Printex 90) and diesel exhaust 
(NIST) NPs or multi-walled carbon nanotubes [43,54,135]. Therefore, it is very unlikely that the 
observed DNA SB in the liver tissue are caused by the liver inflammation as a result of pulmonary 
exposure and release of circulating cytokines. If that was the case, then all three NPs would 
induce genotoxicity in the liver whereas in my study it was only observed in the CB-exposed 
groups.  
Moreover, Risom and colleagues [235] demonstrated that the DNA SB were rapidly repaired 
within a few hours following the induction. However, in our study DNA SB were observed in the 
liver 28 and 180 days following intravenous injection and intratracheal instillation suggesting 
that they were most likely generated continuously throughout the post exposure period. NPs are 
deposited in the liver primary in the Kupffer cells [37] and hepatic retention is protracted [210]. 
76 
 
Therefore, we think that the potential reason for the continuous induction of newly formed DNA 
SB is the physical presence of NPs in the liver. 
In the experiment conducted by Jackson and colleagues [57] an increased number of DNA SB was 
found in the liver of dams exposed to CB NPs by inhalation but not after intratracheal instillation. 
They concluded that the whole-body inhalation exposure led to the secondary uptake of NPs by 
the GIT due to the fur grooming. To address that issue, we included the oral route in our study. 
Based on the obtained results, i.e. lack of particles detected in the liver and no hepatotoxic or 
systemic effects following oral exposure, we think that the secondary oral exposure does not 
contribute to the observed genotoxicity. Our results are in a good agreement with other studies 
where the translocation of insoluble NPs via GIT in rodents was shown to be very limited 
[13,27,236].  
Taken together, all three NPs induced similar long-lasting pulmonary inflammation and acute 
phase response, and all three NPs were observed in the liver following pulmonary exposure. 
However, only CB NPs induced hepatic genotoxicity and led to the increased production of ROS. 
Therefore, we concluded that the primary genotoxicity associated with the physical presence of 
CB NPs and further generation of ROS may be responsible for the observed DNA SB in the liver. 
In addition, results from studies conducted by Bourdon [44] and Jackson [232] revealed that 
intratracheal instillation of CB NPs induced significant changes in hepatic gene expression and 
caused perturbations in cholesterol homeostasis (decreased HDL and increased LDL levels). It 
has been previously reported that pulmonary deposition of NPs impairs cholesterol homeostasis 
and altered levels of lipids circulating in the blood [43,237]. Therefore, it is reasonable to 
simultaneously study different endpoints due to the variability in responses and toxic effects 
induced by NPs. Different assays have different advantages and limitations thus by using a set of 
different tests, complementary to each other, we reduce the risk that the actual toxicity might be 
overlooked.  
Particle-induced lung inflammation followed by sustained acute phase response could contribute 
to increased risk of cardiovascular disease and atherosclerosis [63,204]. Moreover, genotoxic 
effect of CB NPs observed after intravenous injection and intratracheal instillation suggests that 
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the exposure could be, in a long-term perspective, one of the crucial factors that leads to the 
development of liver cancer. 
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6. CONCLUSIONS AND PERSPECTIVES 
In this thesis, I have assessed hepatotoxic effects of NP deposition in the liver following 
intratracheal instillation (IT), intravenous injection (IV) and oral gavage (PO). 
It has been demonstrated that all three NPs used in the present study, i.e. TiO2, CeO2 and CB, 
underwent extrapulmonary translocation following lung exposure and were sequestrated in the 
liver as assessed by ICP-MS and EDFM. No particles were detected in the liver following oral 
gavage suggesting that the main translocation route for pulmonary-administered NPs is 
translocation via systemic circulation rather than secondary uptake by the GIT due to the action 
of mucociliary escalator as a part of the lung clearance process.  
Both TiO2 and CeO2 exhibited similar primary size (i.e. 10.5 and 13.0, respectively) and despite of 
differences in shape, chemical composition and potential differences in solubility, the calculated 
translocation rates for TiO2 and CeO2 NPs were comparable. This suggests that the main feature 
that governs extrapulmonary translocation to the secondary organs is the primary size of 
particles. 
The observed particle size distributions of CeO2 NPs changed over the 180 days post exposure 
period with a noticeable shift towards smaller particle size which indicates that CeO2 NPs 
undergo in vivo-induced size transformation over time both in lung and liver tissue. However, the 
observed changes did not affect long-term accumulation of CeO2 NPs in the liver. 
Based on the obtained results, all the tested NPs were capable of inducing similar level of 
pulmonary inflammation followed by sustained induction of acute phase response in the lungs 
that lasted up to day 180. Increased DNA SB levels were observed only in the CB NPs groups 
exposed by intratracheal instillation and intravenous injection. This suggests that the observed 
hepatic genotoxicity following exposure to CB NPs was likely caused by the physical presence of 
translocated particles rather than by the effects of circulating secondary mediators released 
during pulmonary inflammation and acute phase response in the lungs. In addition, hepatic acute 
phase response was observed only in CeO2 and TiO2 exposed groups while DNA lesions were 
found only in the liver of mice exposed to CB NPs. This suggests that hepatic acute phase 
79 
 
response did not contribute to the observed genotoxic effects. Moreover, occurrence of 
genotoxicity at the later time points, i.e. 28 and 180 days, but not after day 1 following 
intratracheal exposure indicates the time that is needed for particles being translocated from 
lungs to the liver.   
Among the particles used in the study, CB NPs were the most potent ROS generators. This 
suggests that increased ROS production followed by oxidative stress could be responsible for the 
observed primary genotoxicity.  
No significant alterations in body weight, relative and absolute liver weight as well as in selected 
haematological and biochemical markers were observed. A few parameters were occasionally 
and negligibly altered but since no consistent patterns were found we regarded them as chance 
findings. Overall, collected data suggests that exposure to TiO2, CeO2 and CB NPs, regardless the 
administration route, did not induce prominent systemic (apart from pulmonary inflammation 
and acute phase response) and hepatic (apart from DNA SB generated by CB NPs) toxicity.  
High inflammatory background in the liver of control and exposed groups hindered 
histopathological examination and we were not able to determine whether the observed changes 
were induced by NP exposure. Necrotic changes, likewise, could not be solely associated with the 
NP treatment.  
Overall, results from this thesis provided evidences that liver toxicity is an important part of the 
hazard evaluation of pulmonary-deposited NPs. In the present study assessment of 
hepatotoxicity elicited after exposure to NPs was performed using one exposure dose only and 
there is a need to include more doses as well as include more liver endpoints to fully understand 
the mechanism of NPs-induced systemic toxicity. 
Detailed mechanism involved in extrapulmonary translocation to the systemic circulation and 
further deposition in the secondary organs is not yet fully elucidated and therefore it would be 
very interesting to investigate how exactly NPs are hauled in the blood, what governs deposition 
of NPs in the secondary organs and what is the exact mechanism of NP uptake by different cell 
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types. In addition, potential adverse effects following extrapulmonary translocation to other 
secondary organs (e.g. spleen, heart and brain) deserve further attention. 
Conducted epidemiological studies reported association between exposure to particulate matter 
air pollution and increased risk of hepatic cancer. Therefore, due to the genotoxic effects 
expressed as increased DNA SB levels observed in the liver of mice exposed to CB NPs it would in 
the future studies be of interest to assess mutagenicity of CB NPs and conduct additional long-
term animal studies investigating tumorigenic and carcinogenic outcomes in the liver following 
prolonged presence of CB NPs in that organ.    
In addition, in order to assess the risk posed by NPs more studies are needed to evaluate which of 
the observed toxic effects are due to the direct interaction between particles and target 
cell/tissue and which are mediated by the chemical messengers (like cytokines, chemokines etc.). 
Contradictory results from different studies of the same nanomaterials and exposure routes 
indicate that detailed and standardized characterization of various physicochemical properties of 
the tested NPs is required to make the comparison of endpoints assessed in different studies 
feasible. Moreover, further studies are needed to extend the current knowledge concerning 
physical and chemical properties that influence toxicity of NPs.  
My PhD study was one of many other studies investigating mechanisms of particle-driven 
toxicity. More studies using realistic exposure levels are needed to fully understand noxious 
effects following exposure to NPs present in the real-life and not in the laboratory environment. 
Moreover, more human studies on occupational and accidental exposure to NPs with the 
assessment of several liver endpoints would contribute substantially to the evaluation of NPs-
pose health threat.  
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ABSTRACT 
Background: 
Recent findings indicate that cerium oxide (CeO2) nanoparticles (NPs) may undergo in vivo-induced size 
transformation with the formation of smaller particles that could result in a higher translocation following 
pulmonary exposure compared to virtually insoluble particles, like titanium dioxide (TiO2). Therefore, we 
compared liver deposition of CeO2 and TiO2 NPs of similar primary sizes 1, 28 or 180 days after intratracheal 
instillation of 162 µg of NPs in female C57BL/6 mice. Mice exposed to 162 µg CeO2 or TiO2 NPs by 
intravenous injection and oral gavage were included as reference groups to assess the amount of NPs that 
reach the liver bypassing the lungs and the translocation of NPs from the gastrointestinal tract to the liver, 
respectively. Mice exposed to vehicle by all exposure routes were included as controls. 
Results: 
Pulmonary deposited CeO2 NPs were detected in the liver tissue 28 and 180 days post-exposure and TiO2 
NPs were detected in the liver tissue 180 days post-exposure as determined by darkfield imaging and by 
the quantification of Ce and Ti mass concentration by inductively coupled plasma mass spectrometry (ICP-
MS). Both Ce and Ti concentrations increased over time and 180 days post-exposure the calculated 
translocation was 2.87 ± 3.37 % and 1.24 ± 1.98 %, respectively, of the initial pulmonary dose. Size 
distributions of CeO2 NPs determined by single particle ICP-MS showed that the size of CeO2 NPs in both 
lung and liver tissue decreased over time.  No NPs were detected in the liver following oral gavage. 
Conclusion: 
Our results suggest that pulmonary deposited CeO2 and TiO2 NPs translocate to the liver with similar 
calculated translocation rates despite their different chemical composition and shape. The observed 
particle size distributions of CeO2 NPs indicate that CeO2 NPs undergo in vivo processing over time both in 
lung and liver. The fact that no particles were detected in the liver following oral exposure indicates direct 
translocation of NPs from lung to the systemic circulation being the most important route of translocation 
for pulmonary-deposited particles. Overall, our data indicates that liver toxicity may be an important part 
of the hazard evaluation of inhaled NPs. 
 
Keywords – Cerium oxide, Titanium dioxide, Nanoparticles, Liver, Translocation, Size transformation, Intratracheal instillation, 
Intravenous injection, Oral gavage 
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BACKGROUND 
Unique properties exhibited by nanoparticles (NPs) 
such as small size, large surface area and high reactivity 
as compared to fine particles or bulk material has led to 
the development of a wide range applications of NPs in 
science, technology and medicine. NPs can be used in 
various day-to-day consumer products including 
cosmetics, electronics, sporting goods, paints, lacquers 
and tires. They could also serve as food additives, 
pharmaceuticals and be utilized in medical applications 
(e.g. targeted drug delivery and bioimaging). Therefore, 
several portals of entry and different target tissues exist 
[1–4]. Understanding the deposition fate of NPs after 
administration to the body is a crucial part of hazard 
evaluation of nanomaterials. 
Both CeO2 and TiO2 NPs have versatile applications 
and are widely use in everyday life products. Cerium 
oxide (CeO2) can be used as an abrasive agent for 
chemical-mechanical planarization of advanced 
integrated circuits [5], polishing agent for glass mirrors, 
television tubes and ophthalmic lenses [6], oxygen 
sensor [7], diesel fuel catalyst to improve combustion 
and reduce consumption of the fuels [6] and in solid 
oxide fuel cells [8]. Titanium dioxide (TiO2) is widely used 
as white pigment due to its brightness and high 
refractive index [9] and therefore utilize in paints, 
coatings, cosmetics (sunscreen, toothpaste) and in 
pharmaceuticals [10]. Moreover, it has been approved 
as a food additive in Europe (also known as E171) used 
in candy and chewing gum [11].  
Inhalation is the most relevant exposure route for 
occupational exposure to NPs. It has been previously 
observed that particles deposited in the lungs after 
inhalation or intratracheal instillation are cleared from 
the respiratory tract by various clearance mechanisms 
and various routes. Inhaled particles, deposited 
preferentially in the alveolar region, are cleared mainly 
by macrophage-mediated phagocytosis. Internalized 
particles gradually moved toward the mucociliary 
escalator in the upper airways [12]. Once the particles 
reach the bronchi, they are transported up into the 
pharynx and when swallowed, cause gastrointestinal 
tract (GIT) exposure [2,13–15]. Nonetheless, the uptake 
of NPs by the GIT has been shown to be very low [9,15–
17]. Inhaled NPs may also migrate across the alveolar 
epithelium, through interstitium, access systemic 
circulation directly or via lymphatic vessels and 
accumulate in the liver and spleen [18–23]. Inconsistent 
results regarding the fraction of ultrafine particles (UFP) 
that undergo extrapulmonary translocation and further 
deposition in the secondary organs have been reported 
[14,23–25]. The degree of translocation is influenced by 
various physicochemical properties like size, chemical 
composition, shape, electrical charge [14,26]. 
The liver, among other reticuloendothelial organs, 
seems to be the major organ for particles deposition 
after accessing systemic circulation [27–31]. When 
translocated particles reach the liver, they accumulate in 
the Kupffer cells, specialized macrophages located in the 
liver [27,32,33]. The Kupffer cells constitute the first line 
of the defense against xenobiotics. The clearance rate of 
NPs from Kupffer cells is very slow. Thus, 90% of injected 
gold nanoparticle (40 nm) dose was still detected in the 
liver tissue 6 months after exposure [34]. Previous 
studies indicate that pulmonary exposure to reactive 
NPs is associated with genotoxic effect observed in the 
liver tissue [13,35,36].  
Graham and colleagues [37] recently showed that 
hydro-thermally derived CeO2 NPs undergo in vivo 
processing in the liver tissue over time. The originally 
cube-shaped CeO2 NPs became highly fragmented and 
rounded along their edges ninety days after exposure. 
No NP transformation was observed thirty days after 
exposure. Additionally, the accumulation of 1–3 nm 
crystallites in close proximity to the parental CeO2 NPs 
was observed. Dissolution of high-energy edge sites was 
suggested as the underlying mechanism.  
The aim of the present study was to evaluate 
extrapulmonary translocation of lung-deposited CeO2 
and TiO2 and to assess whether the partial solubility of 
CeO2 affect hepatic accumulation. We also wanted to 
determine size distribution changes of long-term 
deposited particles in the lung and liver tissue. 
 
METHODS 
Preparation of NP suspensions and 
characterization of exposure media 
Powdered cerium oxide (CeO2) was provided by 
Degussa-Quimidroga and powdered titanium dioxide 
(TiO2) was provided by NanoAmor (Nanostructured & 
Amorphous Materials). NP suspensions of 3.24 mg/ml 
were prepared in 2% mouse serum as described in 
[38,39]. In short, stock suspensions of 3.24 mg/ml 
alongside control vehicle were sonicated for 15 min on 
ice, to prevent sample overheating, using a probe 
sonicator operating at 100 W/22.5 kHz (Microson 
ultrasonic cell disruptor, XL-2000 Microson™, Qsonica, 
LLC., equipped with disruptor horn with a diameter of 
3.2 mm and maximum peak-to-peak amplitude of 180 
μm). The size distribution of each produced NP 
suspension was determined by dynamic light scattering 
(Zetasizer Nano-ZS, Malvern Instruments, UK) as 
described in [36,40]. The refractive index and light 
absorption for the test materials were: 2.2 and 0.1, 
respectively, for CeO2, 2.903 and 0.1, respectively, for 
TiO2. Optical data for water were used for the control 
vehicle. 
Preparation and analysis of electron microscopy 
samples 
Samples were dispersed on TEM (Transmission 
Electron Microscope) grids covered with holy carbon foil 
according to a standard protocol for diameter and 
morphological analyses of nanomaterial in SEM  
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Table 1. Instrumental settings for ICP-MS analysis 
Parameter (unit) Ce analysis 
Ce single particle 
analysis 
Ti analysis 
RF power (W) 1550 1550 1550 
Plasma gas flow rate (l/min) 14 14 15 
Nebulizer gas flow rate (ml/min) 
 
~1.1 ~1.1 ~1.1 
Auxiliary gas flow rate (ml/min) 
 
~0.8 ~0.8 ~0.1 
Cell gas flow rate (ml/min) n/a n/a 2 ml/min NH3/He 
(10/90)  
+ 1 ml/min He 
Monitored isotopes (m/z) 140Ce 140Ce, 197Au Q1 → Q2 masses: 48→ 
150 (Ti);  
45 → 130 (Sc)  
Dwell time (ms) 10 3 100 
Nebulizer type 
 
 
 
Low-flow 
concentric 
nebulizer 
Low-flow 
concentric 
nebulizer 
Agilent MicroFlow 
(model no. G3139A-100) 
Spray chamber type Cyclonic, Peltier-
cooled (quartz) 
Cyclonic, Peltier-
cooled (quartz) 
Scott double-pass, 
Peltier-cooled (quartz) 
 
 (Scanning Electron Microscope) and TEM. 0.2 mg of 
CeO2 and 0.5 mg of TiO2 were dispersed in 8 ml of N-
methyl 2-pyrrolidone and incubated for 10 min in an 
ultrasound bath. The dispersion was sonicated using a 
probe sonicator with a 13 mm probe tip for 10 min at 
10 % amplitude on ice. After sonication, 10 µL of sample 
was dispersed onto a TEM-grid. The samples were dried 
in a vacuum chamber for 5 min. Afterwards samples 
were further dried under red light (warming lamp) for 
24 h. 
Images were recorded at the ZEISS facility in 
Oberkochen, Germany by curtesy of Dr. Xiong Liu, using 
a GeminiSEM 300 equipped with a STEM detector 
(ZEISS, Oberkochen, Germany). Plasma cleaning was 
applied to the samples inside the microscope chamber, 
to derive a better image quality. 
Animal study  
216 young adult C57BL/6 (B6JBOM-F) female mice 
were purchased from Taconic (Ry, Denmark) at 6 weeks 
of age and body weight of 17.5 ± 0.9 g (mean ± SD). 
Mice were acclimated for 2 weeks before the beginning 
of the experiment. Upon delivery mice were randomly 
divided into experimental groups and control groups 
(n=9) and housed in polypropylene cages (Type III with 
Tapvei bedding and enrichment – nesting material and 
den), 5 or 4 mice in each, under the following 
conditions: 12 h light/12 h dark cycle, room temperature 
of 22°C ± 1° and the relative humidity of 55% ± 5. 
Throughout the whole experiment mice were given a 
standard pellet diet (Altromin No. 1324) and acidified 
water (pH 4) ad libitum. All mice were weighted weekly 
and food intake was noted. For 6 months exposure 
groups, body weight was recorded once in 2 weeks 
intervals after day 28. Mice were observed daily for any 
sign of abnormalities in their clinical appearance. 
Mice were dosed a single dose of 162 µg of CeO2 or 
TiO2 NPs in 50 µl of 2% serum in nanopure water by 
intratracheal instillation (IT), oral gavage (PO) or 
intravenous injection (IV). Control mice received 50 µl of 
2 % serum. The dose corresponds to the pulmonary 
deposition during 13 8-h working days at the Danish 
occupational exposure limit of 10 mg/m3 for TiO2 
assuming 9% alveolar deposition [41,42]. Prior to the 
administration of NP suspension by either intravenous 
injection or intratracheal instillation animals were 
anaesthetized by subcutaneously injection in the neck 
with 0.5 ml/100g of Hypnorm® (Fentanyl citrate 0.315 
mg/ml and Fluanisone 10 mg/ml, Nomeco) and 
Dormicum® (Midazolam 5 mg/ml, Roche) diluted 1:1 in a 
sterile water and mixed together. Orally administered 
mice were not anaesthetized during dosing. 
Intratracheal instillation was performed as previously 
described [42]  In brief, mice were placed on a 40° slope 
(upside down, with the head towards the floor) and a 
diode lamp was located on the larynx for a better 
visualization. A small spatula was used to press the 
tongue towards the lower jaw and the 22 GA BD Insyte 
catheter (Becton Dickinson, Utah, USA) with a shortened 
needle was used to intubate the trachea. A volume of 50 
µl followed by 200 µl air in a 250 µl SGE glass syringe 
(250F-LT-GT, MicroLab, Aarhus, Denmark) was instilled. 
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In order not to block the airways and to assure that the 
NP suspension maintains in the lung, mice were placed 
back into a vertical position with the head up as soon as 
the catheter was removed. For oral gavage, mice were 
gently restrained in a vertical position to immobilize the 
head and the gavage needle (0.9 x 38 mm, NOVA-SCB, 
Sweden) was inserted into the esophagus and further 
toward the stomach. For intravenous injection 
anaesthetized mice were restrained in a Plexiglas 
restraining tube. A tail-vein injection was performed 
with a 0.4 ⨉ 20 mm needle (Terumo Europe, n.v. 3001, 
Leuven, Belgium). After intratracheal instillation, gavage 
and intravenous injection animals were transferred back 
to their cages, heated with a heating lamp and/or 
warming blanket and monitored until they fully 
recovered from anesthesia. The animals did not show 
any adverse effects caused by the administration 
procedure. The study was conducted in the agreement 
with the Danish law regulating experiment on animals 
(Permission 2012-15-2934-00089 C6) and the Technical 
University of Denmark´s animal welfare protocol.  
Necropsy and organ collection 
After the exposure period – 1 day, 28 days or 180 
days, animals were weighted and prepared for necropsy. 
Mice were terminated by the overdose of Hypnorm – 
Dormicum mixture (0.5 – 0.7 ml/100 g). The mice 
abdomen and thorax were opened and all macroscopic 
abnormalities were noted in the autopsy report. Pieces 
of liver and lung tissue for further ICP-MS analysis were 
collected and snapped frozen in cryotubes (NUNC) in 
liquid nitrogen and stored at -80 °C until used. A piece of 
liver tissue was fixated in 4% neutral buffered formalin 
for 24 hours and embedded in paraffin blocks on the 
next day. Lungs were removed intact, filled with 
formalin and submerged in 4% neutral buffered 
formalin. Liver and lungs tissue sections of 3 µm 
thickness were cut and stained with hematoxylin and 
eosin for further light and darkfield microscopy. 
Enhanced darkfield microscopy 
Cytoviva enhanced darkfield hyperspectral system 
(Auburn, AL, USA) was used to detect particles in liver 
and lung, by scanning histological sections at 40x 
magnification in enhanced darkfield mode. Images were 
acquired at 40x and 100x on an Olympus BX 43 
microscope with a Qimaging Retiga4000R camera. 
Uneven illumination in brightfield images was corrected 
using ImageJ [43] and the Calculator Plus plugin via the 
formula: Corrected_image = (image / background) * 
255. The background image was a maximum projection 
of 3 background brightfield images without tissue.  
Determination of mass concentration of Ce and Ti 
in mouse organs by ICP-MS  
The total mass concentration of cerium (Ce) and 
titanium (Ti) in animal tissues (liver and lung) was 
determined by inductively coupled plasma-mass 
spectrometry (ICP-MS). Ultrapure water (18.2 mΩ/cm) 
was obtained from a Millipore Element apparatus 
(Millipore, Milford, MA, USA) and used throughout the 
work.  
Sample preparation  
For analysis of Ce by ICP-MS, approximately 100 mg 
of the liver tissue was thawed, exactly weighed, mixed 
with 1.5 ml of ultrapure water and homogenized using 
an Ultra Turrax homogenizer (DI 25 Basic, Ika-Werke, 
Staufen, Germany) for 3 min at 8000 rpm. For Ti analysis 
Ceramic Bead Tubes (⌀ 1.4 mm, made of zirconium 
oxide, MoBio, Denmark) were used for liver tissue 
homogenization to avoid potential release of Ti-
containing particles from the Ultra Turrax homogenizer. 
Approximately 100 mg of the liver tissue was thawed, 
exactly weighed, mixed with 1.5 ml of ultrapure water 
and ceramic beads and subsequently homogenized for 3 
min using a Tissue Lyser (Qiagen, manufactured by 
Retsch). A volume of tissue homogenate corresponding 
to 40 mg of tissue was transferred to disposable 
standard glass vials (Wheaton® 15x46 mm, cap 13-425) 
and subsequently digested in a mixture of 0.250 ml 
concentrated nitric acid (68% HNO3, PlasmaPure, SCP 
Science, Quebec, Canada) and 0.125 ml hydrogen 
peroxide (Suprapur, Merck, Darmstadt, Germany) in a 
microwave oven (Multiwave 3000, Anton Paar GmbH, 
Graz, Austria) equipped with a 64MG5 rotor at elevated 
temperature and pressure (~ 140°C; max. 20 bar). After 
digestion, ultrapure water was added to a final sample 
weight of 3 g. Samples were further diluted 10- to 1000-
fold with ultrapure water prior to analysis. The rest of 
the Ce and Ti homogenate was stored at -20 °C for single 
particle ICP-MS analysis. Approximately 40 mg of the 
lung tissue was prepared as described above excluding 
the homogenization procedure.  
Analytical technique  
The Ce mass concentration in the tissues was 
determined by using an iCAP Q ICP-MS instrument 
(Thermo Fisher Scientific GmbH, Bremen, Germany) 
equipped with an ASX-520 autosampler (Cetac 
Technologies, Omaha, USA). Typical instrumental 
settings for the analysis are given in Table 1. The 
concentration of Ce was quantified against an external 
calibration curve prepared in 2% nitric acid from a Ce 
stock solution of 1000 µg/ml (SCP Science, Quebec, 
Canada). To reduce carry-over, careful rinsing with 2% 
nitric acid between samples was performed. 
The Ti mass concentration in the tissues was 
determined by using an Agilent 8800 Triple Quadrupole 
ICP-MS instrument (Agilent Technologies, California, 
USA) equipped with an ASX-520 autosampler (Cetac 
Technologies, Omaha, USA). Typical instrumental 
settings for the analysis are given in Table 1. The 
concentration of Ti was quantified against an external 
calibration curve prepared in 2% nitric acid from Ti stock 
solution of 1.000 µg/ml (SCP Science, Quebec, Canada) 
and with scandium (Sc) as an internal standard (stock 
solution of 1.000 µg/ml, SCP Science, Quebec, Canada). 
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To reduce carry-over, careful rinsing with 2% nitric acid 
between samples was performed.  
Blank samples, laboratory duplicates and spiked 
samples were included in all analyses for quality control. 
No suitable certified reference materials for CeO2 or 
TiO2 were available. The limit of detection (LOD) in the 
liver tissue was estimated to be 63 ± 21 ng/g for Ce and 
676 ± 123 ng/g for Ti. LOD in the lung tissue was 
estimated to be 1400 ng/g for Ce and 1467 ± 1025 ng/g 
for Ti. The LOD in tissues varied for the different sample 
types due to different sample intake in the digestion 
step and the sample dilution prior to analysis.  
Determination of size distribution of CeO2 NPs in 
mouse organs by spICP-MS  
Sample preparation 
A previously developed enzymatic digestion 
procedure was modified and applied [44]. Briefly, a 
volume of liver homogenate which contained 25 mg of 
liver tissue or ~ 25 mg of unhomogenized lung tissue 
was mixed with 3 ml of 3 mg/ml Proteinase K solution in 
50 mM ammonium bicarbonate buffer at pH 7.4, 
containing 5 mg/ml SDS and 0.2 mg/ml NaN3 as 
antimicrobial agent and 1 ml of ultrapure water. The 
mixture was incubated over night at 40 °C in a water 
bath under continuous stirring. As a blank sample, 
unexposed liver or lung tissue was included. Prior to the 
spICP-MS measurement, samples were further diluted 
between 100- and 50.000-fold with ultrapure water, 
depending on the Ce mass concentration measured by 
conventional ICP-MS. 
Analytical technique 
The iCAP Q ICP-MS instrument was used for spICP-
MS analysis. Instrument settings are given in Table 1. 
The peristaltic pump was set to 40 rpm for all 
experiments, which corresponded to a sample flow rate 
of approximately 0.4 ml/min, which was accurately 
determined daily by weighing the amount of water that 
was delivered by the peristaltic pump for 1 min. 
 
 
Figure 1. Size distribution of CeO2 and TiO2 particle 
suspensions obtained by DLS. CeO2 and TiO2 particle were 
suspended in 2% serum in nanopure water and sonicated as 
described. 
Instrument calibration was achieved by analysis of a 
blank and five Ce standards ranging from 0.2 to 5.0 ng/l 
diluted from a certified solution in 100x diluted 
enzymatically digested liver tissue. The 140Ce intensity 
for each solution was then averaged from the entire 
length of the analysis (180 s). To evaluate for possible 
instrumental drift over time the standards were 
analyzed at the beginning and the end of the analysis 
sequence. The transport efficiency of the liquid samples 
through the sample introduction system was 
determined according to the “particle frequency” 
method as described by [45] by the measurement of 
reference gold nanoparticle (AuNP) suspension (RM 
8013, National Institute of Standards and Technology, 
Gaithersburg (NIST), MD, USA) with a known average 
particle diameter of 56 nm (based on the measurements 
by transmission electron microscopy provided by NIST) 
and a gold mass concentration of 51.86 ± 0.64 µg/g 
(information value provided by NIST), diluted 106-times 
with ultrapure water. The transport efficiency was 
calculated as the percentage of all Au NPs detected by 
spICP-MS versus the theoretical (calculated) particle 
number in the introduced sample volume, derived from 
the TEM-based average size, the measured uptake rate 
and time of introduction of the sample suspension into 
the ICP-MS instrument. 
For each sample the 140Ce signal intensity was 
continuously monitored for 60 s or 180 s which 
corresponded to 20.000 or 60.000 data points, 
respectively, when using 3 ms dwell time. Following the 
analysis of each sample, ultrapure water was analyzed 
to illustrate if carry-over from the previous 
measurement could be excluded. Intensity data were 
recorded by the ICP-MS software and exported to 
Microsoft Excel 2010 for Windows (Microsoft Inc., USA) 
for further processing. Raw signal intensity data were 
plotted (in counts per second) versus number of events 
to create a signal distribution histogram. Very low signal 
intensities were considered to be instrument 
background or for slightly higher intensity values 
dissolved cerium or cerium clusters. An iterative 
algorithm was applied where particle events were 
distinguished as outliers from the background/dissolved 
ion signal if the measured intensity was more than five 
times the standard deviation of the whole data set as 
described by [46].  
Statistical analysis 
All presented values are expressed as mean ± 
standard deviation of the mean (SD) unless stated 
differently. One-way or two-way analysis of variance 
(ANOVA) was used to analyze the data sets. In order to 
fulfil the normality and variance homogeneity criteria 
some variables were logarithmically transformed. Non-
normally distributed data were ranked before applying 
nonparametric one-way or two-way ANOVA analysis. If 
the statistical significance was reached in the ANOVA 
analysis, Tukey post-hoc multiple comparison test was 
used to test the differences between the test groups. P-
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value of 0.05 was considered significant. All statistical 
analyses were calculated using SAS 9.4 statistical 
software (SAS Institute Inc., Cary, NC, USA). 
 
RESULTS 
Mortality 
After administration of NPs mice were monitored 
daily for any signs of sickness or injury, abnormalities in 
their general appearance as well as changes in their 
behavior. Among 216 mice used in the experiment, 3 
unexpected deaths were reported during the up to 6 
months long post exposure period. These were one 
mouse from the PO 6 months CeO2 group, one mouse 
from IV 28 days control group, one mouse was from IV 6 
months TiO2 group. The causes of death were not 
established and the mice were excluded from the 
experiment. 
Physicochemical characterization of nanomaterials 
The key physicochemical parameters of the studied 
nanomaterials have been previously published and are 
summarized in Table 2. Agglomerate size of particle 
suspensions was determined using dynamic light 
scattering (DLS). The hydrodynamic number-based size 
distribution showed a single peak with the average 
diameter below 100 nm for both CeO2 and TiO2 NP 
suspensions (Fig. 1). Median particle diameters 
measured for CeO2 and TiO2 were 79 nm and 68 nm, 
respectively. Z-average and polydispersity index were 
159.7 and 0.216, respectively, for CeO2 and 125.9 and 
0.122, respectively, for TiO2. 
TEM images  
CeO2 NPs appear as aggregates of primary crystals 
(Fig. 2A). Images taken at high magnification in STEM 
mode (results not shown) showed that the size of 
primary particles varies from few nm up to several tens 
of nanometer. The aggregate size cannot be determined 
from the images obtained. Particles regardless of size 
appear cubic (fluorite structure, space group Fm3m) 
however, the crystalline structure and phase of particles 
was not investigated in the scope of this study.  
TiO2 NPs appear as aggregates of primary crystals 
(Fig. 2B). Images taken at high magnification in STEM 
mode (results not shown) showed that the primary 
particles are needle-like crystals with a length of 50 to 
60 nm and a diameter of 10 to 15 nm.  
Brightfield and enhanced darkfield microscopy of 
lung and liver tissues 
Figures 3 and 4 show lung and liver sections, 
respectively, from mice intratracheally instilled with a 
control vehicle (2 % serum) or 162 µg/animal of CeO2 or 
TiO2 180 days post exposure. Lung sections from mice  
 
 
Figure 2. STEM images of CeO2 NPs (A) and TiO2 NPs (B). 
 
 
Figure 3. Brightfield (1) and enhanced darkfield (2) microscopy 
images of H&E stained lung tissue from intratracheally instilled 
mice that received a control vehicle (A) or 162 µg/animal of 
CeO2 (B) or TiO2 (C) NPs at 180 days post exposure. In the lung 
sections from mice exposed to CeO2 and TiO2 light scattering 
aggregates of foreign material were observed using enhanced 
darkfield microscopy (B2 and C2, respectively, white 
arrowheads). The aggregates exhibited a brownish appearance 
in brightfield (B1 and C1, black arrowheads). 
 
exposed to CeO2 and TiO2 revealed presence of foreign 
material aggregates in the pulmonary region, thus 
documenting successful pulmonary dosing. The 
aggregates showed intense light scattering in enhanced 
darkfield (Fig. 3 B2 and C2, white arrowheads) and had a 
brownish appearance in brightfield (Fig. 3 B1 and C1, 
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Figure 4. Brightfield (1) and enhanced darkfield (2) microscopy images of H&E stained liver tissue from intratracheally instilled mice 
that received a control vehicle (A) or 162 µg/animal of CeO2 (B) or TiO2 (C) NPs at 180 days post-exposure. In the liver sections from 
mice exposed to CeO2 and TiO2 foreign material aggregates were observed using enhanced darkfield microscopy, mainly in 
sinusoids and often close to small nuclei (B and C, respectively, 2, 4 and 6, white arrowheads). The aggregates were not detectable 
in brightfield at 40x magnification (B1, C1) but exhibited a brownish appearance at 100x magnification (B and C, 3 and 5, black 
arrowheads). Appearance of a typical artefact is shown (A, 3-4, arrowheads). Panels 3-6 correspond to the rectangular zones in 
panel 1-2 captured at higher magnification. 
 
Table 2. Key physicochemical parameters of the tested nanomaterials 
 CeO2 TiO2 (rutile)  
Source Degussa/Quimidrogaa NanoAmorb  
Product form Powder Powder  
Primary particle size 13.0 ± 12.1 nma 10.5 nmb  
Specific surface area 56.7 m2/ga 139.1 m2/gb  
Particle density 7.29 g/cm3a 4.23 g/cm3c  
a [47]; b [48]; c[49] 
 
Table 3. Mass recovery of CeO2 as particles by spICP-MS compared to ICP-MS (%) and median particle diameters in the lungs 1 and 
180 days post-exposure. Values are given as mean ± standard deviation. 
Lungs 
Mass recovery of CeO2 as particles compared 
to ICP-MS (%) 
Median particle diameter (nm) 
IT 1 day (N=6) 40 ± 28 35 ± 3 
IT 180 days (N=4) 6 ± 8 25 ± 1 
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Table 4. Mass recovery of CeO2 as particles by spICP-MS compared to ICP-MS (%) and median particle diameters in the liver 1, 28 
and 180 days post-exposure. Values are given as mean ± standard deviation. 
Liver 
Mass recovery of CeO2 as particles compared to ICP-
MS (%) 
Median particle diameter (nm) 
IV 1day (N=3) 66 ± 1 33 ± 1 
IV 28 days (N=2) 39 ± 4 33 ± 1 
IV 180 days (N=3) 13 ± 5 28 ± 1 
IT 180 days (N=5) 13 ± 7 25 ± 1 
 
 
black arrowheads). In the two exposure groups the 
foreign material was predominantly found in the  
alveolar region, retained in macrophages, in the 
interstitium, and in the alveolar lumen (Fig. 3, B-C). 
Sections of liver tissue were scanned for presence 
of foreign material. Liver sections from mice exposed to 
CeO2 and TiO2 by intratracheal instillation revealed the 
presence of light scattering aggregates of foreign 
material that were also visible in brightfield at high 
magnification. The foreign material was predominantly 
found in sinusoids and often in close proximity to small 
nuclei, probably phagocytized by Kupffer cells (Fig. 4 B-
C, white and black arrowheads). In all groups, including 
vehicle controls, highly scattering material with a 
different appearance (intensity, size or color) was 
occasionally found (example in Fig. 4A, arrowheads). The 
localization indicated artefacts from tissue preparation. 
Following oral gavage, neither CeO2 nor TiO2 NPs 
could be detected in liver tissue (Additional file 1).  
Biodistribution of NPs in the liver and lung tissue 
TiO2 and CeO2 content in the liver and lung tissues 
was assessed by quantifying Ce and Ti mass 
concentrations by inductively coupled plasma mass 
spectrometry (ICP-MS). Ce concentrations in the liver 
were statistically significantly increased 28 and 180 days 
after intratracheal exposure to CeO2 NPs when 
compared to the vehicle control (P ≤ 0.001 and 
P ≤ 0.0001, respectively) and when compared to the PO 
exposed groups (P ≤ 0.0001 and P ≤ 0.0001, respectively) 
(Fig. 5 A). Ti concentrations in the liver were statistically 
significantly increased 180 days after intratracheal 
exposure to TiO2 NPs (P ≤ 0.05) when compared to the 
vehicle control, but no statistically significant differences 
between IT and PO groups were found at any of the 
analyzed time points (Fig. 5 B). The proportion of 
particles that had accumulated in the liver 180 days post 
exposure for CeO2 and TiO2 was 2.87 ± 3.37 % and 
1.24 ± 1.98 % (mean ± SD), respectively, of the total 
lung-delivered dose (162 000 ng/lung). The observed 
difference in the translocation was not statistically 
significant. No elevated Ti or Ce concentrations were 
detected in the livers from orally gavaged mice (Fig. 5A 
and 5B). The Ce and Ti concentrations in liver of vehicle 
exposed mice were below detection limit at all assessed 
time points.  
After intratracheal instillation of CeO2 NPs, Ce 
concentrations in lung were statistically significantly 
increased at all assessed time points (P ≤ 0.001 after day 
1, P ≤ 0.0001 after day 28 and P ≤ 0.0001 after day 180) 
compared to vehicle control (Additional file 2). Ti 
concentrations in lung after intratracheal instillation of 
TiO2 NPs were also statistically significantly increased at 
all assessed time points (P ≤ 0.05 after day 1, P ≤ 0.001 
after day 28, P ≤ 0.001 after day 180) compared to 
vehicle control (Additional file 2). At day 1 and day 28 
CeO2 contents in the lungs were statistically significantly 
different compared to TiO2 contents (P ≤ 0.05 and P ≤ 
0.05, respectively) (Additional file 2). The Ce and Ti 
concentrations in lung of vehicle-exposed mice were 
below detection limit at all assessed time points.  
Assessment of Ce NPs size distribution by single 
particle ICP-MS 
The size distributions of CeO2 NPs in the liver and 
lung tissue were assessed by single particle  
ICP- MS (spICP-MS). The spICP-MS was used to analyze 
CeO2 NPs in the size range between 18 and 150 nm. 
Larger NPs were detected in all tissue samples but 
excluded from the quantification. Smaller NPs were 
below the detection limit. The size distribution of CeO2 
NPs in lung tissue (Fig. 7) 1 day after pulmonary 
exposure was similar to the size distribution of the 
administered particles when subjected to the same 
enzymatic treatment as the tissue samples. The mode of 
the size distribution was at around 20 nm and in the 
same range as the size LOD of the method. The median 
particle diameter was 35 nm. 180 days post exposure, 
the size distribution of pulmonary particles shifted 
towards smaller sizes with the median particle diameter 
decreasing from 35 nm (1 day) to 25 nm (180 days). The 
mass recovery of CeO2 NPs compared to ICP-MS 
decreased from 40% ± 28 (1 day, N=6) to 6% ± 8% (180 
days, N=4) presumably due to the shift of the size 
distribution to values below the size LOD of the method 
(Table 3). CeO2 NPs frequency in the lung tissue 1 day 
and 180 days following intratracheal instillation and 
normalized to the % of recovery is presented in 
Additional file 3. 
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Figure 5. Mass concentration of Ce (A) and Ti (B) in liver tissue measured by ICP-MS following intratracheal instillation and oral 
gavage of CeO2 and TiO2 NPs, respectively. Data are presented as mean + SD. An asterisk (*) denotes P ≤ 0.05, (***) P ≤ 0.001, 
(****) P < 0.0001 of Ce or Ti mass concentration in exposed groups compared to vehicle controls. Hashtags (###) denote P < 0.001 
and (####) P < 0.0001 of Ce mass concentration in intratracheally exposed group (IT) compared to orally exposed groups (PO). LOD 
– Limit of detection. 
 
 
One day post exposure, the IV dosed particles 
residing in the liver had the same size distribution as the 
dosed NP dispersion (Fig. 8). The particle size 
distributions were similar 1 and 28 days post exposure 
(median diameter 33 nm). Smaller CeO2 NPs were 
detected 180 days post exposure (median diameter 28 
nm). Similarly to the lung tissues, the mass recovery of 
CeO2 NPs in comparison to ICP-MS decreased from 
66% ± 1 (1 day, N=3) to 13% ± 5 (180 days, N=3) 
(Table 4). CeO2 NPs frequency in the liver tissue 1 day, 
28 days and 180 days following intravenous injection 
and 180 days following intratracheal instillation and 
normalized to % of recovery is presented in Additional 
file 4. 
The size distribution of the NPs that had 
translocated from lung to liver had a size distribution 
that was comparable to the size distribution of the IV 
dosed particles 180 days post-exposure (Fig. 8). Thus, 
the spICP-MS analysis suggested that the CeO2 NP size 
decreased over time both in lung and liver tissue. 
 
DISCUSSION  
Study concept 
We studied liver deposition of CeO2 and TiO2 NPs 
over time following pulmonary exposure in mice. NPs 
deposited in the lungs undergo extrapulmonary 
translocation and liver is one of the major secondary 
organs for particles sequestration [19,50]. NPs may be 
cleared from the lungs via mucociliary escalator 
resulting in subsequent oral exposure or may migrate 
across the alveolar epithelium, through interstitium and  
 
 
Figure 6. Liver content of Ce and Ti NPs detected in the liver 1 
day, 28 days and 180 days following intratracheal instillation 
measured by ICP-MS expressed as percentage (%) of the total 
pulmonary dose of CeO2 and TiO2 found in the liver. Data are 
presented as mean + SD.  
 
 
gain access to the systemic circulation. We show that 
pulmonary deposited CeO2 NPs were detected in the 
liver tissue 28 and 180 days post exposure and TiO2 NPs 
were detected in the liver tissue 180 days post exposure 
as determined by darkfield imaging and by the 
quantification of Ce and Ti mass concentration by ICP-
MS. Darkfield imaging showed that the foreign material 
was predominantly found in sinusoids and often in close 
proximity to small nuclei, probably phagocytized by  
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Figure 7. Particle size distribution of CeO2 NPs in lung tissue 1 
day (N=6) and 180 days (N=4) after intratracheal instillation 
measured by spICP-MS and normalized to the maximum of the 
distribution. The particle size distribution of CeO2 NP in the 
dosed suspension with and without enzymatic treatment is 
shown for comparative reasons. 
 
 
Figure 8. Particle size distribution of CeO2 NPs in liver tissue 1 
day (N=3), 28 days (N=2), 180 days (n=3) after intravenous 
injection and 180 days (N=5) after intratracheal instillation 
measured by spICP-MS and normalized to the maximum of the 
distribution. The particle size distribution of CeO2 NPs in the 
dosed suspension with and without enzymatic treatment is 
shown for comparative reasons. 
 
Kupffer cells. Similarly, previous study reported that IV 
dosed gold NPs accumulated in Kupffer cells in the liver 
[27]. The lack of detection of NPs in the liver following 
oral gavage by either method indicates that the 
presence of NPs in the liver after intratracheal 
instillation cannot be explained by the swallowing of 
fraction of the instilled dose that was transported from 
the respiratory tract via mucociliary escalator 
movements as a clearance mechanism of deposited 
particles. It also suggests that the direct translocation of 
NPs from lung to the systemic circulation is the most 
important route of translocation for pulmonary-
deposited particles. In agreement with this, TiO2 NPs 
have previously been detected in blood smears taken 24 
hours after pulmonary exposure [20].  
Inhalation is a physiological route for exposure to 
NPs present in the ambient air, but we decided to use 
intratracheal instillation since it allowed precise control 
of the delivered dose. In the present study, we exposed 
animals via three different routes therefore it was 
important to deliver the same dose regardless the 
administration method in order to compare results from 
different groups. The dose used in the present study is 
relevant for the occupational exposure and corresponds 
to the pulmonary deposition during thirteen 8-h working 
days at the Danish occupational exposure limit of 10 
mg/m3 for TiO2 assuming the particle size distribution 
previously shown for aerosolisation of similarly sized 
TiO2 NPs [41]. 
Extrapulmonary translocation of NPs 
In the present study 180 days following pulmonary 
exposure 2.87 ± 3.37 % of the total lung-delivered dose 
was found in the liver of mice intratracheally instilled 
with CeO2 NPs while 1.24 ± 1.98 % of the total TiO2 dose 
translocated to the liver. The observed difference in the 
amount of NPs found in the liver was not statistically 
significant despite the difference in solubility as 
described in [51] and the different shapes of the 
particles (cubic in the case of CeO2 and needle-like in the 
case of TiO2 NPs).  
Inconsistent results regarding the fraction of NPs 
that undergo extrapulmonary translocation and further 
accumulation in the secondary organs have been 
previously reported. Some studies [21,23,24,52] 
reported negligible or low rates (below 1 %) of 
translocation of particles primarily deposited in the lung 
to the secondary tissue. Kreyling [23] demonstrated 
“minute” (<1 %) extrapulmonary translocation of 
ultrafine radio-labelled 192Ir particles (15 and 80 nm 
count median diameter) to liver, spleen, kidneys, heart 
and brain of WKY male rats following 1h inhalation and 
measured up to 7 days post-exposure. Size dependent 
translocation was observed with an order of magnitude 
lower 192Ir fraction found in the secondary organs 
following inhalation of 80 nm Ir NPs. Similarly, negligible 
translocation was reported by Sadauskas and co-
workers [24] who found 1.4‰ (measured by ICP-MS) to 
1.9‰ (measured by neuron activation analysis, NAA) of 
the dose in the liver of C57BL mice intratracheally 
instilled with 5 repeated doses of 50 µl 2 nm Au NPs (15 
x 1013 particles/ml) and terminated 24h following the 
last exposure. No gold was detected in the liver of mice 
instilled with 40 nm Au NPs (9 x 1010 particles/ml) and 
117 
100 nm (6 x 109 particles/ml). A study of the distribution 
pattern in male Wistar-Kyoto rats exposed by inhalation 
to ultrafine Au NPs (5 – 8 nm and concentration of 
88µg/m3) demonstrated low, but significant increase of 
gold in blood on day 0 (0.05% of the lung burden) and 
on day 7 (0.04% of the lung burden) (Takenaka et al. 
2006). A human study of ultrafine inhaled technetium 
99m (99mTc)-labelled carbonaceous particles (100 nm, 
mean + SD deposited activity was 26 + 11 MBq) showed 
negligible pulmonary clearance with no detected liver 
radioactivity during the 48-h observation period [52].  
In contrast to the mentioned studies, Yu and 
colleagues [25] demonstrated higher translocation 
(above 1%) of inhaled Au NPs (median size between 76 
and 79 nm and concentration of 2 x 106 #NSPs/cm3) in 
various distant organs of male Wistar rats including 
kidney, spleen, heart, blood, liver, testis and several 
others with 4.9% of the lung concentration detected in 
blood 15 days after exposure. Increased hepatic content 
of Ce NPs following intratracheal instillation was also 
found in male Sprague-Dawley rats. Animals exposed to 
high concentration (7.0 mg/kg b.w.) of CeO2 NPs (~10 
nm) exhibited significantly elevated Ce concentration 
~7% of the initial dose (500 ng/g) 28 days post-exposure 
[30].  
The conflicting results regarding the extent of 
extrapulmonary translocation in the mentioned studies 
are likely due to the differences in the particle 
composition, size, surface properties as well as in the 
experimental set-ups (inhalation vs. instillation or 
method used to determined concentration of NPs in the 
secondary tissues). What is more, most of the studies 
measure extrapulmonary translocation over a short 
period of time and therefore higher translocation over 
longer post-exposure period cannot be excluded. For 
example, Mercer and colleagues [53] detected 7.3 % of 
the initial inhaled dose of MWCNT (5 mg/m3, 5h per day 
for 12 days, 4 times per week) in the liver of C57BL6/J 
mice one year following exposure. In contrast, they 
reported “only” 1.1 % translocation to the liver found on 
day 1. 
Rapid and significant translocation of inhaled 
ultrafine 13C particles (count median diameter of 20-29 
nm) into systemic circulation following subsequent 
deposition in liver was observed [19]. Fisher 344 rats 
were exposed by 6 h whole-body inhalation to 80 or 180 
µg/m3 of 13C NPs and liver burden was monitored up to 
24 h following exposure. A significant amount of 13C NPs 
was detected in the liver as early as 0.5 h post-inhalation 
at the higher exposure concentration. However, in our 
study we found no translocation of particles to the liver 
24 h following the exposure, but this may be caused by a 
high limit of detection in our method. Lack or low level 
of detected particles in the secondary organs could be 
related to the analytical method sensitivity as only a 
small fraction of the administered dose is initially 
translocated.  
 
Absorption of NPs from the GIT 
In the present study, we found no digestive tract 
absorption of either CeO2 or TiO2 following oral gavage. 
Our findings are consistent with other studies which 
have shown that NPs pass through the GIT with no or 
negligible absorption and are eliminated rapidly via 
feces [12].  
Wang [9] found no liver deposition of TiO2 NPs in 
either young or adult Sprague-Dawley rats following 
repeated oral exposure to 200 mg/kg bw of TiO2 NPs (75 
± 15 nm) for 30 consecutive days. The measured Ti 
content in blood, liver, kidney and spleen was not 
statistically different from the control group indicating 
very low absorption of Ti NPs from the gastrointestinal 
tract. Another study on biodistribution of orally 
administered TiO2 NPs demonstrated minute absorption 
from the GIT, but to a very limited extent. Male and 
female Wistar rats were once or repeatedly gavaged 
with 1 ml (exposure suspension concentration of 2.56 
mg/ml) of 5 different TiO2 NPs (mean particles size from 
38 – 267 nm) and investigated up to 90 days. Increased 
Ti-levels were detected in liver and spleen of only a few 
rats. Low Ti levels in mesenteric lymph nodes were 
detected. Overall, this results indicate minor absorption 
of TiO2 in the GIT [17].  
Moreover, a single gavage study conducted by 
other investigators reported no uptake of ultrafine (15 – 
80 nm) 192Ir particles (5 kBq, 0.2 ml) from the GIT of 
male WKY rats demonstrated as lack of detectable 192Ir 
in any of the analyzed tissues and revealed immense 
fecal excretion of particles within 2 - 3 d post-exposure 
[23]. Similarly, a study conducted by Semmler and 
colleagues [15] investigated lung retention and 
clearance of inhaled 192Ir-radiolabelled ultrafine iridium 
particles (15 – 20 nm) in male Wistar-Kyoto rats 
(terminated either 3 weeks, 2 or 6 months post-
exposure) revealed that particles were cleared from the 
peripheral lung via mucociliary escalator action into the 
gastrointestinal tract and were found in feces suggesting 
predominance of this clearance pathway.  
Significantly increased contents of Ti in liver and 
kidney of female CD-1 (ICR) mice exposed by single oral 
gavage to 80 nm TiO2 NPs and in kidney of mice exposed 
to 25 nm TiO2 NPs were reported 14 days post exposure 
[54]. It is worth to emphasize that extremely high dose 
of NPs (5 g/kg bw) was used in this study compared to 
the dose administered in our study (~ 0.009 g/kg bw) 
which could explain the different results. Park and 
colleagues [55] found elevated (however, not 
statistically significantly compared to the control group) 
content of orally administered CeO2 NPs (30 nm) in all 
examined tissues (liver, kidney, spleen, lung, testis and 
brain) of male SD rats. Significantly increased level of Ce 
in lung tissue was found in animals exposed to high dose 
(5 g/kg bw) at all assessed time points (1, 7 and 14 days) 
while it was seen only in lungs of animals exposed to the 
low dose (100 mg/kg bw) after day 1. The presence of 
CeO2 NPs in the lungs could be explained as a side-effect 
of inaccurate dosing method. 
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 In vivo-induced size transformation of CeO2 NPs 
We have observed that the median particle 
diameter decreased for CeO2 NPs deposited both in the 
liver and lung tissue over the 180 days post exposure 
period. A shift towards smaller particle size of IV-
administered CeO2 NPs and increased reactive surface 
area has been previously demonstrated [37]. They 
claimed that in vivo induced size transformation took 
place in the liver 90 days after exposure resulting in the 
onset of very small, 1 – 3 nm, ultrafine crystallites (called 
second-generation ceria particles). In the present study, 
we report shifts in size distributions of CeO2 NPs and 
show in addition, that the change occurs both in liver 
and lung. As a possible mechanism for the in vivo 
processing Graham suggested partial dissolution of ceria 
in the liver with the acidic environments of lysosomes 
promoting the process. Since NPs are primarily found in 
macrophages in both liver and lung tissues [27,56], it is 
very likely that the dissolution occurs intracellularly in 
the lysosomal structures.  
The CeO2 NPs studied by Graham et al. were 
hydrothermally derived CeO2 and the question was 
raised if the in vivo transformation of industrially used 
CeO2 NPs would be different than for hydrothermal 
CeO2. Our study could confirm that a change of size 
distribution in vivo occurs also for CeO2 NPs that are 
used in commercial applications.  
The observed size distributions of CeO2 NPs were 
similar for NPs dosed directly to the liver by IV and the 
NPs that had translocated from the lung. Particle 
translocation from lung has been shown to be strongly 
size dependent [23,26]. However, given the similar size 
distribution of NPs in the liver following IV and IT 
exposure, we were unable to determine whether 
dissolution took place in the lungs resulted in the 
translocation of the smaller particles or whether the 
translocated primary particles underwent partial 
dissolution in the liver.  
In the present study, both CeO2 NPs that 
underwent in vivo hepatic- and pulmonary-induced size 
distribution transformation and virtually insoluble TiO2 
NPs accumulated in liver over time following pulmonary 
exposure. Graham and co-workers have previously 
shown that the dissolved Ce recrystallizes as 1-3 nm 
NPs, which is in the size range that allows urinary 
excretion [27]. However, we have no indication that the 
rate of accumulation of CeO2 NPs was lower than the 
accumulation of TiO2 NPs. Thus, the shift in a size 
distribution towards smaller particles that took place 
both in lung and liver did not lead to reduced liver 
accumulation by increased clearance of Ce NPs from the 
liver.  
Conclusions 
The present results indicate that pulmonary 
deposited CeO2 and TiO2 NPs translocate to the liver. 
Despite different chemical composition and shape of 
particles used in the study the calculated translocation 
rates for Ce and Ti are not significantly different. The 
observed particle size distributions of CeO2 NPs indicate 
that CeO2 NPs undergo in vivo processing over time both 
in lung and liver. There is no indication that the partial 
dissolution in lungs and liver results in increased 
clearance of CeO2 NPs from the organism. The results 
underscore liver toxicity as an important endpoint when 
assessing toxicity of NPs. It is important to establish 
whether the 2.87 % of CeO2 and 1.24 % of TiO2 cleared 
from the lungs and translocated to the liver are 
sufficient to elicit toxic effects in extrapulmonary tissue. 
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Supporting Information – Manuscript 1 
 
Additional file 1. 
Enhanced darkfield microscopy images of H&E stained liver tissue from orally administered mice that 
received a control vehicle (A) or 162 µg/animal of CeO2 (B) or TiO2 (C) nanoparticles 1 day (1) or 180 days (2) 
post exposure. No apparent foreign material was detected.  
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Additional file 2. 
Lung content of Ce and Ti NPs measured by ICP-MS following intratracheal instillation. Data are presented 
as mean ± SD. Asterisks (**) denote P ≤ 0.01, (***) P ≤ 0.001, (****) P ≤ 0.0001 in exposed groups 
compared to vehicle controls. Hashtag (#) denotes P ≤ 0.05 and (##) P < 0.01 between Ce and Ti exposed 
groups. 
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Additional file 3. 
CeO2 nanoparticles frequency in lung tissue 1 day (N=6) and 180 days (N=4) after intratracheal instillation 
measured by spICP-MS and normalized to the % of recovery.  
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Additional file 4. 
CeO2 nanoparticles frequency in liver tissue 1 day (N=3), 28 days (N=2), 180 days (n=3) after intravenous 
injection and 180 days (N=5) after intratracheal instillation measured by spICP-MS and normalized to % of 
recovery.  
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ABSTRACT 
Background: 
Little is known about the mechanism underlying the genotoxicity observed in the liver following pulmonary 
exposure to carbon black (CB) nanoparticles (NPs). The genotoxicity could be caused by the presence of 
translocated particles or by circulating inflammatory mediators released during pulmonary inflammation 
and acute-phase response. To address this, we evaluated induction of pulmonary inflammation, pulmonary 
and hepatic acute-phase response and genotoxicity following exposure to titanium dioxide (TiO2), cerium 
oxide (CeO2) or CB NPs. Female C57BL/6 mice were exposed by intratracheal instillation, intravenous 
injection or oral gavage to a single dose of 162 µg NPs/mouse and terminated 1, 28 or 180 days post-
exposure alongside vehicle control.  
Results: 
Liver DNA damage assessed by the Comet Assay was observed after intravenous injection and intratracheal 
instillation of CB NPs but not after exposure to TiO2 or CeO2. Intratracheal exposure to NPs resulted in 
pulmonary inflammation in terms of increased neutrophils influx for all NPs 1 and 28 days post-exposure. 
Persistent pulmonary acute phase response was detected for all NPs at all three time points while only a 
transient induction of hepatic acute phase response was observed. All 3 materials were detected in the 
liver by enhanced darkfield microscopy up to 180 days post-exposure. In contrast to TiO2 and CeO2 NPs, CB 
NPs generated ROS in an acellular assay. 
Conclusion: 
Our results suggest that the observed hepatic DNA damage following intravenous and intratracheal dosing 
with CB NPs was caused by the presence of translocated, ROS-generating, particles detected in the liver 
rather than by the secondary effects of pulmonary inflammation or hepatic acute phase response. 
 
 
Keywords – Carbon black, Cerium oxide, Titanium dioxide, Nanoparticles, Liver, Intratracheal instillation, Intravenous injection, Oral 
gavage, Genotoxicity, DNA strand breaks 
 
BACKGROUND 
The wide range of nanoparticles (NPs) applications 
leads to increased risk of unintended human exposure 
for consumers as well as for workers in the occupational 
environment. Inhaled NPs constitute a potential health 
risk [1] and therefore, understanding the fate and 
toxicity following pulmonary exposure to NPs has 
become an important issue.  
Inhalation of particles leads to size dependent 
pulmonary deposition [2,3]. A large fraction of the 
pulmonary deposited particles is removed from the 
upper airways by the mucociliary escalator and 
subsequently swallowed resulting in secondary exposure 
through the oral route [4–6]. In addition, a small fraction 
of the pulmonary deposited particles undergo 
translocation and primarily accumulate in the liver but 
also in other secondary organs [7–11]. 
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Inhalation and intratracheal instillation of NPs 
induce pulmonary inflammation which is accompanied 
by a pulmonary acute phase response [12–14]. We have 
previously shown that instillation and inhalation of CB 
Printex 90 NPs induced hepatic genotoxicity in terms of 
increased DNA strand break levels and increased levels 
of oxidative DNA damage [13,15,16]. However, the 
underlying mechanism is not clear. Exposure to particles 
can cause primary or secondary genotoxicity. Primary 
genotoxicity refers to DNA damage caused by direct 
physical interaction between particles and the genomic 
DNA and by ROS-mediated DNA damage in the absence 
of inflammation. Secondary genotoxicity refers to DNA 
damage as a result of action of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) as well as 
other secondary mediators (cytokines, chemokines) that 
are generated during particle-induced inflammation and 
acute phase response in the lungs that could initiate 
DNA damaging processes in the liver including induction 
of a hepatic acute phase response [17,18].  
The NPs used in this work, i.e. titanium dioxide 
(TiO2), cerium oxide (CeO2) and carbon black (CB) are all 
worldwide-used high-volume nanomaterials. Moreover, 
CB is a well-known ROS generator [19] and has been 
shown to be mutagenic [20]. TiO2-induced oxidative 
stress [21] and genotoxicity [22,23] were also previously 
reported. In addition, CeO2-mediated DNA damages 
were confirmed in both in vivo [24] and in vitro [25] 
studies. CB NPs were included in the study as the DNA 
damaging test material in liver whereas TiO2 and CeO2 
NPs were included as inflammogenic NPs with relatively 
low ROS generating abilities.  
The objective of the present study was to assess 
the etiology of particle-induced genotoxicity in the liver. 
We therefore dosed mice with 3 different 
nanomaterials: TiO2, CeO2 and CB by pulmonary, oral 
and intravenous dosing to determine whether the 
observed hepatic DNA strand breaks are caused by 
secondary genotoxicity from pulmonary or hepatic 
inflammatory and acute phase responses or by direct 
genotoxicity from translocated NPs. Oral exposure was 
included to assess the contribution from the secondary 
oral exposure that accompanies particle clearance by 
the mucociliary escalator. Intravenous (IV) exposure was 
included to assess the effect of particle translocation 
and hepatic accumulation. 
 
METHODS 
Animal study 
324 young adult C57BL/6 (B6JBOM-F) female mice 
were purchased from Taconic (Ry, Denmark) at 6 weeks 
of age and allowed to acclimate for 2 weeks before 
exposure. All animals were provided with the standard 
pellet diet (Altromin No. 1324) and acidified water ad 
libitum and housed in polypropylene cages with bedding 
and enrichment at controlled temperature 22 ± 1 °C and 
humidity of 55 % ± 5 and with the reverse 12 h light/12 
h dark cycle. The study was conducted in the agreement 
with the Danish Animal Experimental Inspectorate under 
the Ministry of Justice (Permission 2012-15-2934-00089 
C6) and the Technical University of Denmark’s animal 
welfare protocol. 
Preparation of exposure stock 
TiO2 was provided by NanoAmor, CeO2 was 
provided by Degussa-Quimidroga and CB was provided 
by Evonik Degussa. Physicochemical characteristics of 
particles are presented in Table 1. All three materials 
were suspended in 2% v/v mouse serum from C57BL/6 
mice to a final concentration of 3.24 mg/ml and 
dispersed by sonication for 15 min using Microson 
ultrasonic cell disruptor (XL-2000, Microson™, Qsonica, 
LLC.) equipped with disruptor horn with a diameter of 
3.2 mm and maximum peak-to-peak amplitude of 180 
µm. Suspensions were cooled on ice during the 
sonication procedure to prevent sample overheating. 
Control vehicle, 2 % serum, was also sonicated prior to 
exposure as described above.  
Dynamic light scattering (Malvern Zetasizer Nano 
ZS, Malvern Instruments, UK) was used to determine the 
hydrodynamic size distribution in the sonicated 
suspensions before administration. The suspensions 
were prepared as described above and measured in 
transparent 1 ml disposable cuvettes at the temperature 
of 25 °C. Six consecutively repeated measurements were 
performed. Duration of each measurement as well as 
attenuator index and measurement position within the 
cuvette were determined automatically by the 
instrument. For the calculation of the number-based 
particle size distribution, refractive index and extinction 
coefficient (absorption) for the tested materials were as 
followed: 2.9 and 0.1, respectively, for TiO2, 2.2 and 0.1, 
respectively, for CeO2, 2.02 and 2.0, respectively, for CB 
NPs.  
Exposure of mice 
The mice (n=9 per group) were given a single dose 
of 162 µg of TiO2, CeO2, or CB NPs suspension in a 
volume of 50 µl by intratracheal instillation, intravenous 
injection and oral gavage. Control mice received 50 µl of 
2% serum that served as a vehicle for the preparation of 
NPs suspension. The dose used in the experiment was 
equal to the pulmonary deposition after nine 8 h 
working days at the Danish occupational exposure limit 
of 3.5 mg/m3 for CB [13]. Mice subjected to 
intratracheal instillation and intravenous injection were 
anaesthetized with 0.5 ml/100 g body weight of 
Hypnorm® (Fentanyl citrate 0.315 mg/ml and Fluanisone 
10 mg/ml, Nomeco) and Dormicum® (Midazolam 5 
mg/ml, Roche) by subcutaneous injection in the neck 
prior the NP administration. Orally gavaged mice were 
not anaesthetized before the administration. Pulmonary 
exposed mice were dosed by intratracheal instillation as 
described previously [28]. In short, the sedated mice 
devoted for intratracheal instillation were placed on a 
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Table 1. Selected physicochemical parameters of the tested nanomaterials 
 TiO2 CeO2 CB 
Source NanoAmorb Degussa/Quimidrogaa Evonik-Degussa 
Product form Powder Powder Powder 
Primary particle size 10.5 nmb 13.0 ± 12.1 nma 14 nmc 
Specific surface area 139.1 m2/gb 56.7 m2/ga 295 m2/gd 
Particle density 4.23 g/cm3 e 7.29 g/cm3 a 2.1 g/cm3 d 
a [26]; b [27];c [28]; d [29]; e [30]  
 
40° slope (upside down, with the head towards the 
floor) and a diode lamp was placed on the larynx to 
assure better visualization of the airways. The tongue 
was pressed down towards the lower jaw using a small 
spatula. 22 GA BD Insyte catheter (Becton Dickinson, 
Utah, USA) with a shortened needle used to intubate the 
trachea. The proper position of each catheter was 
confirmed by a highly sensitive pressure transducer. In a 
250 µl SGE glass syringe (250F-LT-GT, MicroLab, Aarhus, 
Denmark) a volume of 50 µl of NP suspension followed 
by 200 µl air was instilled. Control groups received 50 µl 
of a control vehicle prepared as described above. After 
the removal of the catheter mice were placed back into 
vertical position with the head up to assure that the NP 
suspension remains in the lung and that the airways are 
unobstructed. We have previously shown the overall 
and even pulmonary distribution of particles using this 
exposure technique [31,32]. Mice devoted for 
intravenous injection were restrained in plexiglas 
restraining tubes with the tail hanging out of the tube. 
Injection was performed using 0.4 ⨉ 20 mm needle 
(Terumo Europe, n.v. 3001, Leuven, Belgium). After the 
exposure, sedated mice were placed back to their cages, 
heated with a heating lamp and/or warming blanket and 
monitored until they fully recovered from anesthesia. 
Mice devoted for oral gavage were immobilized in a 
vertical position and the gavage needle was inserted 
into the esophagus and further toward the stomach to 
release the suspension of particles. After the exposure, 
mice returned to the cages and were closely monitored.  
Necropsy and cells & tissues collection 
1, 28 and 180 days following administration of NPs 
mice were sedated by Hypnorm/Dormicum mixture (0.5 
– 0.7 ml/100g body weight) followed by the 
exsanguination by withdrawing the heart blood. 
Abdomen and thorax of mice were opened and 
macroscopic examination of all organs was performed. 
All observed abnormalities were noted. After 
withdrawal of the heart blood in the intratracheally 
instilled mice bronchoalveolar lavage (BAL) was 
performed (N=6 mice/group). Lungs were flushed twice 
through the trachea with 0.8 ml of 0.9% sterile saline 
(NaCl) as described [33]. Each flush consisted of 3 up 
and down movements and was performed slowly (5-10 
seconds each). The BAL was stored on ice until the 
centrifugation at 400 g for 10 minutes at 4 °C (Ole Dich 
centrifuge) was performed. The supernatant, BAL fluid 
(BALF), was collected in 1.5 ml tubes, snap-frozen in 
liquid nitrogen and stored at -80 °C until used. The BAL 
cells were re-suspended in 100 µl HAMS-F12 medium 
(HAMS-F12, GIBCO #21765, with 1% 
penicillin/streptomycin and 10% fetal bovine serum). 
BAL cells devoted for comet assay were prepared by the 
following procedure as described [33]: 40 µl of the cell 
suspension was mixed with 60 µl of cell culture freezing 
medium (HAMS-F12 with 1% penicillin/streptomycin, 
10% fetal bovine serum and 10% of DMSO), divided into 
two 50 µl aliquots and stored at -80 °C until used. The 
total number of cells presented in the BAL fluid was 
determined using the Nucleo-Counter NC-100 with 
NucleoCassette™ (Chemometec, Allerød, Denmark). 20 
µl of the cell suspension was mixed with 180 µl HAMS 
F12 medium, suspension was divided into 2 aliquots and 
live/dead cells were counted according to the 
manufacturer’s instructions. For the estimation of 
cellular composition in BAL fluid rest of the cell 
suspension (approximately 40 µl) was deposited on the 
microscope slide by centrifugation at room temperature 
for 4 min. at 55 000 g in a Cytofuge® 2 (StatSpin, 
TRIOLAB, Brønby, Denmark). The slides were fixed in 
96% ethanol for 5 minutes and stained with May-
Grünwald-Giemsa dye using standard staining protocol. 
The cellular composition was quantified on 200 cells 
under light microscope (100 x magnifications). The liver 
(N=9/group) and lungs (N=6/group) were divided into 
specific pieces, snap frozen in liquid nitrogen in 
cryotubes (NUNC) and stored at – 80 °C for later use. For 
all mice throughout the whole experiment samples were 
taken from the same parts of organs. Specimens from 
livers (N=9/group) and lungs (N=3/group) were fixed in 
4% neutral buffered formaldehyde, paraffin-embedded 
and 4 μm thick sections were stained with hematoxylin 
and eosin for microscopical examination. 
Brightfield and darkfield microscopy 
Cytoviva enhanced darkfield hyperspectral system 
(Auburn, AL, USA) was used to detect particles in the 
liver tissue, by scanning histological sections at 40 x in 
enhanced darkfield mode. Darkfield images were 
acquired at 40 x and brightfield images were acquired at
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Figure 1. Dynamic light scattering number-based size 
distribution graph of TiO2, CeO2 and CB particles suspension 
(3.24 mg/ml in 2% serum) with a unimodal peak of the average 
diameter below 100 nm. 
 
40x and 100 x on an Olympus BX 43 microscope with a 
Qimaging Retiga4000R camera. Uneven illumination in 
brightfield images was corrected using ImageJ [34] and 
the Calculator Plus plugin via the formula: 
Corrected_image = (image / background) * 255. The 
background image was a maximum projection of 3 
background brightfield images without tissue. 
Preparation of mRNA and cDNA from the liver and 
lung tissue 
Total RNA was isolated from the frozen liver and 
lung tissue (16 – 20 mg) on Maxwell ® 16 (Promega, 
USA) using Maxwell® 16 LEV simply RNA Tissue Kit 
(AS1280, Promega, USA) following the manufacturer’s 
protocol. Tissue lysis was performed by vigorously 
shaking the samples using a Tissuelyser (Qiagen, 
Denmark) with a 5 mm stainless steel beads for 60 s. 
DEPC-treated nuclease-free water was used to elute the 
mRNA. Complementary DNA (cDNA) was prepared using 
TaqMan® reverse transcription reagents (Applied 
Biosystem, USA) as stated in manufacturer’s protocol. 
Concentration of total mRNA was determined by 
NanoDrop 2000c (ThermoFisher, USA).  
Real-time RT-PCR 
Gene expression levels of Saa1 in the liver tissue 
and Saa3 in the lung tissue were assessed using 
quantitative PCR as described previously [23,35]. 18S 
RNA served as a reference gene. Each of the analyzed 
samples was run in triplicates using ViiA7 Real-Time PCR 
detector (Applied Biosystem, USA). TaqMan® 
predeveloped reagents were used throughout the 
analysis. Target and reference gene expression was 
quantified in triplicates in separate wells. Target gene 
expression was determined by the comparative method 
2- ΔCt.  
 
Comet assay 
DNA strand break levels were quantified by the 
comet assay in the liver and lung tissue and BAL cells as 
described in [36]. In brief, single-cell suspension of the 
liver and lung tissue was obtained by the 
homogenization of the deep frozen liver and lung piece 
in an ice-cold Merchant’s buffer through a stainless steel 
mesh (diameter 0.5 cm, mesh size 0.4 mm) mounted on 
a syringe, to yield individual cells. The BAL fluid cells 
were thawed in a 37 °C water bath before diluting with 
the Mechant’s buffer without the filtration step. The cell 
suspension was embedded in a low melting point 
agarose (0.7 %) and deposited on microscope Travigen 
20-Well CometSlides™. The slides were immersed in a 
lysing solution and stored overnight at 4 °C. 
Subsequently, samples were treated with an alkaline 
buffer and alkaline electrophoresis with circulating ice-
cold electrophoresis buffer was performed (25 min, 38 
V/cm, 0.700 A). Thereafter, slides were neutralized in 
neutralization buffer (0.4 M Tris, pH 7.5), fixed with 96 % 
ethanol and stained with a fluorescent DNA intercalating 
dye SYBRGreen®. DNA strand breaks determined as the 
% of DNA in the comet tail (%TDNA) and as the comet 
tail length (TL) were scored by the fully automated 
PatchFinder™ system (IMSTAR, France). In order to 
control the day-to-day variation and to ensure equal 
electrophoresis efficiency both negative (A549 human 
lung epithelial cell line treated with PBS for 30 min at 4° 
C) and positive (A549 human lung epithelial cell line 
treated with 60 µM H2O2 for 30 min at 4° C,) controls 
were included. The high throughput comet assay 
analysis allowed analysis of all related sample on the 
same day decreasing potential variation due to the 
different electrophoresis or the duration of the 
incubation procedure. 
Determination of ROS-generating ability of NPs 
Assessment of NPs ability to generate ROS was 
performed in vitro in a cell-free environment as 
described previously [19,37]. Briefly, 500 µl of 1 mM 
2’,7’-dichlorodihydrofluorescein diacetate (DCFH2-DA) 
(Invitrogen) was chemically hydrolyzed with 2 ml of 0.01 
M NaOH for 30 min to 2′,7′-dichlorodihydrofluorescein 
(DCFH2). DCFH2-DA probe is light sensitive therefore the 
experiment was conducted in a dark environment. The 
formed DCFH2 was further diluted with 10 ml of 25 mM 
phosphate buffer (pH 7.4) to 0.04 mM. The NPs’ ability 
to generate ROS production was determined in Hank’s 
balanced saline solution (HBSS, without phenol) using a 
final DCFH2 concentration of 0.01 mM. Prior to the 
assay, NPs were sonicated (Branson S-450D) for 16 min 
without a pause and further diluted in HBSS. Generated 
ROS caused formation of 2′,7′-dichlorofluorescein (DCF) 
from DCFH2 that was spectrofluorimetrically measured 
following 3 h of incubation in the dark (37°C and 5% 
CO2). Excitation and emission wavelengths were λex = 
490 nm and λem = 520 nm, respectively (Victor Wallac-2 
1420; PerkinElmer, Skovlunde, Denmark).  
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Statistical analysis  
All presented values are expressed as mean ± 
standard deviation (SD) unless stated differently. One-
way or two-way analysis of variance (ANOVA) was used 
to analyze the data sets. In order to fulfil the normality 
and variance homogeneity criteria some variables were 
logarithmically transformed. Non-normally distributed 
data were ranked before applying nonparametric one-
way or two-way ANOVA analysis. If the statistical 
significance was reached in the ANOVA analysis, Tukey 
post-hoc multiple comparison test was used to test the 
differences between the test groups. P-value ≤ 0.05 was 
considered significant. All statistical analyses were 
calculated using SAS 9.4 statistical software (SAS 
Institute Inc., Cary, NC, USA). 
 
Figure 2. Number of neutrophils detected in BAL fluid 
following intratracheal instillation of 162 µg of TiO2, CeO2 or 
CB NPs measured 1, 28 and 180 days after exposure. Particle 
exposed groups n=6, vehicle control n=6. All values are 
presented as mean + SD. An asterisk (*) denotes P ≤ 0.05, (**) 
P ≤ 0.01, (***) P ≤ 0.001 of neutrophil levels in exposed groups 
versus vehicle control. 
 
 
Figure 3. Pulmonary Saa3 mRNA expression levels in mice 
following intratracheal instillation of 162 µg of TiO2, CeO2 or 
CB NPs measured 1, 28 and 180 days after the exposure. Saa3 
mRNA levels were normalized to 18S rRNA. Particle exposed 
groups n=6, vehicle control n=6. All values are presented as 
mean + SD. Asterisks (**) denote P ≤ 0.01, (***) P ≤ 0.001 of 
Saa3 mRNA level in exposed groups versus vehicle control. 
RESULTS 
DLS 
Dynamic light scattering (DLS) was used to 
determine particle agglomerate size of TiO2, CeO2 and 
CB NPs suspensions. The hydrodynamic number-based 
size distribution revealed a narrow, unimodal peak with 
the average diameter below 100 nm for all particle 
suspensions (Fig. 1). The median particle diameter 
measured for TiO2, CeO2 and CB NPs was 68 nm, 68 nm, 
and 51 nm, respectively. Z-average and polydispersity 
index were 131.4 and 0.120, respectively, for TiO2, 148.8 
and 0.174, respectively, for CeO2, 104.3 and 0.157, 
respectively, for CB NPs. 
BAL fluid cellular composition 
Analysis of BAL fluid cellular composition following 
pulmonary exposure to the NPs revealed that 
intratracheal instillation of all three particles resulted in 
increased numbers of total cell counts after day 1 as 
well as increased neutrophil influx in lungs 1 and 28 days 
post-exposure (Fig. 2 and Table 2). Elevation in number 
of total cell counts after day 1 as well as increased 
number of neutrophils at day 1 and day 28 is consistent 
with previous studies [28,38,39]. The distributions of 
total cells, neutrophils, macrophages, lymphocytes, 
eosinophils are shown in Table 2. 
Saa3 mRNA expression in the lung tissue 
Pulmonary acute phase response was assessed as 
Saa3 mRNA expression levels. Analysis of Saa3 gene 
expression revealed acute phase response in the lungs 
following intratracheal instillation of TiO2, CeO2 and CB 
NPs at all three time points. After day 1 and day 28 
pulmonary Saa3 mRNA levels were statistically 
significantly increased compare to the vehicle control for 
all three particles (P ≤ 0.001) with no differences 
between particles. After day 180, pulmonary Saa3 
mRNA levels were statistically significantly increased for 
TiO2 (P ≤ 0.01) and CB (P ≤ 0.001) groups with no 
observed differences between particles (Fig. 3 and 
Additional file 1). 
Overall, our results indicate that pulmonary 
exposure to all three NPs induces pulmonary 
inflammation and pulmonary acute phase response.  
Hepatic presence of NPs 
Hepatic detection of NPs 180 days after 
intravenous injection and intratracheal instillation by 
enhanced darkfield microscopy and brightfield 
microscopy is presented in Figure 4. Aggregates of 
foreign material, visible as white spots were present in 
the liver tissue from mice exposed to TiO2 and CeO2 NPs 
(Figure 4B and 4C, selected NPs marked with white 
arrowheads). In the livers from mice exposed to CB NPs 
black aggregates of foreign material were present 
(Figure 4D, selected NPs marked with black 
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Table 2. BAL fluid cellular composition following intratracheal instillation of 162 µg of TiO2, CeO2 or CB NPs 1, 28  
and 180 days post-exposure  
BAL fluid cellular composition after day 1 
 Control TiO2 CeO2 CB 
Total cells (x 105) 0.9 ± 0.6 2.5 ± 0.9** 3.4 ± 1.1*** 2.4 ± 1.0** 
Neutrophils (x 104) 0.2 ± 0.2 20.2 ± 8.5*** 26.1 ± 9.5*** 20.1 ± 8.3*** 
Macrophages (x 104) 9.0 ± 5.7 4.5 ± 1.9 6.1 ± 1.5 2.9 ± 1.5** 
Lymphocytes (x 102) 1.9 ± 2.9 0.0 ± 0.0 7.1 ± 7.9 0.0 ± 0.0 
Eosinophils (x103) 0.0 ± 0.1 3.0 ± 2.5** 13.3 ± 9.2*** 7.6 ± 6.8** 
BAL fluid cellular composition after day 28 
 Control TiO2 CeO2 CB 
Total cells (x 105) 1.4 ± 0.5 1.1 ± 0.2 1.6 ± 0.7 1.6 ± 0.8 
Neutrophils (x104) 0.6 ± 0.3 1.9 ± 0.9* 2.6 ± 1.6** 3.8 ± 1.7*** 
Macrophages (x104) 7.9 ± 2.0 9.3 ± 2.3 12.9 ± 5.5 11.9 ± 5.5 
Lymphocytes (x102) 8.5 ± 13.7 35.5 ± 44.3 28.3 ± 55.4 53.7 ± 78.1 
Eosinophils (x103) 51.2 ± 39.3 0.1 ± 0.2** 0.2 ± 0.3* 0.0 ± 0.0*** 
BAL fluid cellular composition after day 180 
 Control TiO2 CeO2 CB 
Total cells (x 105) 0.7 ± 0.3 1.0 ± 0.2 0.9 ± 0.3 1.3 ± 0.6 
Neutrophils (x104) 0.3 ± 0.4 0.6 ± 0.4 0.3 ± 0.3 1.1 ± 0.7 
Macrophages (x104) 7.0 ± 2.9 9.4 ± 2.1 8.4 ± 2.9 11.9 ± 4.9 
Lymphocytes (x102) 0.0 ± 0.0 0.0 ± 0.0 0.5 ± 1.1 0.0 ± 0.0 
Eosinophils (x103) 0.3 ± 0.4 0.4 ± 0.5 4.9 ± 6.8 4.9 ± 4.4 
Particle exposed groups n=6, vehicle control n=6. All values are presented as mean ± SD. An asterisk (*) denotes  
P ≤ 0.05, (**) P ≤ 0.01, (***) P ≤ 0.001 of different cells level in exposed groups versus vehicle control.  
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Table 3. DNA strand break levels (% tail DNA) in liver tissue following intratracheal instillation, intravenous injection and oral  
gavage of 162 µg of TiO2, CeO2 or CB NPs 1, 28 and 180 days after the exposure determined by the Comet assay 
DNA SB in the liver following intratracheal instillation 
 Control TiO2 CeO2 CB 
day 1 4.1 ± 4.6 4.3 ± 1.5 3.7 ± 1.4 5.6 ± 3.7 
day 28 3.0 ± 1.4 2.9 ± 0.8 5.2 ± 5.9 9.4 ± 7.2**## 
day 180 3.5 ± 0.8 3.4 ± 1.0 5.5 ± 2.4 12.2 ± 8.7***###† 
DNA SB in the liver following intravenous injection 
 Control TiO2 CeO2 CB 
day 1 3.1 ± 0.9 3.0 ± 1.0 3.7 ± 1.1 17.9 ± 7.9***###††† 
day 28 5.2 ± 4.0 3.6 ± 1.1 9.7 ± 4.9 16.1 ± 10.2***### 
day 180 3.3 ± 0.7 5.8 ± 7.2 3.7 ± 2.0 22.8 ± 11.1***###††† 
DNA SB in the liver following oral gavage 
 Control TiO2 CeO2 CB 
day 1 5.5 ± 3.8 4.6 ± 3.5 7.9 ± 8.6 13.9 ± 10.4 
day 28 3.0 ± 0.6 2.8 ± 0.6 3.3 ± 0.7 2.4 ± 0.6 
day 180 2.8 ± 0.8 3.5 ± 0.9 3.8 ± 3.5 7.2 ± 6.5 
Particle exposed groups n=9, vehicle control n=9. All values are presented as mean ± SD. Asterisks (**) denote P ≤ 0.01, (***) P ≤ 
0.001 of DNA SB levels in exposed groups versus vehicle control. Hashtags (##) denote P ≤ 0.01 and (###) P ≤ 0.001 of DNA SB levels 
in the CB groups compared to TiO2 groups. Cross (†) denotes P ≤ 0.05, (†††) P ≤ 0.001 of DNA SB levels in the CB groups compared 
to CeO2 groups.  
 
Table 4. DNA strand break levels (% tail DNA) in lung tissue 1, 28 and 180 days following intratracheal instillation and from  
the BAL cells 1 and 28 days following intratracheal instillation of 162 µg of TiO2, CeO2 or CB determined by the Comet assay 
DNA SB in the lungs following intratracheal instillation 
 Control TiO2 CeO2 CB 
day 1 3.3 ± 0.8 3.2 ± 0.9 3.8 ± 0.6 4.6 ± 1.0 
day 28 6.1 ± 1.3 5.9 ± 0.9 5.5 ± 1.1 5.3 ± 1.2 
day 180 3.6 ± 1.0 5.2 ± 0.9* 4.2 ± 1.1 5.1 ± 1.4 
DNA SB in the BAL cells  following intratracheal instillation 
 Control TiO2 CeO2 CB 
day 1 4.5 ± 0.7 4.4 ± 0.9 5.6 ± 1.3 5.8 ± 1.2 
day 28 5.9 ± 1.1 4.0 ± 1.0 4.3 ± 1.0 4.0 ± 1.4 
Particle exposed groups n=6, vehicle control n=6. All values are presented as mean ± SD. An asterisk (*) denotes P ≤ 0.05 of   
DNA SB levels in exposed groups versus vehicle control. 
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Figure 4. Enhanced darkfield (A-C) and brightfield (D) results of 
H&E stained liver tissue from intravenously (IV) and 
intratracheally (IT) exposed mice that received control vehicle 
(A) or 162 µg/animal of TiO2 (B), CeO2 (C) or CB (D) NPs 180 
days post-exposure. In the liver sections of mice exposed to 
TiO2 and CeO2 light scattering aggregates were observed using 
enhanced darkfield microscopy (B and C, selected NPs marked 
with white arrowheads). In the liver sections of mice exposed 
to CB NPs black aggregates were observed using brightfield 
microscopy (D, selected NPs marked with black arrowheads). 
 
arrowheads). Following IT exposure (Figure 4B-D, panel 
2) foreign material aggregates were smaller and much 
less frequent than aggregates detected in the liver tissue 
after IV exposure (Figure B-D, panel 1). In all exposure 
groups aggregates were primarily detected in sinusoids 
and partly perivascular and often appeared to be 
phagocytized by Kupffer cells. Black or white spots were 
occasionally also seen in vehicle controls, but the 
appearance and location indicated artefacts from tissue 
preparation. 
 
 
Figure 5. Hepatic Saa1 mRNA expression levels in mice 
following intratracheal instillation (I.T.), intravenous injection 
(I.V.) and oral gavage (P.O.) of 162 µg of TiO2, CeO2 or CB 
measured 1 day after exposure. Particle exposed groups n=9, 
vehicle control n=9. All values are presented as mean + SD. 
Asterisks (**) denote P ≤ 0.01 and (***) P ≤ 0.001 of Saa1 
mRNA level in exposed groups versus vehicle control. Hashtag 
(#) denotes P ≤ 0.05 of Saa1 mRNA level in TiO2 vs CB groups. 
Crosses (†††) denote P ≤ 0.001 of Saa1 mRNA level in CeO2 vs 
CB groups. Double cross (‡) denotes P ≤ 0.05 and (‡‡‡) denote 
P ≤ 0.001 of Saa1 mRNA level in TiO2 vs CeO2 groups.  
 
Saa1 mRNA expression in liver tissue 
Hepatic acute phase response was assessed by the 
measurement of Saa1 mRNA expression levels. Analysis 
of Saa1 gene expression revealed hepatic acute phase 
response on day 1 following intratracheal instillation and 
intravenous injection (Fig. 5 and Additional file 2). No 
other time or particle-related changes in hepatic Saa1 
expression level were observed. 
One day following intratracheal instillation hepatic 
Saa1 mRNA levels were statistically significantly 
increased compared to the vehicle control for TiO2 (P ≤ 
0.01) and CeO2 (P ≤ 0.001) exposed groups. CeO2 NPs 
exposure induced statistically significant higher hepatic 
acute phase response than TiO2 (P ≤ 0.05) and CB (P ≤ 
0.001) exposed groups. 
One day following intravenous injection hepatic 
Saa1 mRNA level was statistically significantly increased 
only for TiO2 compared to the vehicle control (P ≤ 0.01). 
There were statistically significant differences between 
TiO2 and CeO2 (P ≤ 0.001) and between TiO2 and CB (P ≤ 
0.05) exposed groups. 
DNA strand breaks in liver and lung  
DNA strand break levels were determined in the 
liver and lung tissue as well as in the BAL cells using 
comet assay (Table 3 and 4).  
In the pulmonary exposed groups DNA strand break 
levels in the liver tissue expressed as % tail DNA 
(%TDNA) were statistically significantly increased 
compared to the vehicle control in the CB group (3.2 
fold increase, P ≤ 0.01) 28 days following exposure. CB 
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Figure 6. DNA strand break levels in the liver tissue (% tail 
DNA) detected by comet assay following intravenous injection 
of 162 µg of TiO2, CeO2 or CB NPs measured 1, 28 and 180 days 
after exposure. Particle exposed groups n=9, vehicle control 
n=9. All values are presented as mean + SD. Asterisks (***) 
denote P ≤ 0.001 of DNA SB level in exposed groups versus 
vehicle control. Hashtags (###) denote P ≤ 0.001 of DNA SB 
level in TiO2 vs CB groups. Crosses (†††) denote P ≤ 0.001 of 
DNA SB level in CeO2 vs CB groups. 
 
Figure 7. DNA strand break levels in the liver tissue (% tail 
DNA) detected by comet assay following intratracheal 
instillation of 162 µg of TiO2, CeO2, CB measured 1, 28 and 
180 days after exposure. Particle exposed groups n=9, vehicle 
control n=9. All values are presented as mean + SD. Asterisks 
(**) denote P ≤ 0.01, (***) denote P ≤ 0.001 of DNA SB level in 
exposed groups versus vehicle control. Hashtags (##) denote P 
≤ 0.01, (###) denote P ≤ 0.001 of DNA SB level in TiO2 vs CB 
groups. Cross (†) denotes P ≤ 0.05 of DNA SB level in CeO2 vs 
CB groups. 
 
exposure also induced statistically significantly higher 
DNA strand break levels than TiO2 exposure (3.2 fold, P ≤ 
0.01). 180 days after intratracheal instillation %TDNA 
was statistically significantly increased for CB exposed 
group compared to vehicle control (3.8 fold, P ≤ 0.001), 
TiO2 (3.9 fold, P ≤ 0.0001) and CeO2 (2.4 fold, P ≤ 0.05) 
(Table 3). 
Analysis of the %TDNA in intravenously exposed 
groups revealed statistically significantly differences 
between CB and vehicle control and between CB and 
TiO2 and CeO2 exposed groups (5.8, 5.9 and 4.8 fold 
increase, respectively, P ≤ 0.0001 for all groups) 1 day 
following intravenous injection. 28 days post-exposure, 
DNA strand break levels in the CB group were 
statistically significantly increased compared to vehicle 
control (3.1 fold, P ≤ 0.001) and TiO2 exposed group (4.4 
fold, P ≤ 0.0001). 180 days following exposure, DNA 
strand break levels in the CB group were statistically 
significantly increased compared to vehicle control and 
TiO2 and CeO2 exposed groups (6.9, 4.0 and 6.2 fold, 
respectively, P ≤ 0.0001 for all groups) (Table 3). 
In the orally exposed groups %TDNA levels the liver 
tissue were unaffected by exposure at all assessed time 
points (Table 3). 
In the lung tissue after intratracheal instillation 
%TDNA was unaffected by the exposure after day 1 and 
day 28 whereas significant increase in %TDNA was 
measured in TiO2 group compared to vehicle control (1.5 
fold increase, P ≤ 0.05) 180 days post instillation (Table 
4). In the BAL cells %TDNA was unaffected by the 
exposure after day 1 and day 28 (Table 4). DNA strand 
breaks in the BAL cells 180 days following exposure were 
not analyzed as the samples were lost. 
ROS-generation assay  
Among analyzed NPs, CB exhibited the greatest 
ability to generate ROS (Fig. 8). CeO2 NPs also generated 
ROS but the level was negligible and only marginally 
elevated above background. There was no signal 
detected for TiO2 at any of the analyzed concentrations. 
 
DISCUSSION  
We have previously observed that pulmonary 
exposure to reactive NPs induced genotoxicity in the 
liver tissue [13,16,23,40]. Therefore, in the present 
work, we wanted to determine whether the observed 
hepatic DNA strand breaks following pulmonary 
exposure to CB NPs were caused by primary genotoxicity 
due to the direct effects of translocated particles and 
their ability to induce reactive oxygen species formation 
[19] or by secondary genotoxicity caused by pulmonary 
inflammation and acute phase response triggering 
molecular signaling cascade (release of cytokines, 
chemokines and ROS/RNS) that, in turn, initiate 
downstream toxic effects in the liver [40,41]. 
Hepatic genotoxicity and possible mechanism for 
the adverse hepatic effects 
We have recently reported extrapulmonary 
translocation of CeO2 and TiO2 NPs following 
intratracheal exposure (Modrzynska et al., unpublished 
manuscript). Inductively coupled plasma mass 
spectrometry (ICP-MS) analysis revealed increased 
concentrations of Ce and Ti in the liver following 
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Figure 8. NPs-induced generation of reactive oxygen species 
(ROS) measured in a cell-free assay. All values are presented as 
mean +/- SD from 3 independent measurements. 
 
intratracheal instillation. Moreover, enhanced darkfield 
microscopy showed that CB NPs, which due to the high 
abundance of carbon in the ambient air are not 
detectable by ICP-MS, were also present in the liver 
tissue following pulmonary exposure.  
In the present study, intravenous injection of CB 
NPs resulted in increased DNA strand break (SB) levels 1, 
28 and 180 days post-exposure, whereas intratracheal 
instillation of CB induced DNA SBs 28 and 180 days post-
exposure. We recently reported that intratracheally 
instilled TiO2 and CeO2 NPs were detected in the liver 28 
and 180 days post-exposure (in case of CeO2 NPs) or 180 
days (in case of TiO2 NPs) but no NPs were detected 1 
day following the exposure (Modrzynska et al., 
unpublished manuscript). Therefore, of the fact that 
hepatic genotoxicity was only observed at the later time 
points following pulmonary exposure might reflect the 
time needed for particles to translocate in sufficient 
amounts from lungs to the liver. 
It has been previously suggested by Jackson [40] 
that the observed liver DNA SBs could be a result of 
gastrointestinal tract exposure due to the whole-body 
inhalation and further fur grooming. However, our 
results showed lack of translocated CeO2 and TiO2 NPs in 
the liver after oral exposure (Modrzynska et al., 
unpublished manuscript). Overall, no hepatotoxic effects 
were observed following oral gavage since the dosing 
did not elicit neither acute phase response nor 
genotoxicity in the liver. This indicates that the 
secondary oral exposure caused by swallowing a portion 
of lung-deposited particles did not contribute to the 
observed adverse effects. In general, larger dose or 
repeated oral exposure were needed to evoke the toxic 
effect observed in the other studies [24,42,43] 
CB is a well characterized carbonaceous 
nanomaterial and very potent ROS generators 
[20,44,45]. Exposure to CB NPs has been shown to 
induce oxidative DNA damage, increased levels of DNA 
strand breaks [19,46] as well as mutagenicity in vivo and 
in vitro [20,47]. The mutation spectrum observed in vitro 
is consistent with being caused by oxidative DNA 
damage [44]. The aforementioned studies are in a good 
agreement with the present results, showing that CB is 
much more potent in terms of generating ROS than TiO2 
and CeO2 NPs. Moreover, CB NPs contain very low levels 
of organic impurities [20,48,49] that excludes the 
hypothesis that CB-induced genotoxicity is caused by 
polycyclic aromatic hydrocarbons (PAH) that are 
absorbed on particles’ surface.  
Pulmonary acute phase response but no hepatic 
acute phase response 
In our previous studies [12,14,50–52] we 
demonstrated that Saa3 was the most upregulated 
acute phase gene during pulmonary acute phase 
response and, frequently, the most differentially 
expressed gene. Saa1 was the most differentially 
expressed acute phase response gene in the liver [53]. 
Therefore, Saa3 mRNA expression levels were used as a 
biomarker for pulmonary acute phase response whereas 
Saa1 gene as a biomarker for hepatic acute phase 
response [54,55]. 
Pulmonary exposure to all three NPs induced 
similar pulmonary inflammation in terms of neutrophil 
influx that persisted up to day 28 and long-lasting 
pulmonary acute phase response that sustained for 180 
days. The highest induction of acute phase was 
observed after day 1 and declined in a time-dependent 
manner remaining elevated for TiO2 and CB NPs 180 
days following exposure. Pulmonary acute phase 
response was similar for all three particles when 
compared to the control and no differences between 
particles were observed. Thus, if the hepatic 
genotoxicity was caused by systemic circulation of 
pulmonary inflammatory messengers, then all the 
assessed NPs would induce hepatic genotoxicity. 
Instead, hepatic genotoxicity was only observed in CB 
exposed groups. Therefore, it is unlikely that circulating 
cytokines released by pulmonary-mediated 
inflammation and acute phase response caused the DNA 
lesions. Moreover, a recent meta-analysis of global 
transcriptional pattern following pulmonary exposure to 
CB and TiO2 NPs indicated that exposure to CB and TiO2 
induced similar changes in pulmonary transcription [56]. 
Both materials evoked comparable neutrophilic-
dominated lung inflammation and similarly altered 
expression level of many pro-inflammatory genes. In 
addition, our previous studies indicated that CB [15] and 
TiO2 [51] NPs induced similar alterations in the 
expression profile of selected cytokines genes in the 
lung tissue. Demonstrated resemblances in the elicited 
pulmonary response following exposure to CB and TiO2 
should lead to the similar induction level of different 
secondary mediators that would cause similar level of 
hepatic DNA SBs in both exposure groups. Instead, we 
have only observed hepatic genotoxicity in the CB NPs 
exposed mice, which is an additional evidence of 
primary genotoxicity caused by the deposited CB NPs 
rather than by the effects of circulating secondary 
mediators. 
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In the present study, we found induction of hepatic 
acute phase response following lung instillation of TiO2 
NPs and CeO2 NPs and following intravenous injection of 
TiO2 NPs that was present at day 1 but has already 
subsided by the day 28.  Induction of hepatic acute 
phase response was much weaker and shorter than the 
pulmonary acute-phase response. Pulmonary exposure 
to TiO2 increased pulmonary Saa3 expression level 100- 
fold whereas 17.3 fold induction and 9.4 fold induction 
of hepatic Saa1 was measured after intravenous 
injection and intratracheal instillation, respectively. No 
acute phase response was detected in the liver of orally 
gavaged animals. In addition CB NPs exposure by IV or 
IT, in contrast to TiO2 and CeO2 did not induce hepatic 
acute phase response, therefore hepatic acute phase 
response is also not a likely cause of the observed 
genotoxicity. 
We have previously reported negligible or no 
hepatic acute phase response following pulmonary 
exposure measured by analysis of the transcriptional 
changes in liver mRNA of mice exposed to diesel exhaust 
particles (DEP), CB, multi walled carbon nanotubes 
[12,54]. Transient acute phase response in the liver 
tissue was also reported after pulmonary exposure to 
162 µg/mouse of TiO2 as reported by [23]. Hepatic acute 
phase response induced by intravenous injection of gold 
particles has been reported by Zhang and co-workers 
[57]. They used Saa reporter mouse model to detect 
transcriptional activation of hepatic Saa using 
bioluminescence imaging. Their results demonstrated 
that among all of the assessed particles 50 nm Au 
nanospheres exhibited the highest capacity to induce 
activation of hepatic Saa. The highest activation was 
detected 4 h following intravenous injection. The signal 
was transient and gradually declined. In the present 
study lack of detection of hepatic acute phase response 
after intravenous injection of CeO2 and CB at all three 
time points as well as temporary induction of acute 
phase response in the TiO2 group on day 1 could be 
explained by the brief and transient nature of acute 
phase response induction in the liver that causes 
difficulties in the measurement. 
Overall, our results suggest that the observed 
hepatic DNA damage following IV and IT exposure to CB 
was caused by the presence of translocated NPs in the 
liver and their ability to induce oxidative stress rather 
than by secondary effects of pulmonary inflammation 
and acute phase response. Particles deposited in the 
liver are primary accumulated in the Kupffer cells [58]. 
Thus, only a small fraction of the liver cells are directly 
exposed to the particle-generated ROS [40]. Apparently, 
this was sufficient to induce hepatic genotoxicity. 
Our results may also imply that inhaled carbon 
nanoparticles could induce hepatic genotoxicity leading 
to liver carcinogenesis. It is supported by 
epidemiological studies showing that exposure to traffic 
related air pollution is associated with risk of liver cancer 
[59,60]. The International Agency for Research on 
Cancer (IARC) has classified CB NPs as possibly 
carcinogenic to humans [61]. It can be speculated that 
the presence of CB NPs in the liver may, in a long-time 
perspective, contribute to the onset of cancer. 
Conclusions 
Pulmonary exposure to three different NPs, TiO2, 
CeO2 and CB induced long lasting pulmonary 
inflammation and acute phase response. Indications of 
translocation to the liver were found for all NPs. 
However, only CB dosed by IT and IV induced hepatic 
genotoxicity. Therefore, our findings indicate that 
hepatic DNA strand breaks following pulmonary 
exposure to CB are likely caused by direct effects of CB 
NPs that translocate from lung to liver rather than being 
caused by inflammatory or acute phase responses. 
Furthermore, the lack of particle translocation, 
inflammation and acute phase response following oral 
exposure to NPs suggest that the secondary oral 
exposure following pulmonary clearance of inhaled 
particles does not contribute to the observed hepatic 
genotoxicity. 
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Supporting Information – Manuscript 2 
Additional file 1. Pulmonary Saa3 mRNA expression level following intratracheal instillation of 162 µg of 
TiO2, CeO2 or CB NPs 1, 28 and 180 days post-exposure 
Pulmonary Saa3 mRNA expression following intratracheal instillation 
 Control TiO2 CeO2 CB 
day 1 511 ± 938 51977 ± 28702*** 28509 ± 20645*** 22295 ± 11663*** 
day 28 112 ± 36 4227 ± 4388*** 1623 ± 1003*** 3297 ± 2204*** 
day 180 51 ± 6 515 ± 288** 344 ± 433 838 ± 715*** 
Particle exposed groups n=6, vehicle control n=6. All values are presented as mean ± SD. Asterisks (**) 
denote P ≤ 0.01, (***) P ≤ 0.001 of Saa3 mRNA level in exposed groups versus vehicle control. 
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Additional file 2. Hepatic Saa1 mRNA expression level following intratracheal instillation, intravenous 
injection and oral gavage of 162 µg of TiO2, CeO2 or CB NPs 1, 28 and 180 days post-exposure  
Hepatic Saa1 mRNA expression following intratracheal instillation 
 Control TiO2 CeO2 CB 
day 1 1608 ± 1250 
** 
15044 ± 12053 
***†††‡ 
62975 ± 40137 7649 ± 13853 
day 28 1388 ± 634 1321 ± 512 852 ± 724 943 ± 590 
day 180 671 ± 242 1311 ± 1122 852 ± 556 682 ± 147 
Hepatic Saa1 mRNA expression following intravenous injection 
 Control TiO2 CeO2 CB 
day 1 
 
4601 ± 4707 
**#‡‡‡ 
79551 ± 80452 1410 ± 1213 13115 ± 19003 
day 28 961 ± 524 753 ± 419 542 ± 255 543 ± 306 
day 180 592 ± 387 732 ± 739 910 ± 445 848 ± 351 
Hepatic Saa1 mRNA expression following oral gavage 
 Control TiO2 CeO2 CB 
day 1 649 ± 228 715 ± 306 625 ± 260 1158 ± 923 
day 28 875 ± 485 650 ± 315 654 ± 249 332 ± 125 
day 180 945 ± 1322 751 ± 553 984 ± 1324 677 ± 576 
Particle exposed groups n=9, vehicle control n=9. Messenger RNA expression levels were normalized to 18S 
rRNA. All values are presented as mean ± SD. Asterisks (**) denote P ≤ 0.01 and (***) P ≤ 0.001 of Saa1 
mRNA level in exposed groups versus vehicle control. Hashtag (#) denotes P ≤ 0.05 of Saa1 mRNA level in 
TiO2 vs CB groups. Crosses (†††) denote P ≤ 0.001 and below of Saa1 mRNA level in CeO2 vs CB groups. 
Double cross (‡) denotes P ≤ 0.05 and (‡‡‡) denote P ≤ 0.001 of Saa1 mRNA level in TiO2 vs CeO2 groups. 
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BACKGROUND 
Widespread use of nanoparticles (NPs) in various consumer products as well as in 
medicine or industry led to increased human exposure through different portal routes. It 
has been previously shown that particles upon inhalation [1,2], intratracheal instillation 
(IT) [3,4], intravenous injection (IV) [5,6] and oral exposure (PO) [7,8] reach the 
systemic circulation and primarily accumulate in the Kupffer cells in the liver [5,9–12]. 
Intrasinusoidal localization of Kupffer cells, make them efficient scavengers of different 
invading pathogens from the blood circulation [13]. Clearance of particles from the liver 
appears to be very slow [14] and this raises the question of the possible toxicological 
effects of prolonged hepatic accumulation of NPs.  
Liver, as a major metabolic center of the body, plays an important role in detoxification 
of most drugs and other foreign substances. High flow of blood through the liver causes 
substantial exposure to several xenobiotics, including NPs [15]. Our former studies 
demonstrated that intratracheal and intravenous exposure to titanium dioxide (TiO2), 
cerium oxide (CeO2) and carbon black (CB) NPs resulted in liver deposition of all three 
NPs as assessed by inductively coupled plasma mass spectrometry (ICP-MS) and 
enhanced darkfield microscopy (EDFM) (Modrzynska et al., unpublished manuscript 1). 
Moreover, presence of deposited CB NPs induced primary hepatic genotoxicity 
expressed as increased DNA strand break levels evoked by augmented production of 
reactive oxygen species (ROS) (Modrzynska et al., unpublished manuscript 2). NP-
induced genotoxicity in the liver following exposure to CB and TiO2 NPs was also 
formerly reported [16–19].  
Previous studies have shown that sequestration of NPs in the liver is correlated with 
cellular dysfunction and liver injury. IT of CeO2 NPs caused dose-dependent hydropic 
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degeneration, hepatocyte enlargement, sinusoidal dilatation and accumulation of 
granular materials. Concomitant findings demonstrated significant reduction in liver 
weight as well as elevations in serum alanine transaminase level (ALT) [20]. Long-term 
exposure of intragastrically administered TiO2 NPs in mice led to focal inflammatory cell 
infiltration, nucleus vacancy, vein congestion and oedema in the liver tissue. Significant 
elevation in serum biochemical parameters including alkaline phosphatase (ALP), 
aspartate aminotransferase (AST), ALT and lactate dehydrogenase (LDH) was observed 
[21]. In mice intravenously injected with citrate (CT) or polyvinylpyrrolidone (PVP) 
coated silver NPs (10 nm, 40 nm, 100 nm) administration of the smallest particles 
caused severe midzonal hepatocellular necrosis and hemorrhage and occasional portal 
vein endothelial damage, regardless of coating. Moreover, mice injected with 10 nm Ag 
NPs exhibited significant difference in percentage of body weight loss and relative 
spleen weight compared to control group and 40 and 100 nm exposed mice [22]. 
Therefore, to address the possible toxicological effects of hepatic accumulation of NPs 
we dosed mice with three high volume NPs, i.e. TiO2, CeO2 and CB NPs by three different 
routes intratracheal instillation (IT), intravenous injection (IV) and oral gavage (PO) and 
assessed liver function and liver morphology 1, 28 and 180 days post-exposure. 
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MATERIALS & METHODS 
Animal study  
324 young adult C57BL/6 (B6JBOM-F) female mice were purchased from Taconic (Ry, 
Denmark) at 6 weeks of age and body weight of 17.5 ± 0.9 g (mean ± SD). Mice were 
acclimated for 2 weeks before the beginning of the experiment. Upon delivery mice were 
randomly divided into experimental groups and control groups (n=9) and housed in 
polypropylene cages (Type III with Tapvei bedding and enrichment – nesting material 
and den), 5 or 4 mice in each, under the following conditions: 12 h light/12 h dark cycle, 
room temperature of 22 °C ± 1 °C and the relative humidity of 55 % ± 5. Throughout the 
whole study mice were given a standard pellet diet (Altromin No. 1324) and acidified 
water ad libitum. All mice were weighted weekly and feed intake was recorded. For 6 
months exposure groups, body weight was recorded once in 2 weeks intervals after day 
28. Mice were observed daily for any sign of abnormalities in their clinical appearance. 
The study was conducted in the agreement with the Danish Animal Experimental 
Inspectorate under the Ministry of Justice (Permission 2012-15-2934-00089 C6) and the 
Technical University of Denmark’s animal welfare protocol. 
Preparation of NP suspensions and characterization of exposure media 
TiO2 was provided by NanoAmor, CeO2 was provided by Degussa-Quimidroga and CB 
was provided by Evonik Degussa. NP suspensions of 3.24 mg/ml were prepared in 2% 
mouse serum as previously described [23,24]. In short, stock suspensions of 3.24 mg/ml 
alongside control vehicle were sonicated for 15 min on ice, using a probe sonicator 
operating at 100 W/22.5 kHz (Microson ultrasonic cell disruptor, XL-2000 Microson™, 
Qsonica, LLC., equipped with disruptor horn with a diameter of 3.2 mm and maximum 
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peak-to-peak amplitude of 180 μm). The size distribution of each produced NP 
suspension was determined by dynamic light scattering (DLS, Zetasizer Nano-ZS, 
Malvern Instruments, UK) as described in [18,25]. The refractive index and light 
absorption for the test materials were: 2.9 and 0.1, respectively, for TiO2, 2.2 and 0.1, 
respectively, for CeO2, 2.0 and 2.0, respectively, for CB NPs. Optical data for water were 
used for the control vehicle. Selected physicochemical parameters of the tested 
nanomaterials are presented in Table 1. 
Table 1. Selected physicochemical parameters of the tested nanomaterials 
 TiO2 CeO2 CB 
Source NanoAmorb Degussa/Quimidrogaa Evonik-Degussa 
Product form Powder Powder Powder 
Primary particle size 10.5 nmb 13.0 ± 12.1 nma 14 nmc 
Specific surface area 139.1 m2/gb 56.7 m2/ga 295 m2/gd 
Particle density 4.23 g/cm3 e 7.29 g/cm3 a 2.1 g/cm3 d 
a [26]; b [27];c [28]; d [29]; e [30]; 
Exposure of mice 
The mice (n=9 per group) were given a single dose of 162 µg of TiO2, CeO2, or CB NPs 
suspension in 50 µl 2% sibling serum by IT, IV or PO. Control mice received 50 µl of 2% 
serum. The dose used in the experiment was equal to the pulmonary deposition after 
nine 8 h working days at the Danish occupational exposure limit of 3.5 mg/m3 for CB. 
Mice subjected to IT and IV were anaesthetized with 0.5 ml/100 g body weight of 
Hypnorm® (Fentanyl citrate 0.315 mg/ml and Fluanisone 10 mg/ml, Nomeco) and 
Dormicum® (Midazolam 5 mg/ml, Roche) by subcutaneous injection in the neck prior 
the NPs administration. Orally gavaged mice were not anaesthetized before the 
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administration. Pulmonary exposed mice were dosed by IT as described previously [28]. 
In short, the sedated mice devoted for IT were placed on a 40° slope (upside down, with 
the head towards the floor) and a diode lamp was placed on the larynx to assure better 
visualization of the airways. The tongue was pressed down towards the lower jaw using 
a small spatula. 22 GA BD Insyte catheter (Becton Dickinson, Utah, USA) with a 
shortened needle used to intubate the trachea. The proper position of each catheter was 
confirmed by a highly sensitive pressure transducer. In a 250 µl SGE glass syringe 
(250F-LT-GT, MicroLab, Aarhus, Denmark) a volume of 50 µl of NP suspension followed 
by 200 µl air was instilled. Control groups received 50 µl of a control vehicle prepared as 
described above. After the removal of the catheter mice were placed back into vertical 
position with the head up to assure that the NP suspension remains in the lung and that 
the airways are unobstructed. We have previously shown the overall and even 
pulmonary distribution of particles using this exposure technique [31]. Mice devoted for 
IV were restrained in plexiglas restraining tubes with the tail hanging out of the tube. 
Injection was performed using 0.4 ⨉ 20 mm needle (Terumo Europe, n.v. 3001, Leuven, 
Belgium). After the exposure, sedated mice were placed back to their cages, heated with 
a heating lamp and/or warming blanket and monitored until they fully recovered from 
anesthesia. Mice devoted for oral gavage were immobilized in a vertical position and the 
gavage needle was inserted into the esophagus and further toward the stomach to 
release the suspension of particles. After the exposure, mice returned to the cages and 
were closely monitored. 
Necropsy, blood sampling and tissues collection 
One, 28 and 180 days following administration of NPs mice were sedated by the 
Hypnorm/Dormicum mixture (0.5 – 0.7 ml/100g body weight) followed by the 
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exsanguination by withdrawing the heart blood. Prior the sedation, approximately 
100 µl of blood was taken from the facial vein by a quick incision, without anesthesia, 
and collected in EDTA covered tubes for further hematology analysis. Fresh blood 
samples were rotated for approximately 20 min using a rotating device prior to the 
measurement on the abcTM Animal Blood Counter instrument (Horiba Abx Scil Abc Vet 
Animal Blood Counter) to equally distribute EDTA powder. Hematological parameters 
measured in this study included: white blood cells (WBC), red blood cells (RBC), 
hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean cell 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and platelets 
(PLT). The rest of the heart blood was collected in heparin covered tubes and 
centrifuged for 10 min, at 4 °C, at 2500g. Plasma was transferred into a new tube and 
stored at -80 °C until used. Abdomen and thorax of mice were opened and macroscopic 
examination of all organs was performed. All observed abnormalities were noted in the 
necropsy report. Liver weights were registered. The lungs from three mice from each 
group (except for the vehicle control group - 1 day and 28 days after oral exposure 
where lungs from four animals were taken) were fixed in situ, by cannulating the trachea 
and delivering 4% neutral buffered formaldehyde solution via the cannula at a constant 
fluid pressure of 25 cm before the thorax was opened. Thereafter, the lungs were 
excised and immersed in 4% neutral buffered formaldehyde solution until further 
processing. Livers from all animals from all groups were excised and specimens were 
fixed in 4% neutral buffered formaldehyde solution. The tissue samples were then 
embedded in paraffin, sectioned in 4–6 µm slices and stained with hematoxylin and 
eosin (H&E staining) for histological examination. 
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Liver enzyme activities 
ALT, ALP and AST enzyme activities in plasma collected from IT, IV or PO administered 
mice were determined on Pentra 400 (Horiba ABX, Montpellier, France) using 
commercially available kits (Horiba ABX Medical, Montpellier, France; catalogue no. 
A11A01627, A11A01626 and A11A01629, respectively). Samples from each exposure 
group were run in the same batch in a random order to decrease variation and a control 
sample was included for every 15th sample.  
Enhanced darkfield microscopy 
Cytoviva enhanced darkfield hyperspectral system (Auburn, AL, USA) was used to detect 
particles in the liver tissue, by scanning histological sections at 40 x in enhanced 
darkfield mode. Darkfield images were acquired at 40x and brightfield images were 
acquired at 40x and 100x on an Olympus BX 43 microscope with a Qimaging 
Retiga4000R camera. Uneven illumination in brightfield images was corrected using 
ImageJ [32] and the Calculator Plus plugin via the formula: Corrected_image = (image / 
background) * 255. The background image was a maximum projection of 3 background 
brightfield images without tissue. 
Statistical analysis 
All presented values are expressed as mean ± standard deviation (SD) unless stated 
differently. One-way or two-way analysis of variance (ANOVA) was used to analyze the 
data sets. In order to fulfil the normality and variance homogeneity criteria some 
variables were logarithmically transformed whereas some were ranked before applying 
nonparametric one-way or two-way ANOVA analysis. If the statistical significance was 
reached in the ANOVA analysis, Tukey post-hoc multiple comparison test was used to 
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test the differences between the test groups. P-value < 0.05 was considered significant. 
All statistical analyses were calculated using SAS 9.4 statistical software (SAS Institute 
Inc., Cary, NC, USA). The data on the incidence of histological changes in the liver were 
analyzed by Fisher’s exact test (the software package Graph Pad Prism 7.02, Graph Pad 
Software Inc., La Jolla, CA, USA). 
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RESULTS 
DLS  
Dynamic light scattering (DLS) was used to evaluate size distribution profile of TiO2, 
CeO2 and CB NPs suspensions used for animal exposure. The measurement revealed a 
narrow, unimodal peak of hydrodynamic number-based size distribution with the 
average diameter below 100 nm for all the analyzed suspensions (Fig. 1). Median 
particle diameters measured for TiO2, CeO2 and CB NPs were 68 nm, 68 nm and 51 nm, 
respectively. Z-average and polydispersity index determined for TiO2, CeO2 and CB NPs 
were 127.3 and 0.162, 146.6 and 0.173, 188.2 and 0.261, respectively. 
 
Figure 1. Dynamic light scattering number-based size distribution of TiO2, CeO2 and CB NP 
suspensions. 
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General appearance and mortality of mice used in the study 
Throughout the experiment mice were closely monitored to ensure well-being of the 
animals. None of the mice showed any signs of pain, injury or abnormalities in their 
clinical appearance during the up to 6 months post-exposure period. However, among 
324 mice used in the experiment, 4 unexpected deaths were reported. These were one 
mouse from the PO 6 months CeO2 group, one mouse from IV 28 days control group, one 
mouse was from IV 6 months TiO2 group, one mouse from IT 6 months CB group. The 
causes of death were not established at the necropsy and the mice were excluded from 
the experiment. 
Body and liver weight 
In order to assess toxicity induced by exposure to NPs body weights and liver weights 
were recorded on the termination days. There were no alterations of body weight at any 
of the analyzed time points compared to the vehicle control groups (data not shown). IT, 
IV and PO administration of CeO2 and CB NPs had no significant effects on mice liver 
weight compared to the vehicle control. PO treatment induced statistically significant 
decrease in liver weight 28 days following exposure to TiO2 NPs when compared to the 
vehicle control group (P < 0.05), to the CeO2 group (P < 0.05) and to the CB group  
(P < 0.01). Relative liver weight (g/100g body weight) was statistically significantly 
decreased 180 days following PO exposure to TiO2 when compared to the vehicle 
control group (P < 0.05) and to the CeO2 group (P < 0.05). IT and IV exposure did not 
alter liver weight following exposure to TiO2 NPs at any time point (data not shown).  
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Hematology 
The following hematological markers were analyzed: white blood cells (WBC), red blood 
cells (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration 
(MCHC) and platelets (PLT) (Table 2). One day post-exposure IT administration of CB 
NPs significantly decreased MCHC level compared to the vehicle control group (P < 
0.05). PLT level was statistically significantly decreased 1 day after IV administration of 
TiO2 NPs compared to the vehicle control group (P < 0.001) and in TiO2 vs CeO2 group  
(P < 0.01). 28 days post-exposure in IT exposed mice alterations in MCV, MCH, MCHC 
and HGB levels were measured. MCV level was significantly increased in TiO2 group 
compared to the vehicle control (P < 0.05). MCH level was decreased in TiO2 group 
compared to the vehicle control (P < 0.05) as well as in CeO2 group compared to the 
vehicle control (P < 0.001) and in CeO2 vs CB group (P < 0.05). Exposure to CeO2 
significantly decreased MCHC level when compared to the vehicle control group (P < 
0.01). HGB was significantly decreased in CeO2 and CB groups compared to the vehicle 
control (P < 0.05). 180 days after intratracheal exposure MCV, MCH and MCHC levels 
were altered. MCV was significantly decreased in CB group compared to the vehicle 
control group (P < 0.05). MCH level was significantly decreased in TiO2 group and CB 
compared to the vehicle control group (P < 0.05 and P < 0.01, respectively). Similar 
alterations were measured for MCHC level where significant decrease was detected in 
TiO2 and CB group compared to the vehicle control group (P < 0.05 and P < 0.01, 
respectively). Intravenous exposure to TiO2 NPs caused significant decrease in MCHC 
level when compared to the vehicle control group (P < 0.05). In orally gavaged animals 
180 days post-exposure significant changes were detected in MCH and MCHC. Level of 
MCH was significantly decreased in TiO2, CeO2 and CB groups compared to the vehicle 
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control (P < 0.01, P < 0.01 and P < 0.001, respectively). MCHC was significantly 
decreased in CeO2 and CB exposed groups compared to the vehicle control (P < 0.001 
and P < 0.0001, respectively) as well as in CB vs TiO2 group (P < 0.01) (Table 2). 
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Table 2. Hematology results from mice exposed by intratracheal instillation, intravenous injection and oral gavage to 162 μg of TiO2, 
CeO2 or CB NPs 
 
IT 1 day IT 28 days IT 6 months 
 
Control TiO2 CeO2 CB Control TiO2 CeO2 CB control TiO2 CeO2 CB 
  mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD 
WBC 37 ± 1.2 3.8 ± 1.3 4.7 ± 1.3 3.6 ± 0.8 5.7 ± 1.0 5.4 ± 1.4 5.4 ± 1.9 5.5 ± 1.5 5.4 ± 2.5 4.4 ± 1.1 5.1 ± 1.9 6.4 ± 2.2 
RBC 10.7 ± 0.5 10.3 ± 1.5 9.9 ± 1.9 10.9 ± 0.2 10.5 ± 0.4 10.3 ± 0.3 9.5 ± 2.5 10.6 ± 0.4 10.2 ± 0.4 10.5 ± 0.5 10.2 ± 0.4 10.3 ± 0.3 
HGB 16.3 ± 0.6 15.6 ± 2.1 14.9 ± 2.8 16.2 ± 0.3 15.6 ± 0.6 15.3 ± 0.4 14.0 ± 3.5* 15.5 ± 0.4* 15.5 ± 0.7 15.4 ± 0.6 14.9 ± 0.4 15.0 ± 0.3 
HCT 51.9 ± 2.0 49.4 ± 7.2 47.5 ± 9.2 52.0 ± 1.1 49.7 ± 1.7 48.9 ± 1.1 45.2 ± 12.2 50.2 ± 1.5 47.5 ± 2.2 47.9 ± 2.4 46.8 ± 1.6 47.4 ± 1.4 
MCV 48.4 ± 0.5 48.0 ± 0.5 48.1 ± 0.6 47.9 ± 0.6 47.6 ± 0.5 47.7 ± 0.9* 47.2 ± 0.7 47.3 ± 0.7 46.7 ± 0.9 45.8 ± 0.4 46.2 ± 1.0 46.1 ± 0.4* 
MCH 15.2 ± 0.2 15.2 ± 0.3 15.0 ± 0.2 14.9 ± 0.3 15.0 ± 0.2 14.9 ± 0.3* 14.8 ± 0.6***† 14.6 ± 0.2 15.2 ± 0.4 14.7 ± 0.3* 14.7 ± 0.3 14.6 ± 0.2** 
MCHC 31.3 ± 0.3 31.6 ± 0.4 31.4 ± 0.3 31.1 ± 0.5* 31.5 ± 0.5 31.2 ± 0.4 31.3 ± 1.4** 31.9 ± 3.5 32.6 ± 0.2 32.2. ± 0.5* 31.9 ± 0.3 31.6 ± 0.3* 
PLT 713.8 ± 163.4  655.8 ± 177.1 686.6 ± 133.3 750.1 ± 62.6 742.8 ± 82.2 717.8 ± 80.1 687.6 ± 114.3 685.3 ± 92.7 755.7 ± 92.9 771.0 ± 197.5 814.6 ± 133.4 856.0 ± 212.6 
 
IV 1 day IV 28 days IV 6 months 
 
Control TiO2 CeO2 CB Control TiO2 CeO2 CB control TiO2 CeO2 CB 
  mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD 
WBC 4.2 ± 1.4 4.5 ± 1.4 4.2 ± 1.1 3.6 ± 1.2 5.8 ± 1.6 5.2 ± 1.8 4.6 ± 1.5 4.8 ± 0.9 6.6 ± 3.0 4.5 ± 1.8 4.6 ± 1.7 4.3 ± 1.5 
RBC 10.1 ± 1.5 10.5 ± 0.4 10.3 ± 0.7 10.4 ± 0.7 10.3 ± 0.5 9.9 ± 1.3 10.4 ± 0.3 10.2 ± 0.4 10.5 ± 0.6 10.9 ± 0.4 10.1 ± 0.5 10.2 ± 0.4 
HGB 15.6 ± 2.2 16.0 ± 0.6 15.8 ± 0.8 15.9 ± 1.0 15.6 ± 0.8 14.8 ± 1.7 15.5 ± 0.3 15.3 ± 0.6 15.6 ± 0.5 15.6 ± 0.5 14.9 ± 0.7 15.1 ± 0.5 
HCT 48.5 ± 7.4 50.6 ± 2.1 49.5 ± 3.6 49.9 ± 3.2 49.0 ± 2.4 47.5 ± 6.2 49.5 ± 1.1 48.4 ± 2.1 48.6 ± 2.0 49.7 ± 1.5 46.8 ± 2.4 47.5 ± 1.4 
MCV 48.0 ± 0.9 48.0 ± 0.5 48.0 ± 0.0 48.1 ± 0.6 47.9 ± 0.4 47.8 ± 0.7 47.8 ± 0.4 47.7 ± 0.7 46.3 ± 0.7 45.8 ± 0.7 46.2 ± 0.7 46.3 ± 1.1 
MCH 15.5 ± 0.2 15.2 ± 0.1 15.3 ± 0.5 15.4 ± 0.2 15.2 ± 0.2 14.9 ± 0.5 15.0 ± 0.3 15.0 ± 0.3 14.8 ± 0.4 14.4 ± 0.4 14.7 ± 0.4 14.8 ± 0.5 
MCHC 32.3 ± 0.6 31.6 ± 0.4 32.1 ± 1.2 31.9 ± 0.2 31.8 ± 0.4 31.3 ± 0.9 31.3 ± 0.4 31.5 ± 0.4 32.0 ± 0.4 31.4 ± 0.4* 31.8 ± 0.6 31.9 ± 0.2 
PLT 827.8 ± 50.4 482.8 ± 222.8***‡‡ 795.9 ± 46.2 686.0 ± 217.9 676.4 ± 80.7 673.2 ± 197.2 714.1 ± 48.1 765.1 ± 42.3 794.7 ± 143.9 742.9 ± 240.1 892.3 ± 156.0 807.6 ± 120.4 
 
PO 1 day PO 28 days PO 6 months 
 
Control TiO2 CeO2 CB Control TiO2 CeO2 CB control TiO2 CeO2 CB 
  mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD 
WBC 4.5 ± 1.5 4.5 ± 0.8 4.3 ± 1.2 4.1 ± 0.9 4.3 ± 1.2 5.3 ± 2.1 3.2 ± 1.6 5.8 ± 1.3 4.5 ± 1.3 5.4 ± 2.1 4.3 ± 0.7 5.0 ± 0.9 
RBC 10.4 ± 0.3 10.4 ± 0.9 10.7 ± 0.5 10.7 ± 0.4 10.4 ± 0.3 10.2 ± 1.6 10.1 ± 1.3 10.1 ± 0.6 10.4 ± 0.4 10.9 ± 0.4 10.7 ± 0.3 10.5 ± 0.5 
HGB 15.8 ± 0.6 15.5 ± 1.3 15.9 ± 0.5 15.9 ± 0.6 15.6 ± 0.3 14.8 ± 2.2 14.4 ± 1.8 14.9 ± 0.7 14.9 ± 0.6 15.1 ± 0.7 15.0 ± 0.5 14.5 ± 0.7 
HCT 50.3 ± 1.6 50.0 ± 4.5 51.2 ± 1.9 51.4 ± 1.9 49.3 ± 1.3 48.2 ± 7.7 47.8 ± 6.2 48.1 ± 2.7 47.8 ± 1.8 49.5 ± 2.1 48.8 ± 1.4 47.6 ± 2.4 
MCV 48.2 ± 0.7 48.2 ± 0.4 48.0 ± 0.5 48.1 ± 0.6 47.6 ± 0.5 47.0 ± 0.0 47.3 ± 0.5 47.8 ± 0.4 46.0 ± 0.5 45.4 ± 0.5 45.5 ± 0.5 45.3 ± 0.5 
MCH 15.2 ± 0.3 15.0 ± 0.2 14.9 ± 0.4 14.9 ± 0.1 15.0 ± 0.3 14.5 ± 0.3 14.3 ± 0.5 14.8 ± 0.2 14.3 ± 0.3 13.9 ± 0.3** 14.0 ± 0.2** 13.8 ± 0.3*** 
MCHC 31.5 ± 0.3 31.1 ± 0.4 31.1. ± 0.5 31.0 ± 0.3 31.6 ± 0.5 30.9 ± 0.6 30.2 ± 1.1 31.0 ± 0.5 31.2 ± 0.3 30.6 ± 0.5 30.7 ± 0.3*** 30.5 ± 0.4****## 
PLT 746.2 ± 129.7 723.0 ± 157.7 750.6 ± 96.8 771.0 ± 36.6 701.0 ± 138.0 705.7 ± 140.6 649.0 ± 179.6 624.8 ± 142.3 839.0 ± 195.5 963.0 ± 140.3 719.6 ± 248.0 832.8 ± 64.4 
WBC - white blood cells (x103/μl), RBC – red blood cells (x106/ μl), HGB – hemoglobin (g/dl), HCT – hematocrit (%), MCV – mean corpuscular volume (fL), MCH – mean corpuscular hemoglobin (pG), MCHC 
– mean corpuscular hemoglobin concentration (%), PLT – platelets (x103/μl), IT – intratracheal instillation, IV – intravenous injection, PO – oral gavage;  
Particle exposed groups n=9, vehicle control n=9. All values are presented as mean ± SD. Asterisk (*) denotes P ≤ 0.05, (**) denote P ≤ 0.01, (***) P ≤ 0.001, (****) P ≤ 0.0001 of blood marker level in exposed 
group versus vehicle control. Hashtags (##) denote P ≤ 0.01 of blood marker level in CB group compared to TiO2 group. Cross (†) denotes P ≤ 0.05 of blood marker level in CeO2 group compared to CB group. 
Double crosses (‡‡) denote P ≤ 0.01 of blood marker level in TiO2 group compared to CeO2 group. 
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Plasma liver enzyme activities 
Alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine 
transaminase (ALT) activities were measured in plasma 28 days post-exposure in order 
to assess NP-induced hepatotoxic effects on liver function. There were no significant 
changes in any of the analyzed liver enzyme activities (Table 3). 
Table 3. Alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine 
transaminase (ALT) enzyme activities in plasma following intratracheal instillation, 
intravenous injection and oral gavage to 162 μg of TiO2, CeO2 or CB NPs measured 28 
days post-exposure 
Liver enzymes activity 28 days following IT exposure 
 
ALP AST ALT 
 
mean ± SD mean ± SD mean ± SD 
Control 119 ± 17 185 ± 141 35 ± 8 
TiO2 138 ± 16 132 ± 78 38 ± 3 
CeO2 113 ± 13 293 ± 179 41 ± 9 
CB 133 ± 19 329 ± 366 47 ± 13 
Liver enzymes activity 28 days following IV exposure 
 
ALP AST ALT 
 
mean ± SD mean ± SD mean ± SD 
Control 125 ± 17 151 ± 85 39 ± 5 
TiO2 121 ± 13 91 ± 20 34 ± 7 
CeO2 119 ± 13 136 ± 25 39 ± 8 
CB 128 ± 14 120 ± 56 38 ± 8 
Liver enzymes activity 28 days following PO exposure 
 
ALP AST ALT 
 
mean ± SD mean ± SD mean ± SD 
Control 136 ± 17 109 ± 48 42 ± 8 
TiO2 145 ± 22 94 ± 26 43 ± 7 
CeO2 133 ± 17 180 ± 131 51 ± 20 
CB 123 ± 12 156 ± 205 40 ± 18 
Alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine transaminase (ALT), intratracheal 
instillation (IT), intravenous injection (IV), oral gavage (PO) 
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Particle detection in lung and liver by enhanced darkfield microscopy 
Particle presence was assessed at day 1 and day 180 in lung after IT exposure (Fig. 2) 
and in liver after IT and IV exposure (Fig. 3), using enhanced darkfield microscopy. 
In lungs 24 hours after IT of TiO2 and CeO2, aggregates of foreign material were 
observed mainly in the alveolar region, either phagocytized by macrophages or free in 
alveolar lumen or at alveolar walls (Fig. 2C and E). 180 days after IT, the foreign material 
was additionally found accumulated in laden macrophages (Fig. 2D and F) and 
occasionally near blood vessels. 
Aggregates in the liver 24h after IV were dispersed across whole tissue sections (Fig. 3D 
and H), mainly in sinusoids and often close to Kupffer cells (inserts in Fig. 3D and H). 
180 days after IT, particles were partly accumulated in fewer and larger aggregates in 
parenchyma (Fig. 3E and I) and occasionally near blood vessels.  
Foreign material was also present in some but not all infiltrations of inflammatory cells 
in lung after IT exposure (Fig. 2D and F) and in liver after IV exposure at day 1 and 180. 
Foreign material aggregates were seen in liver 180 days after IT exposure (Fig. 3F and J). 
These aggregates were smaller and much less frequent than aggregates detected in the 
liver 180 days after IV exposure. The aggregates were predominantly found in sinusoids 
and often appeared to be phagocytized by Kupffer cells. 
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Figure 2. Lung tissue 1 and 180 days after IT exposure to vehicle control (A-B), TiO2 (C-D) and CeO2 (E-F) 
NPs. C and E: Using enhanced darkfield microscopy, light scattering aggregates of foreign material (white) 
were observed in the alveolar region 1 day after exposure. D and F: 180 days after exposure, aggregates 
were additionally accumulated in laden macrophages and occasionally at blood vessels and in 
inflammatory cell infiltrates. Scale bar in A applies to all images. 
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Figure 3. Liver tissue 1 and 180 days after IV and IT exposure to vehicle control (A-C), TiO2 (D-F) and 
CeO2 (H-J) NPs. D and H: Aggregates of foreign material (white) were dispersed across liver sections 1 day 
after IV exposure and often appeared phagocytized by Kupffer cells (inserts in D and H). E and I: 180 days 
after IV exposure, material was partly accumulated in larger aggregates in liver parenchyma. F and J: 
Aggregates seen 180 days after IT were small and much less frequent (arrowheads). Scale bar in A applies 
to all images. 
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Liver and lungs histopathology  
The histopathological evaluations of lungs and livers from mice exposed by IT, IV and PO  
to a single dose of 162 µg of TiO2, CeO2 or CB NPs are summarized in Tables 4 and 5. 
 
The microscopic changes observed in the lungs after IT and IV exposures indicated 
inflammation. One day after IT exposure, extravasation, oedema of connective tissue, 
inflammatory cell infiltration peribronchial and/or perivascular were recorded in all 
NPs treated groups and single macrophages or single laden macrophages in the surface 
of alveoli were recorded in the TiO2 and in CeO2 groups (Table 4). These changes were 
also observed 28 and 180 days after exposure. Aggregates of inflammatory cells 180 
days after exposure were both small and big in TiO2 group (Fig. 4C), big in CeO2 group 
(Fig. 4F), and relatively small in CB group (Fig. 4I) as compared to the two other treated 
groups. Small aggregates of macrophages were observed on day 28 in all NP exposed 
groups. Aggregates of macrophages appeared biggest in size after exposure to TiO2 (Fig. 
4B) on day 28 and were also observed 180 days after exposure.  
 
One day after IV exposure, extravasation was only recorded in the CB group (Table 4). 
Oedema of connective tissue between bronchioles and blood vessels was present in the 
vehicle control and NPs treated groups (Fig. 5A and B) and it was the most expressed in 
the CeO2 group as indicated by its presence in all examined animals (Table 4). 
Inflammatory cell infiltrations were recorded in the vehicle control and TiO2 groups. 
Single macrophages were seen in all groups but the laden with test material (as 
indicated by the larger and dark appearance) were only recorded in the CB group. In this 
group the agglomerated test material was present in the lumen of blood vessels (Fig. 5E) 
and in the alveolar lumen, which could indicate its migration to the alveolar space. 28 
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days after IV exposure oedema of connective tissue was still present in all groups. The 
oedema was also visible in the TiO2 and CB groups 180 days after IV exposure. Single 
macrophages were recorded in the control group on day 180, and in the TiO2 and CB 
groups on days 28 and 180.  
 
Other microscopic changes in lung recorded in groups exposed either by IT or IV were: 
(a) desquamation of bronchiole epithelium following IT exposure on day 28 in the 
vehicle control (1/3), following IV exposure on days 1 and 28 in the vehicle control (1/3 
at both time points) and in the TiO2 group (2/3 and 1/3 respectively); (b) hyperplasia of 
connective tissue (visible as single fibroblasts of supportive tissue surrounding 
bronchioles) after IV exposure on 1 day in the CeO2 (1/3) and CB (1/3) groups and on 
day 28 in the TiO2 group (1/3), and (c) emphysema after IV exposure in  CB group (1/3).  
 
The observed microscopic changes after PO exposure included: (a) small infiltration of 
inflammatory cells on day 1 in the CeO2 group and on day 180 in all NPs groups, (b) 
oedema of connective tissue on day 1 in the CeO2 group and on day 180 in the TiO2 and 
CB groups, and (c) single macrophages in the CeO2 group on day 180. 
 
Furthermore, congestion was seen in all groups regardless of exposure route and time 
and therefore it was not considered treatment related but as a consequence of 
insufficient exsanguination of the carcass. 
167 
 
 
 
Figure 4. Microscopic changes in the lungs of mice after intratracheal instillation (IT) with TiO2 (A-C), 
CeO2 (D-F) and CB (G-I) NPs 1, 28, or 180 days respectively. A-C: congestion (short arrows), single 
macrophages (arrows), big aggregates of macrophages (double arrows), inflammatory cell aggregate 
(short wide arrow); D-F: congestion (short arrows), single (arrows) and small aggregates (double arrows) 
of macrophages, perivascular inflammatory cell aggregate (short wide arrow); G-I: congestion (short 
arrows), oedema (asterisks), single macrophages (arrows), aggregate of inflammatory cells (short wide 
arrow), test material (circle). 
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Figure 5. Microscopic changes in the lungs of mice scarified at different times after intravenous (IV) or 
per oral (PO) exposures to the test nanomaterials or a vehicle. A-C: TiO2 1, 28 or 180 days after IV 
exposure respectively: congestion (short arrows), single macrophages (arrows), perivascular oedema 
(asterisks); D: CeO2 IV 180 days after exposure: perivascular small infiltration of inflammatory cells; E-F: 
CB 1 or 28 days after IV exposure: small congestion (short arrows), oedema (asterisks), single 
macrophages (arrows), test material (circle); G – TiO2 180 days after PO exposure, H - vehicle control 1 
day after PO and I – vehicle control 28 days after IV exposure: normal structure of the lungs with 
congestion (short arrows).    
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Table 4. Type and incidence of typical microscopic changes in the lungs of mice 1, 28 or 180 days after a single exposure to 162 µg of 
TiO2, CeO2 or CB NPs administered by intratracheal instillation, intravenous injection or oral gavage 
Change Intratracheal instillation  Intravenous injection  Oral gavage 
Control TiO2 CeO2 CB  Control TiO2 CeO2 CB  Control TiO2 CeO2 CB 
Inflammatory cell infiltration 
peribronchial and/or 
perivascular  
              
day 1 0/3 1/3 1/3 1/3  1/3 1/3 0/3 0/3  0/4 0/3 1/3 0/3 
day 28 1/3 1/3 1/3 1/3  0/3 0/3 0/3 1/3  0/4 0/3 0/3 0/3 
day 180 0/3 3/3 2/3 2/3  1/3 0/3 2/3 0/3  0/3 1/3 1/3 1/3 
 
Macrophages single  
              
day 1 0/3 3/3 1/3 0/3  1/3 1/3 1/3 0/3  0/4 0/3 0/3 0/3 
day 28 1/3 2/3 1/3 0/3  0/3 0/3 0/3 1/3  0/4 0/3 0/3 0/3 
day 180 0/3 2/3 2/3 0/3  1/3 1/3 0/3 0/3  1/3 0/3 1/3 0/3 
 
Macrophages single laden 
(with the test material) 
              
day 1 0/3 3/3 0/3 0/3  0/3 0/3 0/3 1/3  0/4 0/3 0/3 0/3 
day 28 0/3 3/3 3/3 3/3  0/3 1/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 180 0/3 1/3 1/3 3/3  0/3 1/3 0/3 1/3  0/3 0/3 0/3 0/3 
 
Macrophages (laden), 
aggregates smalla)  
              
day 1 0/3 0/3 0/3 0/3  0/3 0/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 28 0/3 3/3 1/3 1/3  0/3 0/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 180 0/3 0/3 0/3 1/3  0/3 0/3 0/3 0/3  0/3 0/3 0/3 0/3 
 
Macrophages (laden) 
aggregates bigb) 
              
day 1 0/3 1/3 0/3 0/3  0/3 0/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 28 0/3 1/3 0/3 0/3  0/3 0/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 180 0/3 1/3 0/3 0/3  0/3 0/3 0/3 0/3  0/3 0/3 0/3 0/3 
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Oedema of connective tissue 
peribronchial and/or 
perivascular 
              
day 1 0/3 2/3 3/3 1/3  1/3 2/3 3/3 2/3  0/4 0/3 1/3 0/3 
day 28 3/3 2/3 3/3 1/3  1/3 3/3 2/3 1/3  0/4 0/3 0/3 0/3 
day 180 0/3 3/3 1/3 2/3  0/3 1/3 0/3 1/3  0/3 1/3 0/3 1/3 
 
Congestion 
              
day 1 2/3 3/3 3/3 2/3  2/3 1/3 2/3 1/3  4/4 3/3 3/3 3/3 
day 28 3/3 3/3 3/3 3/3  3/3 3/3 3/3 3/3  4/4 3/3 3/3 3/3 
day 180 2/3 1/3 3/3 2/3  3/3 3/3 0/3 0/3  2/3 3/3 3/3 2/3 
 
Extravasation 
              
day 1 2/3 3/3 1/3 1/3  0/3 0/3 0/3 1/3  0/4 0/3 0/3 0/3 
day 28 0/3 1/3 0/3 0/3  0/3 0/3 0/3 0/3  0/4 0/3 0/3 0/3 
day 180 2/3 1/3 1/3 0/3  0/3 0/3 0/3 0/3  0/3 0/3 0/3 0/3 
a): 1-4 macrophages at one site close to each other; b): more than 5 macrophages at one site close to each other;
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The microscopic changes in the liver were of inflammatory, regressive, degenerative and 
circulatory types (Table 5 and Fig. 6 liver after IV). The recorded inflammatory changes 
were defined as foci small of inflammatory cells (FsIC: focal small infiltrates or 
aggregates consisting of mononuclear, polymorphonuclear and/or hystiocytic cells), 
which occasionally accompanied hepatocellular necrosis or as polymorphonuclear cell 
foci (PNCF: bigger in size focal infiltrates or aggregates of mono- and 
polymorphonuclear and/or hystiocytic cells surrounded by eosinophilic necrotic 
hepatocytes, with apopototic bodies/debris often present). In general, the incidence of 
inflammatory changes regardless of the route of exposure and the type of NPs used was 
high and comparable to the vehicle controls. Regressive changes comprised different 
types from slight, like presence of single hepatocytes with pyknotic nuclei, to advanced, 
like areas of necrosis.  
 
After IT exposure a statistically significantly increased incidence of regressive changes 
was recorded in the CeO2 group on day 28 for the presence of hepatocytes with pyknotic 
nuclei, on day 180 for the areas of hepatocytes with pyknotic nuclei and for microfoci of 
necrosis. Also areas of necrosis were seen on day 180 in all livers in the CeO2 group but 
the incidence was not statistically significantly increased compared to the vehicle 
controls. In the TiO2 group the only regressive change with a statistically significantly 
increased incidence was the presence of areas of hepatocytes with pyknotic nuclei. 
Other statistically significantly increased incidences after IT exposure when compared 
to the vehicle control group were recorded for increased number of binucleate 
hepatocytes on day 1 in the TiO2 group, and for vacuolar degeneration on day 28 in the 
CeO2 group. 
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Following IV exposure a statistically significantly increased incidence was recorded on 
day 1 for hypertrophy of Kupffer cells and of binucleate hepatocytes in the TiO2 and CB 
groups, and on day 28 for the presence of areas of hepatocytes with pyknotic nuclei in 
the CeO2 group. 
 
No noteworthy changes were observed following PO exposure. The only statistically 
increased incidence was recorded for areas of hepatocytes with pyknotic nuclei on day 
180 in the CB group. 
  
173 
 
Table 5. Type and incidence of microscopic changes in the livers of mice 1, 28 or 180 days after a single exposure to 162 µg of TiO2, CeO2 
and CB NPs administered by intratracheal instillation, intravenous injection or oral gavage 
Change Intratracheal instillation  Intravenous injection  Oral gavage 
Control TiO2 CeO2 CB  Control TiO2 CeO2 CB  Control TiO2 CeO2 CB 
Foci small of inflammatory cells               
day 1 5/8 3/9 8/9 9/9  8/9 9/9 9/9 9/9  6/9 7/9 5/9 5/9 
day 28 8/9 8/9 6/9 9/9  6/8 9/9 8/9 6/9  9/9 9/9 7/9 7/9 
day 180 7/9 8/9 679 5/8  5/9 6/8 4/9 3/9  7/9 6/9 8/9 8/8 
 
Polymorphonuclear cell foci 
              
day 1 3/8 5/9 3/9 2/9  9/9 6/9 8/9 4/9  3/9 2/9 5/9 3/9 
day 28 8/9 7/9 7/9 8/9  7/8 6/9 8/9 8/9  6/9 8/9 7/9 5/9 
day 180 8/9 5/9 8/9 4/8  6/9 1/8 4/9 2/9  6/9 6/9 9/9 5/8 
 
Hepatocytes with pyknotic nuclei (single) 
              
day 1 0/8 0/9 0/9 1/9  1/9 0/9 1/9 0/9  0/9 0/9 0/9 0/9 
day 28 0/9 1/9 5/9* 2/9  3/8 1/9 0/9 2/9  5/9 2/9 2/9 0/9 
day 180 1/9 0/9 0/9 1/8  1/9 3/8 5/9 2/9  2/9 1/9 1/9 0/8 
 
Hepatocytes with pyknotic nuclei (area of) 
              
day 1 0/8 0/9 1/9 0/9  3/9 7/9 1/9 4/9  0/9 0/9 0/9 0/9 
day 28 1/9 1/9 2/9 0/9  0/8 2/9 7/9** 2/9  0/9 0/9 0/9 0/9 
day 180 3/9 8/9* 8/9* 3/8  0/9 2/8 1/9 5/9  0/9 4/9 4/9 7/8*** 
 
Eosinophilic necrosis of hepatocytes 
              
day 1 3/8 4/9 5/9 4/9  8/9 9/9 8/9 8/9  3/9 2/9 3/9 3/9 
day 28 5/9 6/9 7/9 6/9  5/8 7/9 7/9 9/9  4/9 8/9 7/9 6/9 
day 180 
 
4/9 5/9 6/9 3/8  2/9 1/8 3/9 4/9  3/9 5/9 7/9 5/8 
Microfoci of necrosis in centrilobular (area of)               
day 1 1/8 3/9 1/9 2/9  7/9 4/9 5/9 7/9  0/9 0/9 0/9 3/9 
day 28 3/9 7/9 7/9 4/9  4/8 2/9 5/9 8/9  3/9 4/9 3/9 7/9 
day 180 1/9 5/9 7/9* 4/8  2/9 2/8 7/9 7/9  3/9 7/9 5/9 1/8 
 
Necrosis (area of) 
              
day 1 0/8 0/9 0/9 2/9  8/9 9/9 3/9 4/9  2/9 0/9 0/9 0/9 
day 28 3/9 4/9 6/9 2/9  1/8 1/9 6/9 4/9  0/9 0/9 0/9 0/9 
day 180 5/9 8/9 9/9 6/8  2/9 1/9 5/9 6/9  6/9 5/9 7/9 8/8 
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Hypertrophy of Kupffer cells 
day 1 0/8 0/9 0/9 0/9  3/9 9/9** 3/9 9/9**  0/9 1/9 1/9 0/9 
day 28 2/9 0/9 0/9 2/9  5/8 4/9 4/9 7/9  0/9 0/9 1/9 0/9 
day 180 1/9 0/9 1/9 1/8  0/9 1/8 0/9 2/9  0/9 0/9 2/9 0/8 
 
Hyperplasia (increased number) of Kupffer 
cells 
              
day 1 0/8 1/9 1/9 0/9  0/9 1/9 0/9 4/9  0/9 2/9 4/9 3/9 
day 28 1/9 1/9 1/9 2/9  2/8 0/9 6/9 1/9  0/9 0/9 0/9 0/9 
day 180 0/9 0/9 1/9 0/8  0/9 0/8 0/9 0/9  0/9 1/9 2/9 0/8 
 
Hyperplasia of bile duct epithelial cells 
              
day 1 0/8 0/9 0/9 0/9  9/9 7/9 0/9 6/9  0/9 0/9 0/9 0/9 
day 28 1/9 2/9 1/9 3/9  2/8 2/9 4/9 6/9  0/9 0/9 0/9 0/9 
day 180 3/9 1/9 3/9 0/8  0/9 1/8 0/9 0/9  1/9 1/9 0/9 1/8 
 
Hyperplasia of connective tissue near bile 
ductules or venules (fibrosis) 
              
day 1 0/8 0/9 0/9 0/9  2/9 7/9 1/9 0/9  0/9 0/9 0/9 2/9 
day 28 0/9 2/9 0/9 0/9  0/8 0/9 1/9 3/9  0/9 0/9 0/9 2/9 
day 180 0/9 0/9 2/9 1/8  1/9 1/8 1/9 0/9  1/9 3/9 2/9 0/8 
 
Increased number of binucleate hepatocytes 
              
day 1 0/8 6/9** 1/9 1/9  0/9 5/9* 3/9 5/9*  0/9 0/9 0/9 4/9 
day 28 0/9 4/9 2/9 4/9  1/8 2/9 0/9 0/9  0/9 0/9 0/9 1/9 
day 180 0/9 2/9 0/9 0/8  0/9 0/8 0/9 2/9  0/9 0/9 1/9 0/8 
 
Vacuolar (hydropic) degeneration of 
hepatocytes 
              
day 1 0/8 0/9 0/9 0/9  0/9 0/9 2/9 0/9  2/9 7/9 0/9 1/9 
day 28 2/9 4/9 8/9* 0/9  6/8 4/9 6/9 5/9  0/9 1/9 1/9 5/9 
day 180 2/9 7/9 3/9 6/8  5/9 0/8 4/9 6/9  5/9 3/9 4/9 7/8 
 
Sinusoid dilatation 
              
day 1 0/8 0/9 0/9 0/9  3/9 8/9 3/9 2/9  0/9 0/9 0/9 0/9 
day 28 1/9 0/9 2/9 0/9  0/8 0/9 0/9 0/9  0/9 2/9 1/9 0/9 
day 180 0/9 2/9 0/9 0/8  0/9 0/8 0/9 0/9  0/9 4/9 3/9 0/9 
 
Congestion 
              
day 1 0/8 0/9 0/9 0/9  1/9 5/9 1/9 4/9  0/9 0/9 1/9 0/9 
day 28 6/9 0/9 0/9 0/9  3/8 0/9 6/9 0/9  0/9 0/9 0/9 0/9 
day 180 0/9 1/9 1/9 0/8  0/9 2/8 0/9 1/9  5/9 7/9 6/9 2/8 
175 
 
 
Figure 6. Microscopic changes in the liver of mice 1, 28, or 180 days after single intravenous injection (IV) 
of a vehicle (A-C), TiO2 (D-F), CeO2 (G-I) or CB (J-L) NPs. A-C: FsIC (long arrows), eosinophilic necrosis 
(arrowheads), microfoci of necrosis (circles), binucleate hepatocytes (BH), vacuolar degeneration (white 
spaces in hepatocytes). D-F: FsIC (long arrows), microfoci of necrosis (circles), hypertrophy of Kupffer 
cells (tiny arrows), binucleate hepatocytes (BH), sinusoidal dilatations (SD), vacuolar degeneration (white 
spaces in hepatocytes). G-I: microfoci of necrosis (circles), eosinophilic necrosis (arrowheads), area of 
necrosis (asterisk), hypertrophy of Kupffer cells (tiny arrows), binucleate hepatocytes (BH), vacuolar 
degeneration (white spaces in hepatocytes), hyperplasia of Kupffer cells (thick arrow). J-L: eosinophilic 
necrosis (arrowheads), apoptotic body (AB), microfocus of necrosis (circle), hypertrophy of Kupffer cells 
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(tiny arrows), some of them with black foreign material, sinusoidal dilatation (white long spaces, SD), 
pyknosis of nuclei (P), black foreign material (FM). HE stain, scale bar in A applies to all images. 
  
Figure 7. Microscopic changes in the liver of mice 28 or 180 days after single intratracheal instillation (IT) 
of a vehicle (A-B), TiO2 (C-D), CeO2 (E-F) or CB (G-H) NPs. A-B: microfoci of necrosis (circles), hypertrophy 
of Kupffer cells (tiny arrows), binucleate hepatocytes (BH). C-D: PNCF (double arrows), eosinophilic 
necrosis (arrowheads), microfoci of necrosis (circles), pyknosis of nuclei (P), hyperplasia of Kupffer cells 
(thick arrow), binucleate hepatocytes (BH), vacuolar degeneration (white spaces in hepatocytes). E-F: 
PNCF (double arrows), eosinophilic necrosis (arrowheads), microfoci of necrosis (circles), area of necrosis 
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(asterisk), binucleate hepatocytes (BH), apoptotic body (AB). G-H: PNCF (double arrow), eosinophilic 
necrosis (arrowheads), microfoci of necrosis (circles), hypertrophy of Kupffer cells (tiny arrows), 
hyperplasia of Kupffer cells (thick arrows), pyknosis of nuclei (P), vacuolar degeneration (white spaces in 
hepatocytes). HE stain, scale bar in A applies to all images. 
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DISCUSSION 
In our recent study ICP-MS analysis demonstrated that lung-deposited TiO2 and CeO2 
underwent extrapulmonary translocation that resulted in increased hepatic Ti and Ce 
concentration. Moreover, CB NPs, that due to the high abundance of carbon in the 
ambient air as well as in the tissues are not feasible to be measured by the applied 
analytical technique, were also detected in the liver following intratracheal exposure as 
assessed by EDFM (Modrzynska et al. unpublished manuscript 1). In addition, we have 
shown that IT of all three NPs resulted in a long lasting pulmonary inflammation and 
acute phase response and that IV and IT administration of CB NPs induced primary 
genotoxicity in the liver 28 and 180 days post-exposure in terms of increased DNA 
strand break levels (Modrzynska et al., unpublished manuscript 2). Therefore, in the 
present work we wanted to determine possible systemic toxic effects of hepatic 
accumulation of NPs following IT, IV and PO exposure to TiO2, CeO2 and CB NPs. Thus, 
we investigated if administration of NPs is associated with alterations in morphological 
structure of the liver and if the exposure induced systemic toxicity expressed as changes 
in body and liver weight and in hematological and biochemical parameters.  
The three NPs studied in this work are produced in large quantities and are extensively 
used in high-volumes in many everyday-life areas. Thus, they are high-priority 
nanomaterials for the toxicological assessment. It has been demonstrated that inhalation 
and IT of CB NPs is associated with pulmonary inflammation [33] and induction of acute 
phase response [16]. Moreover, recent studies demonstrated genotoxic effects of CB NPs 
in the liver after pulmonary exposure [16,34]. TiO2 also exhibited ability to induce 
pulmonary toxicity [35], inflammation [36] and oxidative stress [37]. Pulmonary 
damage [38], oxidative stress [39] and genotoxicity [8] were also reported for CeO2 NPs. 
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The dose used in the present study is considered relevant for the occupational exposure 
and is equal to the pulmonary deposition after nine 8 h working days at the Danish 
occupational exposure limit of 3.5 mg/m3 for CB. 
Body and liver weight 
In the present study no alterations of body weight were measured after IT, IV and PO 
administration of TiO2, CeO2 and CB NPs when compared with the vehicle control 
groups. In addition, exposure to CeO2 and CB NPs had no impact on the absolute and 
relative liver weight. The decreases in the absolute and relative liver weights following 
oral exposure to TiO2 NPs in our study could be considered as spurious findings since 
the oral dose was low, absorption of TiO2 NPs from the gastrointestinal tract was shown 
to be low (49) and that previously conducted ICP-MS analysis demonstrated only 
background levels of Ti in the livers from orally treated mice compared to those exposed 
intravenously (Modrzynska et al. unpublished manuscript 1).  
Reduced body weight gain following vascular infusion of CeO2 NPs [40] has been 
previously reported however, relatively high dose, i.e. 85 mg/kg bw, was used in the 
study compared to 9 mg/kg bw administered in my study which could be responsible 
for the observed differences. Significant reduction of the liver weight was also 
demonstrated after intratracheal instillation of CeO2 NPs [20] and after intravenous 
injection of TiO2 NPs [41]. In the study conducted by Xu and colleagues [41] decrease in 
the relative liver weight could be explained by the extremely high doses, i.e. 300 and 645 
mg/kg bw, administered in the mentioned study. In the study conducted by Nalabotu 
and co-workers [20] differences in physicochemical properties between CeO2 NPs used 
in their and my study might be a reason for the divergent results.  
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Hematology 
The knowledge of the changes in basic blood parameters is essential to evaluate welfare 
of animals exposed to NPs and might be an indication of the toxicity induced by the test 
material. Therefore, in the present study several important hematology parameters i.e. 
WBC, RBC, HGB, HCT, MCV, MCH, MCHC and PLT were measured for the further 
assessment of NP-induced toxicity. Occasional differences in hematological parameters, 
i.e. HCT, MCV, MCH, MCHC following exposure to TiO2, CeO2 or CB NPs administered by 
all three routes of exposure were observed. Minor differences were also measured for 
PLT and HGB levels however, since no consistent pattern in the induced changes were 
found, we believe that these could be regarded as chance findings. Similarly, negligible 
alterations in the basic blood parameters were found after oral exposure to Ag NPs [42].  
Furthermore, Yang and co-workers [43] also demonstrated that there were no distinct 
changes in any of the assessed hematological parameters following intravenous 
administration of Ag and Au NPs in mice.  
Liver enzyme activities 
Biochemical analysis of plasma revealed no significant changes in any of the analyzed 
liver enzymes activities. Lack of changes in the clinical biochemistry was also reported 
after oral exposure to Ag NPs [42]. On the contrary, a study conducted by Nalabotu and 
co-workers [20] showed that intratracheal administration of CeO2 NPs (7 mg/kg) was 
associated with hepatic toxicity in terms of decreased liver weight, elevated serum 
alanine transaminase levels and histopathological alterations in the liver tissue. Similar 
results were reported by Chen and colleagues [44] who demonstrated elevation in ALT 
and AST levels following intraperitoneal injection of different TiO2 NPs doses (i.e. 324, 
648, 972, 1296, 1944 or 2592 mg/kg). They also reported hepatocellular necrosis, 
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apoptosis and hepatic fibrosis in the high-dose groups. Therefore, these incoherence 
could be explained by the higher dose used in the mentioned studies or by differences in 
physicochemical properties exhibited by the TiO2 and CeO2 NPs used in our and their 
studies.  
Lung and liver histology 
The observed inflammatory changes in the lung tissue were in accordance with previous 
reports that the air borne exposure to particulate material causes pneumonia [45] and 
indicates that the blood circulatory supply of nanomaterials could also cause transitory 
inflammation in pulmonary tissue [46]. We have also previously reported similar 
inflammatory changes in the lungs [24,47,48]. 
Hyperplasia of connective tissue recorded one day after IV exposure in 1 animal from 
the CeO2 and CB groups and on day 28 in TiO2 group was considered as an incidental 
finding, not related to the treatment. The inflammatory cell infiltrations, oedema of 
connective tissue as well as single macrophages recorded after PO exposure were 
considered as not treatment related considering that the absorption of Ti after oral 
exposure to TiO2 was reported  to be  very low [7,49]. Furthermore, pulmonary 
macrophages in the surface of alveoli or in the interstitium and small numbers of 
migratory cells including monocytes and lymphocytes can  physiologically be present in 
the lung tissue [50]. 
In the present study the incidences of inflammatory changes in the liver were high in all 
vehicle and the NPs exposed groups regardless of the route of administration. Solitary or 
multiple inflammatory changes in the liver may result from toxicant insult, infections 
with viruses and bacteria but they also belong to common incidental findings in the liver 
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of aging mice and sometimes accompany hepatocellular necrosis [50,51]. The high 
background of inflammatory liver changes (of unclear etiology) in the vehicle controls in 
the present study made it impossible to determine whether these changes in the NPs 
exposed mice could be treatment-related.  However, inflammatory changes in the liver 
were previously reported after IT exposure to Nano-TiO2 and Printex 90 (carbon black) 
[52]. Furthermore, the ICP-MS analysis demonstrated the presence of Ti and Ce in the 
liver tissues in the exposed mice (Modrzynska et al., unpublished manuscript 1). 
Additionally, aggregates of foreign material originating from exposure to TiO2 and CeO2 
were detected by the enhanced darkfield microscopy and black foreign material was 
seen in the liver tissue in the brightfield set-ups.  
Similarly, it was not possible to determine whether necrosis in the NPs exposed mice 
could be treatment related. Hepatocellular necrosis is another non-specific entity 
commonly encountered as a focal incidental finding in the liver of aging mice, the typical 
morphological feature of which is coagulation necrosis of hepatocytes with distinct 
eosinophilic cytoplasm and pyknotic or absent nuclei. The etiology of spontaneous 
necrosis is usually unknown, but it may be caused by ischemia, toxicants and infection 
with viruses or bacteria [50]. The incidence of necrosis in the present study increased 
with age in all IT exposed groups but it was not statistically significantly higher in the 
TiO2, CeO2 and CB groups compared to the vehicle control group (89%, 100%, 75% vs 
56%, respectively). No clear relation to age was seen for the incidences of necrosis in IV 
vehicle control and NPs exposed groups, and incidences though appeared higher than in 
the respective age controls were not statistically significantly increased after IV 
exposure. Thus necrosis could not be uniquely associated with the treatment in the 
present study although necrotic changes were previously reported in mice after IT 
exposure [24,47]. On the other hand the increase with age in the incidence of necrosis in 
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all PO treated groups suggested lack of treatment dependency.  The latter seems to be in 
accordance with the lack of detection of Ti and Ce in the liver after oral exposure by ICP-
MS quantification and darkfield microscopy (Modrzynska et al., unpublished manuscript 
1)  and  in accordance with negligible absorption of nanoparticulate TiO2 [7,49]. 
Binucleate hepatocytes are common finding in the mouse liver and are often noted in 
aging mice [50]. In the present study binucleate hepatocytes were often seen in all 
vehicle controls and all NPs exposed groups. However, a significant increase relative to 
the background level in vehicle controls on day 1 after IT exposure in TiO2 group and 
after IV exposure in TiO2 and CB groups could indicate hepatocytic regeneration 
typically seen after a toxic insult [53]. Similar increase in binucleate hepatocytes have 
previously been reported following NPs exposure [24,47,52]. 
The significantly increased incidence of hypertrophy of Kupffer cells observed after IV 
exposure in the present study could be related to the phagocytosis of material 
originating from the exposure to NPs, as shown by microscopy, as well as their function 
in the liver as secretion of inflammatory mediators [50].  
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Conclusions 
NPs can enter the human body by several exposure routes and are further distributed to 
the other parts of the body by systemic circulation. Among other secondary organs liver 
seems to be the primary site for NPs accumulation. Therefore, concerns regarding 
potential adverse hepatotoxic effects have arisen.  
Data from the present study suggest that a single dose of TiO2, CeO2 or CB NPs  
administered either by intratracheal instillation, intravenous injection or by oral gavage  
did not induced systemic toxicity in the mice since no consistent alterations in body or 
liver weight, biochemical or hematological parameters were observed. However, due to 
the high incidences of inflammatory and necrotic changes in the liver of mice from the 
vehicle control groups it was not possible to unambiguously determined whether the 
observed changes in the liver morphology were induced by NPs exposure. 
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